Document and Entity Information
Document and Entity Information | 3 Months Ended |
Sep. 30, 2020 | |
Document and Entity Information [Abstract] | |
Entity Registrant Name | SUNHYDROGEN, INC. |
Entity Central Index Key | 0001481028 |
Amendment Flag | false |
Document Type | S-1 |
Entity Filer Category | Non-accelerated Filer |
Entity Small Business | true |
Entity Emerging Growth Company | false |
Entity Incorporation State Country Code | NV |
Balance Sheets
Balance Sheets - USD ($) | Sep. 30, 2020 | Jun. 30, 2020 | Jun. 30, 2019 |
CURRENT ASSETS | |||
Cash | $ 500,644 | $ 195,010 | $ 35,074 |
Prepaid expenses | 12,545 | 9,378 | 15,000 |
TOTAL CURRENT ASSETS | 513,189 | 204,388 | 50,074 |
PROPERTY & EQUIPMENT | |||
Computers and peripherals | 2,663 | 2,663 | 1,883 |
Vehicle | 50,000 | ||
GROSS PROPERTY AND EQUIPMENT | 52,663 | 2,663 | |
Less: accumulated depreciation | (1,883) | (1,605) | (837) |
NET PROPERTY AND EQUIPMENT | 50,780 | 1,058 | 1,046 |
OTHER ASSETS | |||
Domain, net of amortization of $4,311 and $4,223, respectively | 1,004 | 1,092 | 1,447 |
Trademark, net of amortization of $401 and $371, respectively | 742 | 772 | 886 |
Patents, net of amortization of $18,291 and $16,250, respectively | 82,852 | 84,492 | 97,100 |
TOTAL OTHER ASSETS | 84,598 | 86,356 | 99,433 |
TOTAL ASSETS | 648,567 | 291,802 | 150,553 |
CURRENT LIABILITIES | |||
Accounts payable and other payable | 124,728 | 201,243 | 125,085 |
Accrued expenses | 223,358 | 211,496 | 176,790 |
Accrued interest on convertible notes | 1,586,950 | 432,866 | 415,537 |
Derivative liability | 61,037,804 | 59,657,719 | 3,905,721 |
Convertible promissory notes, net of debt discount of $210,050 and $409,074, respectively | 126,950 | 160,926 | 256,103 |
TOTAL CURRENT LIABILITIES | 61,969,704 | 60,664,250 | 4,879,236 |
LONG TERM LIABILITIES | |||
Convertible promissory notes, net of debt discount of $0 and $0, respectively | 1,460,000 | 1,460,000 | 1,782,600 |
TOTAL LONG TERM LIABILITIES | 1,460,000 | 1,460,000 | 1,782,600 |
TOTAL LIABILITIES | 63,429,704 | 62,124,250 | 6,661,836 |
COMMIMENTS AND CONTINGENCIES (SEE NOTE 8) | |||
SHAREHOLDERS' DEFICIT | |||
Preferred Stock, $0.001 par value; 5,000,000 authorized preferred shares, no shares issued or outstanding | |||
Common Stock, $0.001 par value; 5,000,000,000 shares authorized, 2,171,705,242 and 2,053,410,161 shares issued and outstanding, respectively | 2,171,705 | 2,053,410 | 1,077,319 |
Additional Paid in Capital | 12,803,933 | 11,664,657 | 10,432,575 |
Accumulated deficit | (77,756,775) | (75,550,515) | (18,021,177) |
TOTAL SHAREHOLDERS' DEFICIT | (62,781,137) | (61,832,448) | (6,511,283) |
TOTAL LIABILITIES AND SHAREHOLDERS' DEFICIT | $ 648,567 | $ 291,802 | $ 150,553 |
Balance Sheets (Parenthetical)
Balance Sheets (Parenthetical) - USD ($) | Sep. 30, 2020 | Jun. 30, 2020 | Jun. 30, 2019 |
Statement of Financial Position [Abstract] | |||
Amortization of domain | $ 4,311 | $ 4,223 | $ 3,868 |
Amortization of trademark | 401 | 371 | 257 |
Amortization of patents | 18,291 | 16,650 | 10,391 |
Convertible promissory notes, net of debt discount for current liabilities | 210,050 | 409,074 | 281,783 |
Convertible promissory notes, net of debt discount for long term liabilities | $ 0 | $ 0 | $ 0 |
Preferred stock, par value | $ 0.001 | $ 0.001 | $ 0.001 |
Preferred stock, shares authorized | 5,000,000 | 5,000,000 | 5,000,000 |
Preferred stock, shares issued | |||
Preferred stock, shares outstanding | |||
Common stock, par value | $ 0.001 | $ 0.001 | $ 0.001 |
Common stock, shares authorized | 5,000,000,000 | 5,000,000,000 | 5,000,000,000 |
Common stock, shares issued | 2,171,705,242 | 2,053,410,161 | 1,077,319,339 |
Common stock, shares outstanding | 2,171,705,242 | 2,053,410,161 | 1,077,319,339 |
Statements of Operations
Statements of Operations - USD ($) | 3 Months Ended | 12 Months Ended | ||
Sep. 30, 2020 | Sep. 30, 2019 | Jun. 30, 2020 | Jun. 30, 2019 | |
Income Statement [Abstract] | ||||
REVENUE | ||||
OPERATING EXPENSES | ||||
General and administrative expenses | 438,190 | 370,316 | 1,057,287 | 1,292,662 |
Research and development cost | 138,260 | 143,395 | 615,721 | 528,901 |
Depreciation and amortization | 2,036 | 2,209 | 8,419 | 6,988 |
TOTAL OPERATING EXPENSES | 578,486 | 515,920 | 1,681,427 | 1,828,551 |
LOSS FROM OPERATIONS BEFORE OTHER INCOME (EXPENSES) | (578,486) | (515,920) | (1,681,427) | (1,828,551) |
OTHER INCOME/(EXPENSES) | ||||
Loss on write-off of patent cost | (5,426) | |||
Gain (Loss) on change in derivative liability | (1,380,085) | (434,405) | (54,910,562) | 6,641,761 |
Interest expense | (247,689) | (302,434) | (931,923) | (834,873) |
TOTAL OTHER INCOME (EXPENSES) | (1,627,774) | (736,839) | (55,847,911) | 5,806,888 |
NET INCOME (LOSS) | $ (2,206,260) | $ (1,252,759) | $ (57,529,338) | $ 3,978,337 |
BASIC AND DILUTED LOSS PER SHARE | $ 0 | $ 0 | $ (0.04) | $ 0 |
WEIGHTED-AVERAGE COMMON SHARES OUTSTANDING BASIC AND DILUTED | 2,139,179,833 | 1,173,720,677 | 1,551,749,054 | 924,582,860 |
Statements of Cash Flows
Statements of Cash Flows - USD ($) | 3 Months Ended | 12 Months Ended | ||
Sep. 30, 2020 | Sep. 30, 2019 | Jun. 30, 2020 | Jun. 30, 2019 | |
CASH FLOWS FROM OPERATING ACTIVITIES: | ||||
Net Income (loss) | $ (2,206,260) | $ (1,252,759) | $ (57,529,338) | $ 3,978,337 |
Adjustment to reconcile net income (loss) to net cash (used in) provided by operating activities | ||||
Depreciation & amortization expense | 2,036 | 2,209 | 8,419 | 6,988 |
Stock based compensation expense | 112,035 | 246,994 | 473,853 | 735,772 |
Stock issued for services | 88,301 | 89,450 | 357,134 | 249,435 |
(Gain) Loss on change in derivative liability | 54,910,562 | (7,695,278) | ||
Loss on change in derivative liability | 1,053,517 | |||
Net loss on write-off of patent cost | 5,426 | |||
Amortization of debt discount recorded as interest expense | 199,024 | 242,392 | 714,145 | 610,917 |
Change in assets and liabilities: | ||||
Prepaid expense | (3,167) | 5,214 | 5,622 | (11,058) |
Other asset | 900 | |||
Accounts payable | (76,515) | 7,552 | 76,257 | 13,996 |
Accrued expenses | 11,861 | 54,607 | (23,247) | |
Accrued interest on convertible notes | 48,234 | 68,847 | 227,529 | 226,028 |
NET CASH USED IN OPERATING ACTIVITIES | (444,366) | (155,696) | (695,784) | (853,693) |
CASH FLOWS FROM INVESTING ACTIVITIES | ||||
Purchase of property and equipment | (50,000) | (780) | (13,059) | |
NET CASH USED IN INVESTING ACTIVITIES: | (50,000) | (780) | (13,059) | |
CASH FLOWS FROM FINANCING ACTIVITIES: | ||||
Proceeds from common stock sales | 800,000 | 186,500 | ||
Proceeds from convertible notes payable | 856,500 | 804,500 | ||
NET CASH PROVIDED BY FINANCING ACTIVITIES | 800,000 | 186,500 | 856,500 | 804,500 |
NET INCREASE (DECREASE) IN CASH | 305,634 | 30,804 | 159,936 | (62,252) |
CASH, BEGINNING OF YEAR | 195,010 | 35,074 | 35,074 | 97,326 |
CASH, END OF YEAR | 500,644 | 65,878 | 195,010 | 35,074 |
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION | ||||
Interest paid | 2,249 | 416 | 2,249 | 940 |
Taxes paid | ||||
SUPPLEMENTAL DISCLOSURES OF NON CASH TRANSACTIONS | ||||
Fair value of common stock upon conversion of convertible notes , accrued interest and other fees | $ 257,235 | $ 388,886 | 1,377,186 | 1,540,609 |
Fair value of convertible notes at issuance | $ 841,436 | $ 743,301 |
Statements of Shareholders' Def
Statements of Shareholders' Deficit - USD ($) | Preferred stock | Common stock | Additional Paid-in Capital | Accumulated Deficit | Total |
Balance at Jun. 30, 2018 | $ 852,458 | $ 8,131,620 | $ (21,999,514) | $ (13,015,436) | |
Balance, Shares at Jun. 30, 2018 | 852,458,018 | ||||
Issuance of common stock for conversion of debt and accrued interest | $ 195,464 | 1,345,145 | 1,540,609 | ||
Issuance of common stock for conversion of debt and accrued interest, shares | 195,464,064 | ||||
Issuance of common stock for services | $ 29,397 | 220,038 | 249,435 | ||
Issuance of common stock for services, shares | 29,397,257 | ||||
Stock based compensation expense | 735,772 | 735,772 | |||
Net Income (Loss) | 3,978,337 | 3,978,337 | |||
Balance at Jun. 30, 2019 | $ 1,077,319 | 10,432,575 | (18,021,177) | (6,511,283) | |
Balance, Shares at Jun. 30, 2019 | 1,077,319,339 | ||||
Issuance of common stock for conversion of debt and accrued interest | $ 217,641 | 855,933 | 1,073,574 | ||
Issuance of common stock for conversion of debt and accrued interest, shares | 217,641,145 | ||||
Issuance of common stock for services | $ 22,995 | 66,455 | 89,450 | ||
Issuance of common stock for services, shares | 22,995,143 | ||||
Stock based compensation expense | 246,994 | 246,994 | |||
Net Income (Loss) | (1,252,759) | (1,252,759) | |||
Balance at Sep. 30, 2019 | $ 1,317,955 | 11,601,957 | (19,273,936) | (6,354,024) | |
Balance, Shares at Sep. 30, 2019 | 1,317,955,627 | ||||
Balance at Jun. 30, 2019 | $ 1,077,319 | 10,432,575 | (18,021,177) | (6,511,283) | |
Balance, Shares at Jun. 30, 2019 | 1,077,319,339 | ||||
Issuance of common stock for conversion of debt and accrued interest | $ 884,990 | 492,196 | 1,377,186 | ||
Issuance of common stock for conversion of debt and accrued interest, shares | 884,989,722 | ||||
Issuance of common stock for services | $ 91,101 | 266,033 | 357,134 | ||
Issuance of common stock for services, shares | 91,101,103 | ||||
Stock based compensation expense | 473,853 | 473,853 | |||
Net Income (Loss) | (57,529,338) | (57,529,338) | |||
Balance at Jun. 30, 2020 | $ 2,053,410 | 11,664,657 | (75,550,515) | (61,832,448) | |
Balance, Shares at Jun. 30, 2020 | 2,053,410,164 | ||||
Issuance of common stock for cash | $ 35,573 | 764,427 | 800,000 | ||
Issuance of common stock for cash shares | 35,573,090 | ||||
Issuance of common stock for conversion of debt and accrued interest | $ 79,908 | 177,327 | 257,235 | ||
Issuance of common stock for conversion of debt and accrued interest, shares | 79,908,088 | ||||
Issuance of common stock for services | $ 2,814 | 85,487 | 88,301 | ||
Issuance of common stock for services, shares | 2,813,903 | ||||
Stock based compensation expense | 112,035 | 112,035 | |||
Net Income (Loss) | (2,206,260) | (2,206,260) | |||
Balance at Sep. 30, 2020 | $ 2,171,705 | $ 12,803,933 | $ (77,756,775) | $ (62,781,137) | |
Balance, Shares at Sep. 30, 2020 | 2,171,705,242 |
Basis of Presentation
Basis of Presentation | 3 Months Ended |
Sep. 30, 2020 | |
Accounting Policies [Abstract] | |
Basis of Presentation | 1. Basis of Presentation The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all normal recurring adjustments considered necessary for a fair presentation have been included. Operating results for the three months ended September 30, 2020 are not necessarily indicative of the results that may be expected for the year ended June 30, 2021. For further information refer to the financial statements and footnotes thereto included in the Company’s Form 10-K for the year ended June 30, 2020. Going Concern The accompanying condensed unaudited financial statements have been prepared on a going concern basis of accounting, which contemplates continuity of operations, realization of assets and liabilities and commitments in the normal course of business. The accompanying condensed unaudited financial statements do not reflect any adjustments that might result if the Company is unable to continue as a going concern. The Company does not generate revenue, and has negative cash flows from operations, which raise substantial doubt about the Company’s ability to continue as a going concern. The ability of the Company to continue as a going concern and appropriateness of using the going concern basis is dependent upon, among other things, raising additional capital. The Company has historically obtained funds through private placement offerings of equity and debt. Management believes that it will be able to continue to raise funds by sale of its securities to its existing shareholders and prospective new investors to provide the additional cash needed to meet the Company’s obligations as they become due and will allow the development of its core business. There is no assurance that the Company will be able to continue raising the required capital. |
Organization and Line of Busine
Organization and Line of Business | 12 Months Ended |
Jun. 30, 2020 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
ORGANIZATION AND LINE OF BUSINESS | 1. ORGANIZATION AND LINE OF BUSINESS Organization SunHydrogen, Inc. (formerly HyperSolar, Inc.) (the "Company") was incorporated in the state of Nevada on February 18, 2009. The Company, based in Santa Barbara, California, began operations on February 19, 2009 to develop and market a solar concentrator technology. Line of Business The company is currently developing a novel solar-powered nanoparticle system that mimics photosynthesis to separate hydrogen from water. We intend for technology of this system to be licensed for the production of renewable hydrogen to produce renewable electricity and hydrogen for fuel cells. Going Concern The accompanying audited financial statements have been prepared on a going concern basis of accounting, which contemplates continuity of operations, realization of assets and liabilities and commitments in the normal course of business. The accompanying audited financial statements do not reflect any adjustments that might result if the Company is unable to continue as a going concern. The Company does not generate revenue, and has negative cash flows from operations, which raise substantial doubt about the Company's ability to continue as a going concern. The ability of the Company to continue as a going concern and appropriateness of using the going concern basis is dependent upon, among other things, additional cash infusion. The Company has historically obtained funds through private placement offerings of equity and debt. Management believes that it will be able to continue to raise funds by sale of its securities to its existing shareholders and prospective new investors to provide the additional cash needed to meet the Company's obligations as they become due and will allow the development of its core business. There is no assurance that the Company will be able to continue raising the required capital. |
Summary of Significant Accounti
Summary of Significant Accounting Policies | 3 Months Ended | 12 Months Ended |
Sep. 30, 2020 | Jun. 30, 2020 | |
Accounting Policies [Abstract] | ||
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES | 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES This summary of significant accounting policies of SunHydrogen, Inc. is presented to assist in understanding the Company’s financial statements. The financial statements and notes are representations of the Company’s management, which is responsible for their integrity and objectivity. These accounting policies conform to accounting principles generally accepted in the United States of America and have been consistently applied in the preparation of the financial statements. Cash and Cash Equivalent The Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents. Use of Estimates In accordance with accounting principles generally accepted in the United States, management utilizes estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements as well as the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. These estimates and assumptions relate to useful lives and impairment of tangible and intangible assets, accruals, income taxes, stock-based compensation expense, Binomial lattice valuation model inputs, derivative liabilities and other factors. Management believes it has exercised reasonable judgment in deriving these estimates. Consequently, a change in conditions could affect these estimates. Property and Equipment Property and equipment are stated at cost, and are depreciated using straight line over its estimated useful lives. During the three months ended September 30, 2020, the Company purchased a business vehicle for transporting demonstration units and to serve as a mobile office. The Company recognized depreciation expense of $278 and $157 for the three months ended September 30, 2020 and 2019, respectively. Intangible Assets The Company has patent applications to protect the inventions and processes behind its proprietary bio-based back-sheet, a protective covering for the back of photovoltaic solar modules traditionally made from petroleum-based film. Intangible assets that have finite useful lives continue to be amortized over their useful lives. The Company recognized amortization expense of $1,758 and $2,052 for the three months ended September 30, 2020 and 2019, respectively. Net Earnings (Loss) per Share Calculations Net earnings (Loss) per share dictates the calculation of basic earnings (loss) per share and diluted earnings per share. Basic earnings (loss) per share are computed by dividing by the weighted average number of common shares outstanding during the year. Diluted net earnings (loss) per share is computed similar to basic earnings (loss) per share except that the denominator is increased to include the effect of stock options and stock-based awards (Note 4), plus the assumed conversion of convertible debt (Note 5). For the three months ended September 30, 2020, the Company calculated the dilutive impact of the outstanding stock options of 186,000,000, and the convertible debt of $1,797,000, which is convertible into shares of common stock. The stock options and convertible debt were not included in the calculation of net earnings per share, because their impact was antidilutive. For the three months ended September 30, 2019, the Company calculated the dilutive impact of the outstanding stock options of 196,250,000, and the convertible debt of $2,118,100, which is convertible into shares of common stock. The stock options and convertible debt were not included in the calculation of net earnings per share, because their impact was antidilutive. Equity Incentive Plan and Stock Options Equity Incentive Plan On December 17, 2018, the Board of Directors approved and adopted the 2019 Equity Incentive Plan (“the Plan”), with 300,000,000 shares of common stock set aside and reserved for issuance pursuant to the Plan. The purpose of the Plan is to promote the success of the Company and to increase stockholder value by providing an additional means through the grant of awards to attract, motivate, retain and reward selected employees and other eligible persons. The awards are performance-based compensation that are granted under the Plan as incentive stock options (ISO) or nonqualified stock options. The per share exercise price for each option shall not be less than 100% of the fair market value of a share of common stock on the date of grant of the option. The Company periodically issues stock options and warrants to employees and non-employees in non-capital raising transactions for services. The Company accounts for stock option grants issued and vesting to employees and non-employees in accordance with the authoritative guidance of the Financial Accounting Standards Board whereas the value of the stock compensation is based upon the measurement date as determined at either a) the date at which a performance commitment is reached, or b) at the date at which the necessary performance to earn the equity instruments is complete. Non-employee stock-based compensation charges generally are amortized over the vesting period on a straight-line basis. In certain circumstances where there are no future performance requirements by the non-employee, option grants are immediately vested, and the total stock-based compensation charge is recorded in the period of the measurement date. As of September 30, 2020, the Company has granted 186,000,000 equity incentive stock options leaving a reserve of 114,000,000. The options are exercisable for common stock. Stock based Compensation The Company periodically issues stock options and warrants to employees and non-employees in non-capital raising transactions for services. The Company accounts for stock option and warrant grants issued and vesting to employees based on the authoritative guidance provided by the Financial Accounting Standards Board whereas the value of the award is measured on the date of grant and recognized over the vesting period. The Company accounts for stock option and warrant grants issued and vesting to non-employees in accordance with the authoritative guidance of the Financial Accounting Standards Board whereas the value of the stock compensation is based upon the measurement date as determined at either a) the date at which a performance commitment is reached, or b) at the date at which the necessary performance to earn the equity instruments is complete. Non-employee stock-based compensation charges generally are amortized over the vesting period on a straight-line basis. In certain circumstances where there are no future performance requirements by the non-employee, the option grants immediately vest, and the total stock-based compensation charge is recorded in the period of the measurement date. As of September 30, 2020, the Company has granted 10,000,000 stock-based compensation stock options, which are exercisable for common stock. Fair Value of Financial Instruments Fair value of financial instruments, requires disclosure of the fair value information, whether or not recognized on the balance sheet, where it is practicable to estimate that value. As of September 30, 2020, the amounts reported for cash, accrued interest and other expenses, notes payables, convertible notes, and derivative liability approximate the fair value because of their short maturities. Fair Value of Financial Instruments We adopted ASC Topic 820 for financial instruments measured as fair value on a recurring basis. ASC Topic 820 defines fair value, established a framework for measuring fair value in accordance with accounting principles generally accepted in the United States and expands disclosures about fair value measurements. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC Topic 820 established a three-tier fair value hierarchy which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurements) and the lowest priority to unobservable inputs (level 3 measurements). These tiers include: ● Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets; ● Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and ● Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. We measure certain financial instruments at fair value on a recurring basis. Assets and liabilities measured at fair value on a recurring basis are as follows at September 30, 2020 (See Note 6): Total (Level 1) (Level 2) (Level 3) Liabilities Derivative liability measured at fair value at 9/30/20 $ 61,037,804 - $ - $ 61,037,804 The following is a reconciliation of the derivative liability for which Level 3 inputs were used in determining the approximate fair value: Balance as of June 30, 2020 59,657,719 Fair value of derivative liabilities issued - Loss on change in derivative liability 1,380,085 Balance as of September 30, 2020 $ 61,037,804 Research and Development Research and development costs are expensed as incurred. Total research and development costs were $138,260 and $143,395 for the three months ended September 30, 2020 and 2019, respectively Accounting for Derivatives The Company evaluates all of its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. For stock-based derivative financial instruments, the Company uses a probability weighted average series Binomial lattice formula pricing models to value the derivative instruments at inception and on subsequent valuation dates. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement of the derivative instrument could be required within 12 months of the balance sheet date. Recently Issued Accounting Pronouncements In June 2018, FASB issued accounting standards update ASU 2018-07, (Topic 505) – “Shared-Based Payment Arrangements with Nonemployees”, which simplifies the accounting for share-based payments granted to nonemployees for goods and services. Under the ASU, most of the guidance on such payments to nonemployees will be aligned with the requirements for share-based payments granted to employees. Under the ASU 2018-07, the measurement of equity-classified nonemployee share-based payments will be fixed on the grant date, as defined in ASC 718, and will use the term nonemployee vesting period, rather than requisite service period. The amendments in this update are effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. For all other entities, the amendments are effective for fiscal years beginning after December 15, 2019, and interim periods within fiscal years beginning after December 15, 2020. Early adoption is permitted if financial statements have not yet been issued. The Company is currently evaluating the impact of the adoption of ASU 2018-07 on the Company’s financial statements. In August 2018, the FASB issued accounting standards update ASU 2018-13, (Topic 820) - “Fair Value Measurement”, which changes the unrealized gains and losses, the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements, and the narrative description of measurement uncertainty should be applied prospectively for only the most recent interim or annual period presented in the initial fiscal year of adoption. All other amendments should be applied retrospectively to all periods presented upon their effective date. The amendments in this update are effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019. Early adoption is permitted upon issuance. The Company is currently evaluation the impact of the adoption of ASU 2018-13, on the Company’s financial statements. Management does not believe that any other recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the accompanying condensed financial statements. | 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES This summary of significant accounting policies of SunHydrogen, Inc (formerly HyperSolar, Inc.) is presented to assist in understanding the Company's financial statements. The financial statements and notes are representations of the Company's management, which is responsible for their integrity and objectivity. These accounting policies conform to accounting principles generally accepted in the United States of America and have been consistently applied in the preparation of the financial statements. Cash and Cash Equivalent The Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents. Use of Estimates In accordance with accounting principles generally accepted in the United States, management utilizes estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements as well as the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. These estimates and assumptions relate to useful lives and impairment of tangible and intangible assets, accruals, income taxes, stock-based compensation expense, Cox Rubenstein binomial lattice valuation model inputs, derivative liabilities and other factors. Management believes it has exercised reasonable judgment in deriving these estimates. Consequently, a change in conditions could affect these estimates. Intangible Assets The Company has patent applications to protect the inventions and processes behind its proprietary bio-based back-sheet, a protective covering for the back of photovoltaic solar modules traditionally made from petroleum-based film. Intangible assets that have finite useful lives continue to be amortized over their useful lives. Useful Lives 6/30/2020 6/30/2019 Domain-gross 15 years $ 5,315 $ 5,315 Less accumulated amortization (4,223 ) (3,868 ) Domain-net $ 1,092 $ 1,447 Trademark-gross 10 years $ 1,143 $ 1,143 Less accumulated amortization (371 ) (257 ) Domain-net $ 772 $ 886 Patents-gross 15 years $ 107,491 $ 107,491 Write-off of patent cost (6,349 ) - Less accumulated amortization (16,650 ) (10,391 ) Patents-net $ 84,492 $ 97,100 The Company recognized amortization expense of $7,651 and $6,360 for the years ended June 30, 2020 and 2019, respectively. Property and Equipment Property and equipment are stated at cost, and are depreciated using straight line over its estimated useful lives: Computers and peripheral equipment 5 Years Depreciation expense for the years ended June 30, 2020 and 2019 was $768 and $628, respectively. Net Earnings (Loss) per Share Calculations Net earnings (Loss) per share dictates the calculation of basic earnings (loss) per share and diluted earnings per share. Basic earnings (loss) per share are computed by dividing by the weighted average number of common shares outstanding during the year. Diluted net earnings (loss) per share is computed similar to basic earnings (loss) per share except that the denominator is increased to include the effect of stock options and stock-based awards (Note 4), plus the assumed conversion of convertible debt (Note 5). For the year ended June 30, 2020, the Company calculated the dilutive impact of the outstanding stock options of 186,000,000, and the convertible debt of $2,030,000, which is convertible into shares of common stock. The stock options and convertible debt were not included in the calculation of net earnings per share, because their impact was antidilutive. For the year ended June 30, 2019, the Company calculated the dilutive impact of its outstanding stock options of 186,250,000, and convertible debt of $2,320,486, which is convertible into shares of common stock. The stock options and convertible debt were not included in the calculation of net earnings per share, because their impact was antidilutive. For the Years Ended June 30, 2020 2019 Income (Loss) to common shareholders (Numerator) $ (57,529,338 ) $ 3,978,337 Basic weighted average number of common shares outstanding (Denominator) 1,551,749,054 924,582,860 Diluted weighted average number of common shares outstanding (Denominator) 1,551,749,054 924,582,860 Equity Incentive Plan and Stock Options Equity Incentive Plan On December 17, 2018, the Board of Directors approved and adopted the 2019 Equity Incentive Plan ("the Plan"), with 300,000,000 shares of common stock set aside and reserved for issuance pursuant to the Plan. The purpose of the Plan is to promote the success of the Company and to increase stockholder value by providing an additional means through the grant of awards to attract, motivate, retain and reward selected employees and other eligible persons. The awards are performance-based compensation that are granted under the Plan as incentive stock options (ISO) or nonqualified stock options. The per share exercise price for each option shall not be less than 100% of the fair market value of a share of common stock on the date of grant of the option. The Company periodically issues stock options and warrants to employees and non-employees in non-capital raising transactions for services and for financing cost. The Company accounts for stock option grants issued and vesting to employees and non-employees in accordance with the authoritative guidance of the Financial Accounting Standards Board whereas the value of the stock compensation is based upon the measurement date as determined at either a) the date at which a performance commitment is reached, or b) at the date at which the necessary performance to earn the equity instruments is complete. Non-employee stock-based compensation charges generally are amortized over the vesting period on a straight-line basis. In certain circumstances where there are no future performance requirements by the non-employee, option grants are immediately vested, and the total stock-based compensation charge is recorded in the period of the measurement date. The shares are convertible into common stock upon exercise. As of June 30, 2020, there were 186,000,000 stock options issued, and 114,000,000 additional shares reserved under the Plan. Stock based Compensation The Company periodically issues stock options and warrants to employees and non-employees in non-capital raising transactions for services and for financing costs. The Company accounts for stock option and warrant grants issued and vesting to employees based on the authoritative guidance provided by the Financial Accounting Standards Board whereas the value of the award is measured on the date of grant and recognized over the vesting period. The Company accounts for stock option and warrant grants issued and vesting to non-employees in accordance with the authoritative guidance of the Financial Accounting Standards Board whereas the value of the stock compensation is based upon the measurement date as determined at either a) the date at which a performance commitment is reached, or b) at the date at which the necessary performance to earn the equity instruments is complete. Non-employee stock-based compensation charges generally are amortized over the vesting period on a straight-line basis. In certain circumstances where there are no future performance requirements by the non-employee, the option grants immediately vest, and the total stock-based compensation charge is recorded in the period of the measurement date. As of June 30, 2020, 10,000,000 of such options were outstanding. Fair Value of Financial Instruments Fair value of financial instruments, requires disclosure of the fair value information, whether or not recognized in the balance sheet, where it is practicable to estimate that value. As of June 30, 2020, the amounts reported for cash, accrued interest and other expenses, notes payables, convertible notes, and derivative liability approximate the fair value because of their short maturities. We adopted ASC Topic 820 for financial instruments measured as fair value on a recurring basis. ASC Topic 820 defines fair value, established a framework for measuring fair value in accordance with accounting principles generally accepted in the United States and expands disclosures about fair value measurements. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC Topic 820 established a three-tier fair value hierarchy which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurements) and the lowest priority to unobservable inputs (level 3 measurements). These tiers include: ● Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets; ● Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and ● Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. We measure certain financial instruments at fair value on a recurring basis. Assets and liabilities measured at fair value on a recurring basis are as follows at June 30, 2020 and 2019 (See Note 6): Total (Level 1) (Level 2) (Level 3) Liabilities Derivative liability measured at fair value at 6/30/20 $ 59,657,719 $ - $ - $ 59,657,719 Derivative liability measured at fair value at 6/30/19 $ 3,905,721 $ - $ - $ 3,905,721 Fair Value of Financial Instruments The following is a reconciliation of the derivative liability for which Level 3 inputs were used in determining the approximate fair value: Balance as of June 30, 2018 $ 10,857,698 Fair value of derivative liabilities at issuance 743,301 Gain on change in derivative liability (7,695,278 ) Balance as of June 30, 2019 3,905,721 Fair value of derivative liabilities issued 841,436 Loss on change in derivative liability 54,910,562 Balance as of June 30, 2020 $ 59,657,719 Research and Development Research and development costs are expensed as incurred. Total research and development costs were $615,721 and $528,901 for the years ended June 30, 2020 and 2019, respectively. Accounting for Derivatives The Company evaluates all of its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. For stock-based derivative financial instruments, the Company uses a probability weighted average series Binomial lattice formula pricing models to value the derivative instruments at inception and on subsequent valuation dates. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement of the derivative instrument could be required within 12 months of the balance sheet date. Income Taxes Deferred income taxes are provided using the liability method whereby deferred tax assets are recognized for deductible temporary differences and operating loss and tax credit carry-forwards and deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the differences between the reported amounts of assets and liabilities and their tax bases. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all the deferred tax assets will not be realized. Deferred tax assets and liabilities are adjusted for the effects of the changes in tax laws and rates of the date of enactment. When tax returns are filed, it is highly certain that some positions taken would be sustained upon examination by the taxing authorities, while others are subject to uncertainty about the merits of the position taken or the amount of the position that would be ultimately sustained. The benefit of a tax position is recognized in the financial statements in the period during which, based on all available evidence, management believes it is more likely than not that the position will be sustained upon examination, including the resolution of appeals or litigation processes, if any. Tax positions taken are not offset or aggregated with other positions. Tax positions that meet the more-likely-than-not recognition threshold are measured as the largest amount of tax benefit that is more than (50%) fifty percent likely of being realized upon settlement with the applicable taxing authority. The portion of the benefits associated with tax positions taken that exceeds the amount measured as described above is reflected as a liability for unrecognized tax benefits in the accompanying balance sheet along with any associated interest and penalties that would be payable to the taxing authorities upon examination. Recently Issued Accounting Pronouncements In August 2017, FASB issued accounting standards update ASU-2017-12, (Topic 815) – "Targeted Improvements to Accounting for Hedging Activities", to require an entity to present the earnings effect of the hedging instrument in the same statement line item in which the earnings effect of the hedged item is reported. The amendments in this update are effective for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years. For all other entities, the amendments are effective for fiscal years beginning after December 15, 2019, and interim periods with the fiscal years beginning after December 15, 2020. Early adoption is permitted in any interim period after issuance of the update. The Company does not believe the adoption of ASU-2017 would have a material impact on the Company's financial statements. In June 2018, FASB issued accounting standards update ASU 2018-07, (Topic 505) – "Shared-Based Payment Arrangements with Nonemployees", which simplifies the accounting for share-based payments granted to nonemployees for goods and services. Under the ASU, most of the guidance on such payments to nonemployees will be aligned with the requirements for share-based payments granted to employees. Under the ASU 2018-07, the measurement of equity-classified nonemployee share-based payments will be fixed on the grant date, as defined in ASC 718, and will use the term nonemployee vesting period, rather than requisite service period. The amendments in this update are effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. For all other entities, the amendments are effective for fiscal years beginning after December 15, 2019, and interim periods within fiscal years beginning after December 15, 2020. Early adoption is permitted if financial statements have not yet been issued. The Company is currently evaluating the impact of the adoption of ASU 2018-07 on the Company's financial statements. In August 2018, the FASB issued to accounting standards update ASU 2018-13, (Topic 820) - "Fair Value Measurement", which changes the unrealized gains and losses, the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements, and the narrative description of measurement uncertainty should be applied prospectively for only the most recent interim or annual period presented in the initial fiscal year of adoption. All other amendments should be applied retrospectively to all periods presented upon their effective date. The amendments in this update are effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019. Early adoption is permitted upon issuance. The Company is currently evaluation the impact of the adoption of ASU 2018-13, on the Company's financial statements. In December 2019, the FASB issued to accounting standards amendment updates to ASU 2019-12, (Topic 740) – "Income Taxes", which simplify the accounting for income taxes by removing certain exceptions to the general principles in Topic 740. The amendments also improve consistent application of and simplify GAAP for other areas of Topic 740 by clarifying and amending existing guidance. The amendments in this update are effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020. For all other entities, the amendments are effective for fiscal years beginning after December 15, 2021, and interim periods with fiscal years beginning after December 15, 2022. Early adoption of the amendments is permitted. The Company does not believe the adoption of ASU-2019-12, would have a material impact on the Company's financial statements. Management does not believe that any other recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the accompanying condensed financial statements. |
Capital Stocks
Capital Stocks | 3 Months Ended | 12 Months Ended |
Sep. 30, 2020 | Jun. 30, 2020 | |
Equity [Abstract] | ||
CAPITAL STOCKS | 3. CAPITAL STOCK Three months ended September 30, 2020 During the three months ended September 30, 2020, the Company issued 35,573,090 shares of common stock for cash for aggregate gross proceeds of $800,000. During the three months ended September 30, 2020, the Company issued 79,908,088 shares of common stock upon conversion of convertible notes in the amount of $233,000 in principal, plus accrued interest of $23,335 and other fees of $900 based upon conversion prices ranging from $0.00095 - $0.017995 per share. All note conversions were performed per the terms of their respective agreements and therefore no gain or loss on the conversion was recorded. During the three months ended September 30, 2020, the Company issued 2,813,903 shares of common stock for services rendered at fair value prices of $0.028 - $0.035 per share in the aggregate amount of $88,301. Three months ended September 30, 2019 During the three months ended September 30, 2019, the Company issued 217,641,145 shares of common stock upon conversion of convertible notes in the amount of $388,886 in principal, plus accrued interest of $57,594 and other fees of $3,500, with an aggregate fair value loss on settlement of $623,594 based upon conversion prices ranging from $0.0035 - $0.0069 per share. During the three months ended September 30, 2019, the Company issued 22,995,143 shares of common stock for services rendered at a fair value prices of $0.0035 - $0.0050 per share in the aggregate amount of $89,450. | 3. CAPITAL STOCKS Year ended June 30, 2020 During the year ended June 30, 2020, the Company issued 884,989,722 shares of common stock upon conversion of convertible notes in the amount of $1,166,986 in principal, plus accrued interest of $198,200 and other fees of $12,000 based upon conversion prices ranging from $0.00095 - $0.0041. During the year ended June 30, 2020, the Company issued 91,101,103 shares of common stock for services rendered at fair value prices of $0.002 - $0.0072 per share in the amount of $357,134. Year ended June 30, 2019 During the year ended June 30, 2019, the Company issued 195,464,064 shares of common stock upon conversion of convertible notes in the amount of $411,814 in principal, plus accrued interest of $75,278 with an aggregate fair value loss on settlement of $1,053,517 based upon conversion prices ranging from $0.0055 to $0.0099 During the year ended June 30, 2018, the Company issued 29,397,257 shares of common stock for services rendered at a fair value prices of $0.0063 - $0.0105 per share in the amount of $249,435. |
Options
Options | 3 Months Ended | 12 Months Ended |
Sep. 30, 2020 | Jun. 30, 2020 | |
Share-based Payment Arrangement [Abstract] | ||
OPTIONS | 4. OPTIONS Stock Option Plan As of September 30, 2020, 10,000,000 non-qualified common stock options were outstanding. Each option expires on the date specified in the option agreement, which date is not later than the fifth (5 th On January 23, 2019, the Company issued 170,000,000 stock options. One-third of the options vested immediately, and the remainder vest 1/24 per month over the first twenty four months following the option grant. The options expire 10 years from the initial grant date. The options fully vest by January 23, 2022 On January 31, 2019, the Company issued 6,000,000 stock options, of which two-third (2/3) vest immediately, and the remaining amount shall vest one-twelfth (1/12) per month from after the date of the option grant. The options expire 10 years from the initial grant date. The options fully vested on January 31, 2020. On July 22, 2019, the Company issued 10,000,000 stock options, of which one-third (1/3) vest immediately, and the remaining shall vest one-twenty fourth (1/24) per month from after the date of the option grant. The options expire 10 years from the initial grant date. The options fully vested on July 22, 2020. A summary of the Company’s stock option activity and related information follows: 9/30/2020 9/30/2019 Weighted Weighted Number average Number average of exercise of exercise Options price Options price Outstanding, beginning of period 196,250,000 $ 0.01 186,250,000 $ 0.01 Granted - $ 0.01 10,000,000 $ 0.01 Exercised - - - - Forfeited/Expired (250,000 ) - - - Outstanding, end of period 196,000,000 $ 0.01 196,250,000 $ 0.01 Exercisable at the end of period 174,332,250 $ 0.01 108,916,667 $ 0.01 The weighted average remaining contractual life of options outstanding as of September 30, 2020 and 2019 was as follows: 9/30/20 9/30/19 Exercisable Stock Options Outstanding Stock Options Exercisable Weighted Average Remaining Contractual Life (years) Exercisable Price Stock Options Outstanding Stock Options Exercisable Weighted Average Remaining Contractual Life (years) $ - - - - $ 0.02 250,000 250,000 0.50 $ 0.01 10,000,000 10,000,000 2.01 $ 0.01 10,000,000 5,000,000 3.01 $ 0.0097-0.0099 176,000,000 157,110,167 5.32 - 5.34 $ 0.0097-0.0099 176,000,000 99,777,777 6.32 - 6.34 $ 0.006 10,000,000 7,222,083 5.81 $ 0.006 10,000,000 3,888,889 6.81 196,000,000 174,332,250 196,250,000 108,916,667 The stock-based compensation expense recognized in the statement of operations during the three months ended September 30, 2020 and 2019, related to the granting of these options was $112,035 and $246,994, respectively. | 4. OPTIONS Stock Option Plan The non-qualified common stock options expire on the date specified in the option agreement, which date is not later than the fifth (5 th On January 23, 2019, the Company issued 170,000,000 stock options, of which one-third (1/3) vest immediately, and the remaining shall vest one-twenty fourth (1/24) per month after the date of these options (remaining block). The first block shall become exercisable immediately and is exercisable for a period of seven (7) years. The options fully vest by January 23, 2021. On January 31, 2019, the Company issued 6,000,000 stock options, of which two-third (2/3) vest immediately, and the remaining shall vest one-twelfth (1/12) per month from after the date of these options (remaining block). The first block shall become exercisable immediately and is exercisable for a period of seven (7) years. The options fully vested on January 31, 2020. On July 22, 2019, the Company issued 10,000,000 stock options, of which one-third (1/3) vest immediately, and the remaining shall vest one-twenty fourth (1/24) per month from after the date of these options (remaining block). The first block shall become exercisable immediately and is exercisable for a period of seven (7) years. The options fully vest by July 22, 2021. A summary of the Company's stock option activity and related information follows: 6/30/2020 6/30/2019 Weighted Weighted Number average Number average of exercise of exercise Options price Options price Outstanding, beginning of period 186,250,000 $ 0.01 10,250,000 $ 0.01 Granted 10,000,000 $ 0.01 176,000,000 $ 0.01 Exercised - - - - Forfeited/Expired (250,000 ) - - - Outstanding, end of period 196,000,000 $ 0.01 186,250,000 $ 0.01 Exercisable at the end of period 160,493,150 $ 0.01 85,583,333 $ 0.01 The weighted average remaining contractual life of options outstanding as of June 30, 2020 and 2019 was as follows: 6/30/2020 6/30/2019 Exercisable Stock Options Outstanding Stock Options Exercisable Weighted Average Remaining Contractual Life (years) Exercisable Price Stock Options Outstanding Stock Options Exercisable Weighted Average Remaining Contractual Life (years) $ - - - - $ 0.02 250,000 250,000 0.75 $ 0.01 10,000,000 10,000,000 1.26 $ 0.01 10,000,000 5,250,000 3.26 $ 0.0097-0.0099 176,000,000 144,018,263 5.57 – 5.59 $ 0.0097-0.0099 176,000,000 60,666,667 6.57 - 6.84 $ 0.0060 10,000,000 6,474,887 6.06 $ - - - - 196,000,000 160,493,150 186,250,000 85,583,333 6/30/20 6/30/19 Risk free interest rate 1.47% - 2.58 % 1.94 % Stock volatility factor 54.99% - 189.01 % 146 % Weighted average expected option life 6 years 7 years Expected dividend yield None None The stock-based compensation expense recognized in the statement of operations during the years ended June 30, 2020 and 2019, related to the granting of these options was $473,853 and $735,772, respectively. |
Convertible Promissory Notes
Convertible Promissory Notes | 3 Months Ended | 12 Months Ended |
Sep. 30, 2020 | Jun. 30, 2020 | |
Debt Disclosure [Abstract] | ||
CONVERTIBLE PROMISSORY NOTES | 5. CONVERTIBLE PROMISSORY NOTES As of September 30, 2020, the outstanding convertible promissory notes, net of debt discount of $210,050 are summarized as follows: Convertible Promissory Notes, net of debt discount $ 1,586,950 Less current portion 126,950 Total long-term liabilities $ 1,460,000 Maturities of long-term debt net of debt discount for the next five years are as follows: Period Ended September 30, Amount 2021 337,000 2022 695,000 2023 625,000 2024 140,000 $ 1,797,000 At September 30, 2020, the $1,797,000 in convertible promissory notes had a remaining debt discount of $210,050, leaving a net balance of $1,586,950. The Company issued a 10% convertible promissory note on January 28, 2016 (the “Jan 2016 Note”) in the aggregate principal amount of up to $500,000. Upon execution of the convertible promissory note, the Company received a tranche of $10,000. The Company received additional tranches in the amount of $490,000 for an aggregate sum of $500,000. The Jan 2016 Note matures twelve (12) months from the effective dates of each respective tranche. On January 19, 2017, the investor extended the Jan 2016 Note for an additional sixty (60) months from the effective date of each tranche, which matures on January 27, 2022. The Jan 2016 Note is convertible into shares of common stock of the Company at a price equal to a variable conversion price of the lesser of $0.01 per share or fifty percent (50%) of the lowest trading price since the original effective date of each respective tranche or the lowest effective price per share granted to any person or entity after the effective date to acquire common stock. If the Company fails to deliver shares in accordance with the timeframe of three (3) business days of the receipt of a notice of conversion, the lender, at any time prior to selling all of those shares, may rescind any portion, in whole or in part of that particular conversion attributable to the unsold shares and have the rescinded conversion amount returned to the principal sum with the rescinded conversion shares returned to the Company. In no event shall the lender be entitled to convert any portion of the Jan 2016 Note such that would result in beneficial ownership by the lender and its affiliates of more than 4.99% of the outstanding shares of common stock of the Company. In addition, for each conversion, in the event that shares are not delivered by the fourth business day (inclusive of the day of conversion), a penalty of $1,500 per day shall be assessed for each day after the third business day (inclusive of the day of the conversion) until the shares are delivered. During the three months ended on September 30, 2020, the Company issued 48,802,884 common shares upon conversion of principal in the amount of $33,000, plus interest of $13,363. The balance of the Jan 2016 Note as of September 30, 2020 was $277,000. The Company issued a 10% convertible promissory note on February 3, 2017 (the “Feb 2017 Note”) in the aggregate principal amount of up to $500,000. Upon execution of the convertible promissory note, the Company received a tranche of $60,000. The Company received additional tranches in the amount of $440,000 for an aggregate sum of $500,000. The Feb 2017 Note matures twelve (12) months from the effective dates of each respective tranche. The Feb 2017 Note had a maturity date of February 3, 2018, with an automatic extension of sixty (60) months from the effective date of each tranche. The Feb 2017 Note is convertible into shares of common stock of the Company at a price equal to a variable conversion price of the lesser of $0.01 per share or fifty percent (50%) of the lowest trading price since the original effective date of each respective tranche or the lowest effective price per share granted to any person or entity after the effective date to acquire common stock. If the Company fails to deliver shares in accordance with the timeframe of three (3) business days of the receipt of a notice of conversion, the lender, at any time prior to selling all of those shares, may rescind any portion, in whole or in part of that particular conversion attributable to the unsold shares and have the rescinded conversion amount returned to the principal sum with the rescinded conversion shares returned to the Company. In no event shall the lender be entitled to convert any portion of the Feb 2017 Note such that would result in beneficial ownership by the lender and its affiliates of more than 4.99% of the outstanding shares of common stock of the Company. In addition, for each conversion, in the event, that shares are not delivered by the fourth business day (inclusive of the day of conversion), a penalty of $1,500 per day shall be assessed for each day after the third business day (inclusive of the day of the conversion) until the shares are delivered. The balance of the Feb 2017 Note as of September 30, 2020 was $500,000. The Company issued a 10% convertible promissory note on November 9, 2017 (the “Nov 2017 Note”) in the aggregate principal amount of up to $500,000. Upon execution of the convertible promissory note, the Company received a tranche of $45,000. The Company received additional tranches in the amount of $455,000 for an aggregate sum of $500,000. The Nov 2017 Note matures twelve (12) months from the effective dates of each respective tranche. The Nov 2017 Note had a maturity date of November 9, 2018, with an automatic extension of sixty (60) months from the effective date of each tranche. The Nov 2017 Note is convertible into shares of common stock of the Company at a price equal to a variable conversion price of the lesser of $0.01 per share or fifty percent (50%) of the lowest trading price since the original effective date of each respective tranche or the lowest effective price per share granted to any person or entity after the effective date to acquire common stock. If the Company fails to deliver shares in accordance with the timeframe of three (3) business days of the receipt of a notice of conversion, the lender, at any time prior to selling all of those shares, may rescind any portion, in whole or in part of that particular conversion attributable to the unsold shares and have the rescinded conversion amount returned to the principal sum with the rescinded conversion shares returned to the Company. In no event shall the lender be entitled to convert any portion of the Nov 2017 Note such that would result in beneficial ownership by the lender and its affiliates of more than 4.99% of the outstanding shares of common stock of the Company. In addition, for each conversion, in the event that shares are not delivered by the fourth business day (inclusive of the day of conversion), a penalty of $1,500 per day shall be assessed for each day after the third business day (inclusive of the day of the conversion) until the shares are delivered. The balance of the Nov 2017 Note as of September 30, 2020 was $500,000. The Company issued a 10% convertible promissory note on June 27, 2018 (the “Jun 2018 Note”) in the aggregate principal amount of up to $500,000. Upon execution of the convertible promissory note, the Company received a tranche of $50,000. On October 9, 2018, the Company received another tranche of $40,000, for a total aggregate of $90,000 as of December 31, 2019. The Jun 2018 Note matures twelve (12) months from the effective dates of each respective tranche. The Jun 2018 Note matured on June 27, 2019, which was automatically extended for sixty (60) months from the effective date of each tranche. The Jun 2018 Note is convertible into shares of common stock of the Company at a price equal to a variable conversion price of the lesser of $0.01 per share or fifty percent (50%) of the lowest trading price since the original effective date of each respective tranche or the lowest effective price per share granted to any person or entity after the effective date to acquire common stock. If the Company fails to deliver shares in accordance with the timeframe of three (3) business days of the receipt of a notice of conversion, the lender, at any time prior to selling all of those shares, may rescind any portion, in whole or in part of that particular conversion attributable to the unsold shares and have the rescinded conversion amount returned to the principal sum with the rescinded conversion shares returned to the Company. In no event shall the lender be entitled to convert any portion of the Jun 2018 Note such that would result in beneficial ownership by the lender and its affiliates of more than 4.99% of the outstanding shares of common stock of the Company. In addition, for each conversion, in the event, that shares are not delivered by the fourth business day (inclusive of the day of conversion), a penalty of $1,500 per day shall be assessed for each day after the third business day (inclusive of the day of the conversion) until the shares are delivered. The balance of the Jun 2018 Note as of September 30, 2020 was $90,000. The Company issued a 10% convertible promissory note on August 10, 2018 (the “Aug 2018 Note”) in the aggregate principal amount of up to $100,000. The Aug 2018 Note had a maturity date of August 10, 2019, with an extension of sixty (60) months from the date of the note. The Aug 2018 Note matures on August 10, 2023. The Aug 2018 Note may be converted into shares of the Company’s common stock at a conversion price of the lesser of a) $0.005 per share or b) sixty-one (61%) percent of the lowest trading price per common stock recorded on any trade day after the effective date. The conversion feature of the Aug 2018 Note was considered a derivative in accordance with current accounting guidelines because of the reset conversion features of the Note. The balance of the Aug 2018 Note as of September 30, 2020 was $100,000. On January 20, 2020, the Company issued a 10% convertible promissory note (the “Jan 2020 Note”) to an investor (the “Jan 2020 Note”) in the principal amount of $80,000. The Company received funds of $78,000, less other fees of $2,000. The Jan 2020 Note had a maturity date of January 20, 2021. The Jan 2020 Note was convertible into shares of the Company’s common stock at a conversion price of sixty-one (61%) percent of the lowest two (2) trading prices per common stock during the fifteen (15) trading day prior to the conversion date. The conversion feature of the Jan 2020 Note was considered a derivative in accordance with current accounting guidelines because of the reset conversion features of the Jan 2020 Note. During the three months ended September 30, 2020, the Company issued 23,420,128 shares of common stock upon conversion of principal in the amount of $80,000, plus accrued interest of $3,989, and other fees of $300. The Company recorded amortization of debt discount, which was recognized as interest expense in the amount of $42,404 during the three months ended September 30, 2020. The Jan 2020 Note was fully converted as of September 30, 2020. On February 11, 2020, the Company issued a convertible promissory note (the “Feb 2020 Note”) to an investor (the “Feb 2020 Note”) in the principal amount of $80,000. The Company received funds of $78,000, less other fees of $2,000. The Feb 2020 Note had a maturity date of February 11, 2021. The Feb 2020 Note was convertible into shares of the Company’s common stock at a conversion price of sixty-one (61%) percent of the lowest two (2) trading prices per common stock during the fifteen (15) trading day prior to the conversion date. The conversion feature of the Feb 2020 Note was considered a derivative in accordance with current accounting guidelines because of the reset conversion features of the Feb 2020 Note. During the three months ended September 30, 2020, the Company issued 5,294,205 shares of common stock upon conversion of principal in the amount of $80,000, plus accrued interest of $3,989, and other fees of $300. The Company recorded amortization of debt discount, which was recognized as interest expense in the amount of $49,399 during the three months ended September 30, 2020. The Feb 2020 Note was fully converted as of September 30, 2020. On March 9, 2020, the Company issued a convertible promissory note (the “Mar 2020 Note”) to an investor, (the “Mar 2020 Note”) in the principal amount of $40,000. The Company received funds of $38,000, less other fees of $2,000. The Mar 2020 Note had a maturity date of March 9, 2021. The Mar 2020 Note was convertible into shares of the Company’s common stock at a conversion price of sixty-one (61%) percent of the lowest two (2) trading prices per common stock during the fifteen (15) trading day prior to the conversion date. The conversion feature of the Mar 2020 Note was considered a derivative in accordance with current accounting guidelines because of the reset conversion features of the Mar 2020 Note. During the three months ended September 30, 2020, the Company issued 2,390,871 shares of common stock upon conversion of principal in the amount of $40,000, plus accrued interest of $1,995, and other fees of $300. The Company recorded amortization of debt discount, which was recognized as interest expense in the amount of $25,708 during the three months ended September 30, 2020. The Mar 2020 Note was fully converted as of September 30, 2020. On April 14, 2020, the Company issued a convertible promissory note (the “April 2020 Note”) to an investor in the principal amount of $80,000. The Company received funds of $78,000, less other fees of $2,000. The April 2020 Note matures on April 14, 2021. The April 2020 Note may be converted into shares of the Company’s common stock at a conversion price of sixty-one (61%) percent of the average of the lowest two (2) trading prices per common stock during the fifteen (15) trading day prior to the conversion date. The conversion feature of the April 2020 Note was considered a derivative in accordance with current accounting guidelines because of the reset conversion features of the April 2020 Note. The Company recorded amortization of debt discount, which was recognized as interest expense in the amount of $20,164 during the three months ended September 30, 2020. The balance of the April 2020 Note as of September 30, 2020 was $80,000. On April 15, 2020, the Company issued a convertible promissory note (the “Apr 2020 Note”) to an investor in the aggregate principal amount of $50,000, of which the Company received $10,000 as of June 30, 2020. The Apr 2020 Note matures twelve (12) months from the effective dates of each respective tranche, such that the Apr 2020 Note matures on April 15, 2021, with an automatic extension of sixty (60) months from the effective date of each tranche. The Apr Note is convertible into shares of common stock of the Company at a price equal to a variable conversion price of the lesser of $0.01 per share or fifty percent (50%) of the lowest trading price of common stock recorded on any trade day after the effective date, or (c) the lowest effective price per share granted to any person or entity after the effective date to acquire common stock. If the Company fails to deliver shares in accordance with the timeframe of four (4) business days of the receipt of a notice of conversion, the lender, at any time prior to selling all of those shares, may rescind any portion, in whole or in part of that particular conversion attributable to the unsold shares and have the rescinded conversion amount returned to the principal sum with the rescinded conversion shares returned to the Company. In no event shall the lender be entitled to convert any portion of the Apr 2020 Note such that would result in beneficial ownership by the lender and its affiliates of more than 4.99% of the outstanding shares of common stock of the Company. In addition, for each conversion, in the event that shares are not delivered by the fourth business day (inclusive of the day of conversion), a penalty of $2,000 per day shall be assessed for each day after the fourth business day (inclusive of the day of the conversion) until the shares are delivered. The conversion feature of the April 2020 Note was considered a derivative in accordance with current accounting guidelines because of the reset conversion features of the Apr 2020 Note. The Company recorded amortization of debt discount, which was recognized as interest expense in the amount of $855 during the three months ended September 30, 2020. The balance of the Apr 2020 Note as of September 30, 2020 was $10,000. On May 19, 2020, the Company issued a convertible promissory note (the “May 2020 Note”) to an investor in the principal amount of $80,000. The Company received funds of $78,000, less other fees of $2,000. The May 2020 Note matures on May 19, 2021. The May 2020 Note may be converted into shares of the Company’s common stock at a conversion price of sixty-one (61%) percent of the lowest two (2) trading prices per common stock during the fifteen (15) trading day prior to the conversion date. The conversion feature of the May 2020 Note was considered a derivative in accordance with current accounting guidelines because of the reset conversion features of the May 2020 Note. The Company recorded amortization of debt discount, which was recognized as interest expense in the amount of $20,164 during the year ended June 30, 2020. The balance of the May 2020 Note as of June 30, 2020 was $80,000. On June 18, 2020, the Company issued a convertible promissory note (the “June 2020 Note”) to an investor in the principal amount of $160,000. The Company received funds of $156,000, less other fees of $4,000. The Jun 2020 Note matures on June 19, 2021. The Jun 2020 Note may be converted into shares of the Company’s common stock at a conversion price of sixty-one (61%) percent of the average of the lowest two (2) trading prices per common stock during the fifteen (15) trading day prior to the conversion date. The conversion feature of the Jun 2020 Note was considered a derivative in accordance with current accounting guidelines because of the reset conversion features of the Jun 2020 Note. The Company recorded amortization of debt discount, which was recognized as interest expense in the amount of $40,329 during the three months ended September 30, 2020. The balance of the Jun 2020 Note as of September 30, 2020 was $160,000. All note conversions were performed per the terms of their respective agreements and therefore no gain or loss on the conversion was recorded. | 5. CONVERTIBLE PROMISSORY NOTES As of June 30, 2020, the outstanding convertible promissory notes, net of debt discount of $409,074 are summarized as follows: Convertible Promissory Notes, net of debt discount $ 1,620,926 Less current portion 160,926 Total long-term liabilities $ 1,460,000 Maturities of long-term debt principal for the next four years are as follows: Period Ended June 30, Amount 2021 570,000 2022 575,000 2023 745,000 2024 140,000 $ 2,030,000 At June 30, 2020, the $2,030,000 in convertible promissory notes had a remaining debt discount of $409,074, leaving a net balance of $1,620,926. The Company issued a 10% convertible promissory note on April 9, 2015 (the "April 2015 Note") in the aggregate principal amount of up to $500,000. Upon execution of the convertible promissory note, the Company received a tranche of $50,000. The Company received additional tranches in the amount of $450,000 for an aggregate sum of $500,000. The April 2015 Note matured nine (9) months from the effective dates of each respective tranche. A second extension was granted to October 9, 2016. On January 19, 2017, the investor extended the April 2015 Note for an additional (60) months from the effective date of each tranche, which had a maturity date of April 9, 2020.The April 2015 Note was convertible into shares of common stock of the Company at a price equal to a variable conversion price of the lesser of $0.01 per share or fifty percent (50%) of the lowest trading price since the original effective date of each respective advance or the lowest effective price per share granted to any person or entity after the effective date to acquire common stock. In no event could the lender convert any portion of the April 2015 Note such that would result in beneficial ownership by the lender and its affiliates of more than 4.99% of the outstanding shares of common stock of the Company. During the year ended June 30, 2020, the Company issued 212,079,164 shares of common stock, upon conversion of $192,600, plus accrued interest of $74,285. The balance of the April 2015 Note as of June 30, 2020 was $0. The Company issued a 10% convertible promissory note on January 28, 2016 (the "Jan 2016 Note") in the aggregate principal amount of up to $500,000. Upon execution of the convertible promissory note, the Company received a tranche of $10,000. The Company received additional tranches in the amount of $490,000 for an aggregate sum of $500,000. The Jan 2016 Note matures twelve (12) months from the effective dates of each respective tranche. On January 19, 2017, the investor extended the Jan 2016 Note for an additional sixty (60) months from the effective date of each tranche, which matures on January 27, 2022. The Jan 2016 Note is convertible into shares of common stock of the Company at a price equal to a variable conversion price of the lesser of $0.01 per share or fifty percent (50%) of the lowest trading price since the original effective date of each respective tranche or the lowest effective price per share granted to any person or entity after the effective date to acquire common stock. If the Company fails to deliver shares in accordance with the timeframe of three (3) business days of the receipt of a notice of conversion, the lender, at any time prior to selling all of those shares, may rescind any portion, in whole or in part of that particular conversion attributable to the unsold shares and have the rescinded conversion amount returned to the principal sum with the rescinded conversion shares returned to the Company. In no event shall the lender be entitled to convert any portion of the Jan 2016 Note such that would result in beneficial ownership by the lender and its affiliates of more than 4.99% of the outstanding shares of common stock of the Company. In addition, for each conversion, in the event that shares are not delivered by the fourth business day (inclusive of the day of conversion), a penalty of $1,500 per day shall be assessed for each day after the third business day (inclusive of the day of the conversion) until the shares are delivered. During the year ended June 30, 2020, the Company issued 280,606,492 common shares upon conversion of principal in the amount of $190,000, plus interest of $76,576. The balance of the Jan 2016 Note as of June 30, 2020 was $310,000. The Company issued a 10% convertible promissory note on February 3, 2017 (the "Feb 2017 Note") in the aggregate principal amount of up to $500,000. Upon execution of the convertible promissory note, the Company received a tranche of $60,000. The Company received additional tranches in the amount of $440,000 for an aggregate sum of $500,000. The Feb 2017 Note matures twelve (12) months from the effective dates of each respective tranche. The Feb 2017 Note had a maturity date of February 3, 2018, with an automatic extension of sixty (60) months from the effective date of each tranche. The Feb 2017 Note is convertible into shares of common stock of the Company at a price equal to a variable conversion price of the lesser of $0.01 per share or fifty percent (50%) of the lowest trading price since the original effective date of each respective tranche or the lowest effective price per share granted to any person or entity after the effective date to acquire common stock. If the Company fails to deliver shares in accordance with the timeframe of three (3) business days of the receipt of a notice of conversion, the lender, at any time prior to selling all of those shares, may rescind any portion, in whole or in part of that particular conversion attributable to the unsold shares and have the rescinded conversion amount returned to the principal sum with the rescinded conversion shares returned to the Company. In no event shall the lender be entitled to convert any portion of the Feb 2017 Note such that would result in beneficial ownership by the lender and its affiliates of more than 4.99% of the outstanding shares of common stock of the Company. In addition, for each conversion, in the event, that shares are not delivered by the fourth business day (inclusive of the day of conversion), a penalty of $1,500 per day shall be assessed for each day after the third business day (inclusive of the day of the conversion) until the shares are delivered. The balance of the Feb 2017 Note as of June 30, 2020 was $500,000. The Company issued a 10% convertible promissory note on November 9, 2017 (the "Nov 2017 Note") in the aggregate principal amount of up to $500,000. Upon execution of the convertible promissory note, the Company received a tranche of $45,000. The Company received additional tranches in the amount of $455,000 for an aggregate sum of $500,000. The Nov 2017 Note matures twelve (12) months from the effective dates of each respective tranche. The Nov 2017 Note had a maturity date of November 9, 2018, with an automatic extension of sixty (60) months from the effective date of each tranche. The Nov 2017 Note is convertible into shares of common stock of the Company at a price equal to a variable conversion price of the lesser of $0.01 per share or fifty percent (50%) of the lowest trading price since the original effective date of each respective tranche or the lowest effective price per share granted to any person or entity after the effective date to acquire common stock. If the Company fails to deliver shares in accordance with the timeframe of three (3) business days of the receipt of a notice of conversion, the lender, at any time prior to selling all of those shares, may rescind any portion, in whole or in part of that particular conversion attributable to the unsold shares and have the rescinded conversion amount returned to the principal sum with the rescinded conversion shares returned to the Company. In no event shall the lender be entitled to convert any portion of the Nov 2017 Note such that would result in beneficial ownership by the lender and its affiliates of more than 4.99% of the outstanding shares of common stock of the Company. In addition, for each conversion, in the event that shares are not delivered by the fourth business day (inclusive of the day of conversion), a penalty of $1,500 per day shall be assessed for each day after the third business day (inclusive of the day of the conversion) until the shares are delivered. The balance of the Nov 2017 Note as of June 30, 2020 was $500,000. The Company issued a 10% convertible promissory note on June 27, 2018 (the "Jun 2018 Note") in the aggregate principal amount of up to $500,000. Upon execution of the convertible promissory note, the Company received a tranche of $50,000. On October 9, 2018, the Company received another tranche of $40,000, for a total aggregate of $90,000 as of December 31, 2019. The Jun 2018 Note matures twelve (12) months from the effective dates of each respective tranche. The Jun 2018 Note matured on June 27, 2019, which was automatically extended for sixty (60) months from the effective date of each tranche. The Jun 2018 Note is convertible into shares of common stock of the Company at a price equal to a variable conversion price of the lesser of $0.01 per share or fifty percent (50%) of the lowest trading price since the original effective date of each respective tranche or the lowest effective price per share granted to any person or entity after the effective date to acquire common stock. If the Company fails to deliver shares in accordance with the timeframe of three (3) business days of the receipt of a notice of conversion, the lender, at any time prior to selling all of those shares, may rescind any portion, in whole or in part of that particular conversion attributable to the unsold shares and have the rescinded conversion amount returned to the principal sum with the rescinded conversion shares returned to the Company. In no event shall the lender be entitled to convert any portion of the Jun 2018 Note such that would result in beneficial ownership by the lender and its affiliates of more than 4.99% of the outstanding shares of common stock of the Company. In addition, for each conversion, in the event, that shares are not delivered by the fourth business day (inclusive of the day of conversion), a penalty of $1,500 per day shall be assessed for each day after the third business day (inclusive of the day of the conversion) until the shares are delivered. The Company recorded amortization of debt discount, which was recognized as interest expense in the amount of $2,823 during the year ended June 30, 2020. The balance of the Jun 2018 Note as of June 30, 2020 was $90,000. The Company issued a 10% convertible promissory note on August 10, 2018 (the "Aug 2018 Note") in the aggregate principal amount of up to $100,000. The Aug 2018 Note had a maturity date of August 10, 2019, with an extension of sixty (60) months from the date of the note. The Aug 2018 Note matures on August 10, 2023. The Aug 2018 Note may be converted into shares of the Company's common stock at a conversion price of the lesser of a) $0.005 per share or b) sixty-one (61%) percent of the lowest trading price per common stock recorded on any trade day after the effective date. The conversion feature of the Aug 2018 Note was considered a derivative in accordance with current accounting guidelines because of the reset conversion features of the Note. The Company recorded amortization of debt discount, which was recognized as interest expense in the amount of $11,233 during the year ended June 30, 2020. The balance of the Aug 2018 Note as of June 30, 2020 was $100,000. The Company issued 10% convertible promissory notes on February 14, 2019 thru August 12, 2019, (the "Feb-Aug Notes") in the aggregate principal amount of up to $252,000. The Feb-Aug Notes had maturity dates of February 14, 2020 thru August 12, 2020. The Feb-Aug Notes were convertible into shares of the Company's common stock at a conversion price of sixty-one (61%) percent of the lowest average two (2) trading prices per common stock during the fifteen (15) trading day prior to the conversion date. The conversion feature of the Feb-Aug Notes was considered a derivative in accordance with current accounting guidelines because of the reset conversion features of the Notes. During the year ended June 30, 2020, the Company issued 116,025,867 shares of common stock upon conversion of principal in the amount of $252,000, plus accrued interest of $12,600. The Company recorded amortization of debt discount, which was recognized as interest expense in the amount of $176,288 during the year ended June 30, 2020. The balance of the Feb-Aug Notes as of June 30, 2020 was $0. On December 14, 2018, January 18, 2019, and July 3, 2019, the Company issued convertible promissory notes (the "Dec-Jul Notes") to an investor, (the "Dec-Jul Notes") in the total aggregate principal amount of $140,000. The Dec-Jul Notes had maturity dates of December 14, 2019 and January 18, 2020. The Dec-Jul Notes were convertible into shares of the Company's common stock at a conversion price of sixty-one (61%) percent of the lowest trading prices per common stock during the fifteen (15) trading day prior to the conversion date. The conversion feature of the Dec-Jul Notes was considered a derivative in accordance with current accounting guidelines because of the reset conversion features of the Note. During the year ended June 30, 2020, the Company issued 103,302,185 shares of common stock upon conversion of $132,386 in principal, plus accrued interest of $14,000, and legal fees of $9,000. The Company recorded amortization of debt discount, which was recognized as interest expense in the amount of $91,714 during the year ended June 30, 2020. The balance of the Dec-Jul Notes as of June 30, 2020 was $0. On January 31, 2019 and March 6, 2019, the Company issued convertible promissory notes (the "Jan-Mar Note") to an investor (the "Jan-Mar Note") in the total aggregate principal amount of $160,000. The Jan-Mar Notes had maturity dates of January 31, 2020 and March 6, 2020. The Jan-Mar Notes were convertible into shares of the Company's common stock at a conversion price of sixty-one (61%) percent of the lowest average of the two (2) trading prices per common stock during the fifteen (15) trading day prior to the conversion date. The conversion feature of the Jan-Mar Notes was considered a derivative in accordance with current accounting guidelines because of the reset conversion features of the Jan-Mar Notes. The Company issued 76,591,844 shares of common stock upon the conversion of principal in the amount of $160,000, plus accrued interest of $8,399, and legal fees of $1,500. The Company recorded amortization of debt discount, which was recognized as interest expense in the amount of $101,698 during the year ended June 30, 2020. The balance of the Jan-Mar Notes as of June 30, 2020 was $0. On August 28, 2019, the Company issued a convertible promissory note (the "Aug Note") to an investor, in the principal amount of $80,000. The Company received funds of $78,000, less other fees of $2,000. The Aug Note had a maturity date of August 28, 2020. The Aug Note was convertible into shares of the Company's common stock at a conversion price of sixty-one (61%) percent of the lowest average of the two (2) trading prices per common stock during the fifteen (15) trading day prior to the conversion date. The conversion feature of the Aug Note was considered a derivative in accordance with current accounting guidelines because of the reset conversion features of the Aug Note. During the year ended June 30, 2020, the Company issued 30,227,789 shares of common stock upon conversion of principal in the amount of $80,000, plus accrued interest of $4,219, and legal fees of $600. The Company recorded amortization of debt discount, which was recognized as interest expense in the amount of $58,835 during the year ended June 30, 2020. The balance of the Aug Note as of June 30, 2020 was $0. On October 2, 2019, the Company issued a convertible promissory note (the "Oct Note") to an investor in the principal amount of $80,000. The Company received funds of $78,000, less other fees of $2,000. The Oct Note matures on October 2, 2020. The Oct Note was convertible into shares of the Company's common stock at a conversion price of sixty-one (61%) percent of the lowest average of the two (2) trading prices per common stock during the fifteen (15) trading day prior to the conversion date. The conversion feature of the Oct Note was considered a derivative in accordance with current accounting guidelines because of the reset conversion features of the Oct Note. During the year ended June 30, 2020, the Company issued 39,676,622 shares of common stock upon conversion of principal in the amount of $80,000, plus accrued interest of $4,110, and legal fees of $600. The Company recorded amortization of debt discount, which was recognized as interest expense in the amount of $80,000, during the year ended June 30, 2020. The balance of the Oct Note as of June 30, 2020 was $0. On November 27, 2019, the Company issued a convertible promissory note (the "Nov Note") to an investor in the principal amount of $80,000. The Company received funds of $78,000, less other fees of $2,000. The Nov Note had a maturity date of November 27, 2020. The Nov Note was convertible into shares of the Company's common stock at a conversion price of sixty-one (61%) percent of the lowest average of the two (2) trading prices per common stock during the fifteen (15) trading day prior to the conversion date. The conversion feature of the Nov Note was considered a derivative in accordance with current accounting guidelines because of the reset conversion features of the Nov Note. During the year ended June 30, 2020, the Company issued 26,579,747 shares of common stock upon conversion of principal in the amount of $80,000, plus accrued interest of $4,011, and legal fees of $300. The Company recorded amortization of debt discount, which was recognized as interest expense in the amount of $80,000 during the year ended June 30, 2020. The balance of the Nov Note as of June 30, 2020 was $0. On January 10, 2020, the Company issued a convertible promissory note (the "Jan 2020 Note") to an investor in the principal amount of $80,000. The Company received funds of $78,000, less other fees of $2,000. The Jan 2020 Note matures on January 10, 2021. The Jan 2020 Note may be converted into shares of the Company's common stock at a conversion price of sixty-one (61%) percent of the average of the lowest two (2) trading prices per common stock during the thirty (30) trading day prior to the conversion date. The conversion feature of the Jan 2020 Note was considered a derivative in accordance with current accounting guidelines because of the reset conversion features of the Jan 2020 Note. The Company recorded amortization of debt discount, which was recognized as interest expense in the amount of $37,596 during the year ended June 30, 2020. The balance of the Jan 2020 Note as of June 30, 2020 was $80,000. On February 11, 2020, the Company issued a convertible promissory note (the "Feb 2020 Note") to an investor in the principal amount of $80,000. The Company received funds of $78,000, less other fees of $2,000. The Feb 2020 Note matures on February 11, 2021. The Feb 2020 Note may be converted into shares of the Company's common stock at a conversion price of sixty-one (61%) percent of the average of the lowest two (2) trading prices per common stock during the fifteen (15) trading day prior to the conversion date. The conversion feature of the Feb 2020 Note was considered a derivative in accordance with current accounting guidelines because of the reset conversion features of the Feb 2020 Note. The Company recorded amortization of debt discount, which was recognized as interest expense in the amount of $30,601 during the year ended June 30, 2020. The balance of the Feb 2020 Note as of June 30, 2020 was $80,000. On March 5, 2020, the Company issued a convertible promissory note (the "Mar 2020 Note") to an investor in the principal amount of $40,000. The Company received funds of $38,000, less other fees of $2,000. The Mar 2020 Note matures on March 9, 2021. The Mar 2020 Note may be converted into shares of the Company's common stock at a conversion price of sixty-one (61%) percent of the average of the lowest two (2) trading prices per common stock during the fifteen (15) trading day prior to the conversion date. The conversion feature of the Mar 2020 Note was considered a derivative in accordance with current accounting guidelines because of the reset conversion features of the Mar 2020 Note. The Company recorded amortization of debt discount, which was recognized as interest expense in the amount of $11,528 during the year ended June 30, 2020. The balance of the Mar 2020 Note as of June 30, 2020 was $40,000. On April 14, 2020, the Company issued a convertible promissory note (the "April 2020 Note") to an investor in the principal amount of $80,000. The Company received funds of $78,000, less other fees of $2,000. The April 2020 Note matures on April 14, 2021. The April 2020 Note may be converted into shares of the Company's common stock at a conversion price of sixty-one (61%) percent of the average of the lowest two (2) trading prices per common stock during the fifteen (15) trading day prior to the conversion date. The conversion feature of the April 2020 Note was considered a derivative in accordance with current accounting guidelines because of the reset conversion features of the April 2020 Note. The Company recorded amortization of debt discount, which was recognized as interest expense in the amount of $16,658 during the year ended June 30, 2020. The balance of the April 2020 Note as of June 30, 2020 was $80,000. On April 15, 2020, the Company issued a convertible promissory note (the "Apr 2020 Note") to an investor in the aggregate principal amount of $50,000, of which the Company received $10,000 as of June 30, 2020. The Apr 2020 Note matures twelve (12) months from the effective dates of each respective tranche, such that the Apr 2020 Note matures on April 15, 2021, with an automatic extension of sixty (60) months from the effective date of each tranche. The Apr Note is convertible into shares of common stock of the Company at a price equal to a variable conversion price of the lesser of $0.01 per share or fifty percent (50%) of the lowest trading price of common stock recorded on any trade day after the effective date, or (c) the lowest effective price per share granted to any person or entity after the effective date to acquire common stock. If the Company fails to deliver shares in accordance with the timeframe of four (4) business days of the receipt of a notice of conversion, the lender, at any time prior to selling all of those shares, may rescind any portion, in whole or in part of that particular conversion attributable to the unsold shares and have the rescinded conversion amount returned to the principal sum with the rescinded conversion shares returned to the Company. In no event shall the lender be entitled to convert any portion of the Apr 2020 Note such that would result in beneficial ownership by the lender and its affiliates of more than 4.99% of the outstanding shares of common stock of the Company. In addition, for each conversion, in the event that shares are not delivered by the fourth business day (inclusive of the day of conversion), a penalty of $2,000 per day shall be assessed for each day after the fourth business day (inclusive of the day of the conversion) until the shares are delivered. The conversion feature of the April 2020 Note was considered a derivative in accordance with current accounting guidelines because of the reset conversion features of the Apr 2020 Note. The Company recorded amortization of debt discount, which was recognized as interest expense in the amount of $706 during the year ended June 30, 2020. The balance of the Apr 2020 Note as of June 30, 2020 was $10,000. On May 19, 2020, the Company issued a convertible promissory note (the "May 2020 Note") to an investor in the principal amount of $80,000. The Company received funds of $78,000, less other fees of $2,000. The May 2020 Note matures on May 19, 2021. The May 2020 Note may be converted into shares of the Company's common stock at a conversion price of sixty-one (61%) percent of the lowest two (2) trading prices per common stock during the fifteen (15) trading day prior to the conversion date. The conversion feature of the May 2020 Note was considered a derivative in accordance with current accounting guidelines because of the reset conversion features of the May 2020 Note. The Company recorded amortization of debt discount, which was recognized as interest expense in the amount of $9,205 during the year ended June 30, 2020. The balance of the May 2020 Note as of June 30, 2020 was $80,000. On June 18, 2020, the Company issued a convertible promissory note (the "June 2020 Note") to an investor in the principal amount of $160,000. The Company received funds of $156,000, less other fees of $4,000. The Jun 2020 Note matures on June 19, 2021. The Jun 2020 Note may be converted into shares of the Company's common stock at a conversion price of sixty-one (61%) percent of the average of the lowest two (2) trading prices per common stock during the fifteen (15) trading day prior to the conversion date. The conversion feature of the Jun 2020 Note was considered a derivative in accordance with current accounting guidelines because of the reset conversion features of the Jun 2020 Note. The Company recorded amortization of debt discount, which was recognized as interest expense in the amount of $5,260 during the year ended June 30, 2020. The balance of the Jun 2020 Note as of June 30, 2020 was $160,000. All note conversions were performed per the terms of their respective agreements and therefore no gain or loss on the conversion was recorded. |
Derivative Liabilities
Derivative Liabilities | 3 Months Ended | 12 Months Ended |
Sep. 30, 2020 | Jun. 30, 2020 | |
Derivative Instruments and Hedging Activities Disclosure [Abstract] | ||
DERIVATIVE LIABILITIES | 6. DERIVATIVE LIABILITIES ASC Topic 815 provides guidance applicable to convertible debt issued by the Company in instances where the number into which the debt can be converted is not fixed. For example, when a convertible debt converts at a discount to market based on the stock price on the date of conversion, ASC Topic 815 requires that the embedded conversion option of the convertible debt be bifurcated from the host contract and recorded at their fair value. In accounting for derivatives under accounting standards, the Company recorded a liability representing the estimated present value of the conversion feature considering the historic volatility of the Company’s stock, and a discount representing the imputed interest associated with the embedded derivative. The discount is amortized over the life of the convertible debt, and the derivative liability is adjusted periodically according to stock price fluctuations. The convertible notes (the “Notes”) issued do not have fixed settlement provisions because their conversion prices are not fixed. The conversion features have been characterized as derivative liabilities to be re-measured at the end of every reporting period with the change in value reported in the statement of operations. During the three months ended September 30, 2020, the Company recorded a net loss in change in derivative of $1,380,085 in the statement of operations due to the change in fair value of the remaining notes, for the three months ended September 30, 2020. At September 30, 2020, the fair value of the derivative liability was $61,037,804. For purpose of determining the fair market value of the derivative liability for the embedded conversion, the Company used the Binomial lattice formula. The significant assumptions used in the Binomial lattice formula of the derivatives are as follows: Risk free interest rate 0.12% - 0.28% Stock volatility factor 150.0% - 274.0% Weighted average expected option life 3 months - 5 year Expected dividend yield None | 6. DERIVATIVE LIABILITIES ASC Topic 815 provides guidance applicable to convertible debt issued by the Company in instances where the number into which the debt can be converted is not fixed. For example, when a convertible debt converts at a discount to market based on the stock price on the date of conversion, ASC Topic 815 requires that the embedded conversion option of the convertible debt be bifurcated from the host contract and recorded at their fair value. In accounting for derivatives under accounting standards, the Company recorded a liability representing the estimated present value of the conversion feature considering the historic volatility of the Company's stock, and a discount representing the imputed interest associated with the embedded derivative. The discount is amortized over the life of the convertible debt, and the derivative liability is adjusted periodically according to stock price fluctuations. The convertible notes (the "Notes") issued do not have fixed settlement provisions because their conversion prices are not fixed. The conversion features have been characterized as derivative liabilities to be re-measured at the end of every reporting period with the change in value reported in the statement of operations. During the year ended June 30, 2020, as a result of the Notes issued that were accounted for as derivative liabilities, we determined that the fair value of the conversion feature of the convertible notes at issuance was $841,436, based upon the Cox Rubenstein binomial model. We recorded the full value of the derivative as a liability at issuance with an offset to valuation discount, which will be amortized over the life of the Notes. During the year ended June 30, 2020, the Company recorded a net loss in change in derivative of $54,910,562 in the statement of operations due to the change in fair value of the remaining notes, for the year ended June 30, 2020. At June 30, 2020, the fair value of the derivative liability was $59,657,719. For purpose of determining the fair market value of the derivative liability for the embedded conversion, the Company used the Cox Rubenstein binomial lattice formula. The significant assumptions used in the Cox Rubenstein binomial lattice formula of the derivatives are as follows: Risk free interest rate 0.13% - 0.22% Stock volatility factor 80.0% - 267.0% Weighted average expected option life 0 months - 5 year Expected dividend yield None |
Deferred Tax Benefit
Deferred Tax Benefit | 12 Months Ended |
Jun. 30, 2020 | |
Income Tax Disclosure [Abstract] | |
DEFERRED TAX BENEFIT | 7. DEFERRED TAX BENEFIT The Company files income tax returns in the U.S. Federal jurisdiction, and the state of California. With few exceptions, the Company is no longer subject to U.S. federal, state and local, or non-U.S. income tax examinations by tax authorities for years before 2017. Deferred income taxes have been provided by temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for tax purposes. To the extent allowed by GAAP, we provide valuation allowances against the deferred tax assets for amount when the realization is uncertain. Included in the balance at June 30, 2020 and 2019, are no tax positions for which the ultimate deductibility is highly certain, but for which there is uncertainty about the timing of such deductibility. Because of the impact of deferred tax accounting, other than interest and penalties, the disallowance of the shorter deductibility period would not affect the annual effective tax rate but would accelerate the payment of cash to the taxing authority to an earlier period. The Company's policy is to recognize interest accrued related to unrecognized tax benefits in interest expense and penalties in operating expenses. During the periods ended June 30, 2020 and 2019, the Company did not recognize interest or penalties. At June 30, 2020, the Company had net operating loss carry-forward of approximately $7,722,300, which expires in future years. No tax benefit has been reported in the June 30, 2020 and 2019 financial statements, since the potential tax benefit is offset by a valuation allowance of the same amount. The income tax provision differs from the amount of income tax determined by applying the U.S. federal income tax rate to pretax income from continuing operations for the years ended June 30, 2020 and 2019 due to the following: 6/30/2020 6/30/2019 Book income (loss) $ (12,081,160 ) $ 1,193,500 Non-deductible expenses 11,950,635 ) (1,520,850 ) Depreciation and amortization 310 45 Related party accrual 7,875 (5,100 ) Valuation Allowance 122,340 332,405 Income tax expense $ - $ - Deferred taxes are provided on a liability method, whereby deferred tax assets are recognized for deductible differences and operating loss and tax credit carry-forward and deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the difference between the reported amounts of assets and liabilities and their tax bases. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all the deferred tax assets will not be realized. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all the deferred tax assets will not be realized. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment. Net deferred tax liabilities consist of the following components as of June 30, 2020 and 2019: 6/30/2020 6/30/2019 Deferred tax assets: NOL carryover $ 1,571,210 $ 2,070,125 Research and development 104,500 92,490 Related party accrual 44,465 52,275 Deferred tax liabilities: Depreciation and amortization $ (3,610 ) $ (5,340 ) Less Valuation Allowance $ (1,716,565 ) $ (2,209,550 ) Income tax expense $ - $ - Due to the change in ownership provisions of the Tax Reform Act of 1986, net operating loss carry-forward for Federal income tax reporting purposes are subject to annual limitations. Should a change in ownership occur, net operating loss carry-forward may be limited as to use in future years. O . The Company's tax returns for the previous three years remain open for audit by the respective tax jurisdictions. |
Common Stock Purchase Agreement
Common Stock Purchase Agreements | 3 Months Ended |
Sep. 30, 2020 | |
Common Stock Purchase Agreements [Abstract] | |
COMMON STOCK PURCHASE AGREEMENTS | 7. COMMON STOCK PURCHASE AGREEMENTS On July 27, 2020, the Company entered into a purchase agreement with an investor. Pursuant to the purchase agreement, subject to certain conditions set forth in the purchase agreement, the investor was obligated to purchase up to $2.1 million of the Company’s common stock from time to time through September 30, 2020. The purchase price per share under the purchase agreement was 85% of the lowest closing price during the five (5) business days prior to closing, not to exceed the valuation cap set forth in the purchase agreement. During the three months ended September 30, 2020, the Company issued 20,000,000 shares of common stock at a purchase price of $0.025 per share under the purchase agreement. The Company received net proceeds of $460,350 after legal fees and commissions. On September 21, 2020, the Company entered into a purchase agreement with an investor. Under the purchase agreement, the Company may sell, in its discretion (subject to the terms and conditions of the purchase agreement) up to an aggregate of $4,000,000 of common stock to the investor. The Company has the right, in its sole discretion, subject to the conditions and limitations in the purchase agreement, to direct the investor, by delivery of a purchase notice from time to time to purchase over the 6-month term of the purchase agreement, a minimum of $10,000 and up to a maximum of $400,000 of shares of common stock for each purchase notice (provided that, the purchase amount for any purchase will not exceed two times the average of the daily trading dollar volume of the common stock during the 10 business days preceding the purchase date). The number of purchase shares the Company will issue under each purchase will be equal to 112.5% of the purchase amount sold under such Purchase, divided by the purchase price per share (as defined under the purchase agreement). The “purchase price” is defined as 90% of the lowest end-of-day volume weighted average price of the common stock for the five consecutive business days immediately preceding the purchase date, including the purchase date. The Company may not deliver more than one purchase notice to the investor every ten business days, except as the parties may otherwise agree. . During the three months ended September 30, 2020, the Company received $300,000 for the sale of 15,573,090 shares of common stock under the purchase agreement. |
Commitments and Contingencies
Commitments and Contingencies | 3 Months Ended | 12 Months Ended |
Sep. 30, 2020 | Jun. 30, 2020 | |
Commitments and Contingencies Disclosure [Abstract] | ||
COMMITMENTS AND CONTINGENCIES | 8. COMMITMENTS AND CONTINGENCIES On September 15, 2020, the Company entered into a marketing agreement to position its brand in the market. The fees are to be paid in cash and registered unrestricted stock. As of September 30, 2020, the Company has paid a $26,250 deposit, with the balance of the payments and the stock issuances due and payable through December 2020. On September 1, 2020, the Company entered into a research agreement with the University of Iowa. As consideration under the research agreement, the University of Iowa will receive a maximum of $299,966 from the Company. The research agreement may be terminated by either party upon a sixty (60) day prior written notice or a material breach or default, which is not cured within 90 days of receipt of a written notice of such breach. The term of the research agreement is from September 1, 2020 through August 31, 2020. As of September 30, 2020, the Company has accrued the amount due of $24, 997. In the normal course of business, the Company may be involved in legal proceedings, claims and assessments arising in the ordinary course of business. Such matters are subject to many uncertainties, and outcomes are not predictable with assurance. In the opinion of management, the ultimate disposition of these matters will not have a material adverse effect on the Company’s consolidated financial position or results of operation | 8. COMMITMENTS AND CONTINGENCIES On June 1, 2019, the Company entered into a research agreement with the University of Iowa. As consideration under the research agreement, the University of Iowa will receive a maximum of $144,747 from the Company. The research agreement may be terminated by either party upon a sixty (60) day prior written notice or a material breach or default, which is not cured within 90 days of receipt of a written notice of such breach. The term of the research agreement runs through May 31, 2020, and was extended on September 1, 2020. In the normal course of business, the Company may be involved in legal proceedings, claims and assessments arising in the ordinary course of business. Such matters are subject to many uncertainties, and outcomes are not predictable with assurance. In the opinion of management, the ultimate disposition of these matters will not have a material adverse effect on the Company's consolidated financial position or results of operations. |
Related Party
Related Party | 3 Months Ended | 12 Months Ended |
Sep. 30, 2020 | Jun. 30, 2020 | |
Related Party Transactions [Abstract] | ||
RELATED PARTY | 9. RELATED PARTY As of September 30, 2020, the Company reported an accrual associated with the CEO’s prior year salary in the amount of $211,750. | 9. RELATED PARTY As of June 30, 2020, the Company reported an accrual associated with the CEO's prior year salary in the amount of $211,750. |
Subsequent Events
Subsequent Events | 3 Months Ended | 12 Months Ended |
Sep. 30, 2020 | Jun. 30, 2020 | |
Subsequent Events [Abstract] | ||
SUBSEQUENT EVENTS | 10. SUBSEQUENT EVENTS Management evaluated subsequent events as of the date of the financial statements pursuant to ASC TOPIC 855, and reported the following events: On October 5, 2020, the Company issued 992,387 shares of common stock for services in the amount of $29,722. On October 7, 2020, the Company received gross proceeds of $300,000 for the sale of 13,489,209 shares of commons stock. On October 16, 2020, the Company issued 5,315,949 shares of common stock upon conversion of principal in the amount of 80,000, plus accrued interest of $4,011, and other fees of $300. On October 27, 2020, the Company received gross proceeds of $400,000 for the sale of 19,685,040 shares of common stock. On November 10, 2020, the Company issued 53,615,458 shares of common stock upon conversion of principal in the amount of $35,700 in principal, plus accrued interest of $15,235, On November 12, 2020, the Company received $300,000 for the sale of 15,237,709 shares of common stock. On December 1, 2020, the Company entered into a securities purchase agreement with the purchaser set forth on the signature page thereto for the purchase and sale of an aggregate of 120,000,000 shares of the Company’s common stock and warrants to purchase an aggregate of up to 120,000,000 shares of common stock, in a registered direct offering at a combined purchase price of $0.075 per share and warrant, for aggregate gross proceeds to the Company of $9,000,000. The registered direct offering closed on December 3, 2020. In addition, the Company issued to the placement agent’s designees placement agent warrants to purchase a number of shares equal to 7.0% of the aggregate number of shares sold under the purchase agreement, or warrants to purchase up to an aggregate of 8,400,000 shares. The placement agent warrants generally have the same terms as the warrants issued to the investor, except they have an exercise price of $0.0938 and the placement agent warrants and the shares of common stock issuable thereunder are not registered under the Securities Act of 1933, as amended. On December 28, 2020, the Company entered into a letter agreement with an existing accredited investor to exercise certain outstanding warrants (the “Exercise”) to purchase up to an aggregate of 120,000,000 shares of the Company’s common stock at an exercise price per share of $0.075 (the “Prior Warrants”). In consideration for the immediate exercise of the Prior Warrants for cash, the exercising investor received new unregistered warrants to purchase up to an aggregate of 132,000,000 shares of common stock (the “New Warrants”). The New Warrants have an exercise price of $0.075 per share, with an exercise period of three years from the date of issuance. The closing of the Exercise and issuance of the New Warrants occurred on December 29, 2020. The gross proceeds to the Company from the Exercise were $9.0 million, prior to deducting placement agent fees and offering expenses. The Company issued to the placement agent’s designees warrants to purchase up to an aggregate of 8,400,000 shares of common stock of the Company, which equals 7.0% of the aggregate number of shares of common stock issuable to the investor upon the Exercise. The placement agent warrants have an exercise price of $0.0938 per share and otherwise have identical terms to the New Warrants. | 10. SUBSEQUENT EVENTS Management evaluated subsequent events as of the date of the financial statements pursuant to ASC TOPIC 855, and reported the following events: On July 13, 2020, the Company issued 23,420,128 shares of common stock upon conversion of principal in the amount of $80,000, plus accrued interest of $3,989, and $300 in other fees. On July 14, 2020, the Company issued 1,047,679 shares of common stock for services in the amount of $29,335. On July 15, 2020, the Company issued 48,802,884 shares of common stock upon conversion of principal in the amount of $33,000, plus accrued interest of $13,363. On July 27, 2020, the Company entered into a common stock purchase agreement, whereby an investor purchased 20,000,000 shares of common stock at a purchase price of $0.025. On August 12, 2020, the Company issued 836,678 shares of common stock for services in the amount of $29,267. On August 12, 2020, the Company issued 5,294,205 shares of common stock upon conversion of principal in the amount of $80,000, plus accrued interest of $3,989, and $300 in other fees. On September 1, 2020, the Company entered into a research agreement with the University of Iowa. As consideration under the research agreement, the University of Iowa will receive a maximum of $299,966 from the Company. The research agreement may be terminated by either party upon sixty (60) days prior written notice or by either party upon notice of a material breach or default which is not cured within 90 days of receipt of written notice of such breach. This term of the research agreement runs through August 31, 2021, but may be extended upon mutual agreement of the parties. On September 4, 2020, the Company issued 929,546 shares of common stock for services in the amount of $29,699. On September 11, 2020, the Company issued 2,390,871 shares of common stock upon conversion of principal in the amount of $40,000, plus accrued interest of $1,994.52 and $300 in other expenses. On September 21, 2020, the Company entered into a purchase agreement (the "Purchase Agreement") with GHS Investments, LLC ("GHS"). Under the Purchase Agreement, the Company may sell, in its discretion (subject to the terms and conditions of the Purchase Agreement) up to an aggregate of $4,000,000 of common stock to GHS. The Company has the right, in its sole discretion, subject to the conditions and limitations in the Purchase Agreement, to direct GHS, by delivery of a purchase notice from time to time (a "Purchase Notice") to purchase (each, a "Purchase") over the 6-month term of the Purchase Agreement, a minimum of $10,000 and up to a maximum of $400,000 (the "Purchase Amount") of shares of common stock (the "Purchase Shares") for each Purchase Notice (provided that, the Purchase Amount for any Purchase will not exceed two times the average of the daily trading dollar volume of the common stock during the 10 business days preceding the purchase date). The number of Purchase Shares we will issue under each Purchase will be equal to 112.5% of the Purchase Amount sold under such Purchase, divided by the Purchase Price per share (as defined under the Purchase Agreement). The "Purchase Price" is defined as 90% of the lowest end-of-day volume weighted average price of the common stock for the five consecutive business days immediately preceding the purchase date, including the purchase date. We may not deliver more than one Purchase Notice to GHS every ten business days, except as the parties may otherwise agree. Other than as described above, there are no trading volume requirements or restrictions under the Purchase Agreement. We will control the timing and amount of any sales of our common stock to GHS. We may at any time in our sole discretion terminate the Purchase Agreement. The Purchase Agreement prohibits us from directing GHS to purchase any shares of common stock if those shares, when aggregated with all other shares of our common stock then beneficially owned by GHS and its affiliates, would result in GHS and its affiliates having beneficial ownership, at any single point in time, of more than 4.99% of the then total outstanding shares of our common stock. Events of default under the Purchase Agreement include the following: ● the effectiveness of the registration statement for the Purchase Shares lapses for any reason or is unavailable for the resale by GHS of the Purchase Shares; ● the suspension of our common stock from trading for a period of two business days; ● the delisting of the Company's common stock from the OTC Pink; provided, however, that the common stock is not immediately thereafter trading on the Nasdaq Capital Market, New York Stock Exchange, the Nasdaq Global Market, the Nasdaq Global Select Market, the NYSE American, or the OTCQX or OTCQB; ● the failure for any reason by the transfer agent to issue Purchase Shares to GHS within three business days after the applicable date on which GHS is entitled to receive such securities; ● any breach of the representations and warranties or covenants contained in the Purchase Agreement if such breach would reasonably be expected to have a material adverse effect and such breach is not cured within five business days; ● insolvency or bankruptcy proceedings are commenced by or against us, as more fully described in the Purchase Agreement; or ● if at any time we are not eligible to transfer our common stock electronically via DWAC. So long as an event of default (all of which are outside the control of GHS) has occurred and is continuing, the Company may not deliver to GHS any Purchase Notice. We will pay a finder's fee to J.H. Darbie & Co., Inc. of 4% of the net proceeds we receive from sales of our common stock to GHS under the Purchase Agreement. |
Summary of Significant Accoun_2
Summary of Significant Accounting Policies (Policies) | 3 Months Ended | 12 Months Ended |
Sep. 30, 2020 | Jun. 30, 2020 | |
Accounting Policies [Abstract] | ||
Cash and Cash Equivalent | Cash and Cash Equivalent The Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents. | Cash and Cash Equivalent The Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents. |
Use of Estimates | Use of Estimates In accordance with accounting principles generally accepted in the United States, management utilizes estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements as well as the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. These estimates and assumptions relate to useful lives and impairment of tangible and intangible assets, accruals, income taxes, stock-based compensation expense, Binomial lattice valuation model inputs, derivative liabilities and other factors. Management believes it has exercised reasonable judgment in deriving these estimates. Consequently, a change in conditions could affect these estimates. | Use of Estimates In accordance with accounting principles generally accepted in the United States, management utilizes estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements as well as the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. These estimates and assumptions relate to useful lives and impairment of tangible and intangible assets, accruals, income taxes, stock-based compensation expense, Cox Rubenstein binomial lattice valuation model inputs, derivative liabilities and other factors. Management believes it has exercised reasonable judgment in deriving these estimates. Consequently, a change in conditions could affect these estimates. |
Property and Equipment | Property and Equipment Property and equipment are stated at cost, and are depreciated using straight line over its estimated useful lives. During the three months ended September 30, 2020, the Company purchased a business vehicle for transporting demonstration units and to serve as a mobile office. The Company recognized depreciation expense of $278 and $157 for the three months ended September 30, 2020 and 2019, respectively. | Property and Equipment Property and equipment are stated at cost, and are depreciated using straight line over its estimated useful lives: Computers and peripheral equipment 5 Years Depreciation expense for the years ended June 30, 2020 and 2019 was $768 and $628, respectively. |
Intangible Assets | Intangible Assets The Company has patent applications to protect the inventions and processes behind its proprietary bio-based back-sheet, a protective covering for the back of photovoltaic solar modules traditionally made from petroleum-based film. Intangible assets that have finite useful lives continue to be amortized over their useful lives. The Company recognized amortization expense of $1,758 and $2,052 for the three months ended September 30, 2020 and 2019, respectively. | Intangible Assets The Company has patent applications to protect the inventions and processes behind its proprietary bio-based back-sheet, a protective covering for the back of photovoltaic solar modules traditionally made from petroleum-based film. Intangible assets that have finite useful lives continue to be amortized over their useful lives. Useful Lives 6/30/2020 6/30/2019 Domain-gross 15 years $ 5,315 $ 5,315 Less accumulated amortization (4,223 ) (3,868 ) Domain-net $ 1,092 $ 1,447 Trademark-gross 10 years $ 1,143 $ 1,143 Less accumulated amortization (371 ) (257 ) Domain-net $ 772 $ 886 Patents-gross 15 years $ 107,491 $ 107,491 Write-off of patent cost (6,349 ) - Less accumulated amortization (16,650 ) (10,391 ) Patents-net $ 84,492 $ 97,100 The Company recognized amortization expense of $7,651 and $6,360 for the years ended June 30, 2020 and 2019, respectively. |
Net Earnings (Loss) per Share Calculations | Net Earnings (Loss) per Share Calculations Net earnings (Loss) per share dictates the calculation of basic earnings (loss) per share and diluted earnings per share. Basic earnings (loss) per share are computed by dividing by the weighted average number of common shares outstanding during the year. Diluted net earnings (loss) per share is computed similar to basic earnings (loss) per share except that the denominator is increased to include the effect of stock options and stock-based awards (Note 4), plus the assumed conversion of convertible debt (Note 5). For the three months ended September 30, 2020, the Company calculated the dilutive impact of the outstanding stock options of 186,000,000, and the convertible debt of $1,797,000, which is convertible into shares of common stock. The stock options and convertible debt were not included in the calculation of net earnings per share, because their impact was antidilutive. For the three months ended September 30, 2019, the Company calculated the dilutive impact of the outstanding stock options of 196,250,000, and the convertible debt of $2,118,100, which is convertible into shares of common stock. The stock options and convertible debt were not included in the calculation of net earnings per share, because their impact was antidilutive. | Net Earnings (Loss) per Share Calculations Net earnings (Loss) per share dictates the calculation of basic earnings (loss) per share and diluted earnings per share. Basic earnings (loss) per share are computed by dividing by the weighted average number of common shares outstanding during the year. Diluted net earnings (loss) per share is computed similar to basic earnings (loss) per share except that the denominator is increased to include the effect of stock options and stock-based awards (Note 4), plus the assumed conversion of convertible debt (Note 5). For the year ended June 30, 2020, the Company calculated the dilutive impact of the outstanding stock options of 186,000,000, and the convertible debt of $2,030,000, which is convertible into shares of common stock. The stock options and convertible debt were not included in the calculation of net earnings per share, because their impact was antidilutive. For the year ended June 30, 2019, the Company calculated the dilutive impact of its outstanding stock options of 186,250,000, and convertible debt of $2,320,486, which is convertible into shares of common stock. The stock options and convertible debt were not included in the calculation of net earnings per share, because their impact was antidilutive. For the Years Ended June 30, 2020 2019 Income (Loss) to common shareholders (Numerator) $ (57,529,338 ) $ 3,978,337 Basic weighted average number of common shares outstanding (Denominator) 1,551,749,054 924,582,860 Diluted weighted average number of common shares outstanding (Denominator) 1,551,749,054 924,582,860 |
Equity Incentive Plan and Stock Options | Equity Incentive Plan and Stock Options Equity Incentive Plan On December 17, 2018, the Board of Directors approved and adopted the 2019 Equity Incentive Plan (“the Plan”), with 300,000,000 shares of common stock set aside and reserved for issuance pursuant to the Plan. The purpose of the Plan is to promote the success of the Company and to increase stockholder value by providing an additional means through the grant of awards to attract, motivate, retain and reward selected employees and other eligible persons. The awards are performance-based compensation that are granted under the Plan as incentive stock options (ISO) or nonqualified stock options. The per share exercise price for each option shall not be less than 100% of the fair market value of a share of common stock on the date of grant of the option. The Company periodically issues stock options and warrants to employees and non-employees in non-capital raising transactions for services. The Company accounts for stock option grants issued and vesting to employees and non-employees in accordance with the authoritative guidance of the Financial Accounting Standards Board whereas the value of the stock compensation is based upon the measurement date as determined at either a) the date at which a performance commitment is reached, or b) at the date at which the necessary performance to earn the equity instruments is complete. Non-employee stock-based compensation charges generally are amortized over the vesting period on a straight-line basis. In certain circumstances where there are no future performance requirements by the non-employee, option grants are immediately vested, and the total stock-based compensation charge is recorded in the period of the measurement date. As of September 30, 2020, the Company has granted 186,000,000 equity incentive stock options leaving a reserve of 114,000,000. The options are exercisable for common stock. | Equity Incentive Plan and Stock Options Equity Incentive Plan On December 17, 2018, the Board of Directors approved and adopted the 2019 Equity Incentive Plan ("the Plan"), with 300,000,000 shares of common stock set aside and reserved for issuance pursuant to the Plan. The purpose of the Plan is to promote the success of the Company and to increase stockholder value by providing an additional means through the grant of awards to attract, motivate, retain and reward selected employees and other eligible persons. The awards are performance-based compensation that are granted under the Plan as incentive stock options (ISO) or nonqualified stock options. The per share exercise price for each option shall not be less than 100% of the fair market value of a share of common stock on the date of grant of the option. The Company periodically issues stock options and warrants to employees and non-employees in non-capital raising transactions for services and for financing cost. The Company accounts for stock option grants issued and vesting to employees and non-employees in accordance with the authoritative guidance of the Financial Accounting Standards Board whereas the value of the stock compensation is based upon the measurement date as determined at either a) the date at which a performance commitment is reached, or b) at the date at which the necessary performance to earn the equity instruments is complete. Non-employee stock-based compensation charges generally are amortized over the vesting period on a straight-line basis. In certain circumstances where there are no future performance requirements by the non-employee, option grants are immediately vested, and the total stock-based compensation charge is recorded in the period of the measurement date. The shares are convertible into common stock upon exercise. As of June 30, 2020, there were 186,000,000 stock options issued, and 114,000,000 additional shares reserved under the Plan. |
Stock based Compensation | Stock based Compensation The Company periodically issues stock options and warrants to employees and non-employees in non-capital raising transactions for services. The Company accounts for stock option and warrant grants issued and vesting to employees based on the authoritative guidance provided by the Financial Accounting Standards Board whereas the value of the award is measured on the date of grant and recognized over the vesting period. The Company accounts for stock option and warrant grants issued and vesting to non-employees in accordance with the authoritative guidance of the Financial Accounting Standards Board whereas the value of the stock compensation is based upon the measurement date as determined at either a) the date at which a performance commitment is reached, or b) at the date at which the necessary performance to earn the equity instruments is complete. Non-employee stock-based compensation charges generally are amortized over the vesting period on a straight-line basis. In certain circumstances where there are no future performance requirements by the non-employee, the option grants immediately vest, and the total stock-based compensation charge is recorded in the period of the measurement date. As of September 30, 2020, the Company has granted 10,000,000 stock-based compensation stock options, which are exercisable for common stock. | Stock based Compensation The Company periodically issues stock options and warrants to employees and non-employees in non-capital raising transactions for services and for financing costs. The Company accounts for stock option and warrant grants issued and vesting to employees based on the authoritative guidance provided by the Financial Accounting Standards Board whereas the value of the award is measured on the date of grant and recognized over the vesting period. The Company accounts for stock option and warrant grants issued and vesting to non-employees in accordance with the authoritative guidance of the Financial Accounting Standards Board whereas the value of the stock compensation is based upon the measurement date as determined at either a) the date at which a performance commitment is reached, or b) at the date at which the necessary performance to earn the equity instruments is complete. Non-employee stock-based compensation charges generally are amortized over the vesting period on a straight-line basis. In certain circumstances where there are no future performance requirements by the non-employee, the option grants immediately vest, and the total stock-based compensation charge is recorded in the period of the measurement date. As of June 30, 2020, 10,000,000 of such options were outstanding. |
Fair Value of Financial Instruments | Fair Value of Financial Instruments Fair value of financial instruments, requires disclosure of the fair value information, whether or not recognized on the balance sheet, where it is practicable to estimate that value. As of September 30, 2020, the amounts reported for cash, accrued interest and other expenses, notes payables, convertible notes, and derivative liability approximate the fair value because of their short maturities. Fair Value of Financial Instruments We adopted ASC Topic 820 for financial instruments measured as fair value on a recurring basis. ASC Topic 820 defines fair value, established a framework for measuring fair value in accordance with accounting principles generally accepted in the United States and expands disclosures about fair value measurements. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC Topic 820 established a three-tier fair value hierarchy which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurements) and the lowest priority to unobservable inputs (level 3 measurements). These tiers include: ● Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets; ● Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and ● Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. We measure certain financial instruments at fair value on a recurring basis. Assets and liabilities measured at fair value on a recurring basis are as follows at September 30, 2020 (See Note 6): Total (Level 1) (Level 2) (Level 3) Liabilities Derivative liability measured at fair value at 9/30/20 $ 61,037,804 - $ - $ 61,037,804 The following is a reconciliation of the derivative liability for which Level 3 inputs were used in determining the approximate fair value: Balance as of June 30, 2020 59,657,719 Fair value of derivative liabilities issued - Loss on change in derivative liability 1,380,085 Balance as of September 30, 2020 $ 61,037,804 | Fair Value of Financial Instruments Fair value of financial instruments, requires disclosure of the fair value information, whether or not recognized in the balance sheet, where it is practicable to estimate that value. As of June 30, 2020, the amounts reported for cash, accrued interest and other expenses, notes payables, convertible notes, and derivative liability approximate the fair value because of their short maturities. We adopted ASC Topic 820 for financial instruments measured as fair value on a recurring basis. ASC Topic 820 defines fair value, established a framework for measuring fair value in accordance with accounting principles generally accepted in the United States and expands disclosures about fair value measurements. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC Topic 820 established a three-tier fair value hierarchy which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurements) and the lowest priority to unobservable inputs (level 3 measurements). These tiers include: ● Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets; ● Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and ● Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. We measure certain financial instruments at fair value on a recurring basis. Assets and liabilities measured at fair value on a recurring basis are as follows at June 30, 2020 and 2019 (See Note 6): Total (Level 1) (Level 2) (Level 3) Liabilities Derivative liability measured at fair value at 6/30/20 $ 59,657,719 $ - $ - $ 59,657,719 Derivative liability measured at fair value at 6/30/19 $ 3,905,721 $ - $ - $ 3,905,721 Fair Value of Financial Instruments The following is a reconciliation of the derivative liability for which Level 3 inputs were used in determining the approximate fair value: Balance as of June 30, 2018 $ 10,857,698 Fair value of derivative liabilities at issuance 743,301 Gain on change in derivative liability (7,695,278 ) Balance as of June 30, 2019 3,905,721 Fair value of derivative liabilities issued 841,436 Loss on change in derivative liability 54,910,562 Balance as of June 30, 2020 $ 59,657,719 |
Research and Development | Research and Development Research and development costs are expensed as incurred. Total research and development costs were $138,260 and $143,395 for the three months ended September 30, 2020 and 2019, respectively | Research and Development Research and development costs are expensed as incurred. Total research and development costs were $615,721 and $528,901 for the years ended June 30, 2020 and 2019, respectively. |
Accounting for Derivatives | Accounting for Derivatives The Company evaluates all of its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. For stock-based derivative financial instruments, the Company uses a probability weighted average series Binomial lattice formula pricing models to value the derivative instruments at inception and on subsequent valuation dates. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement of the derivative instrument could be required within 12 months of the balance sheet date. | Accounting for Derivatives The Company evaluates all of its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. For stock-based derivative financial instruments, the Company uses a probability weighted average series Binomial lattice formula pricing models to value the derivative instruments at inception and on subsequent valuation dates. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement of the derivative instrument could be required within 12 months of the balance sheet date. |
Income Taxes | Income Taxes Deferred income taxes are provided using the liability method whereby deferred tax assets are recognized for deductible temporary differences and operating loss and tax credit carry-forwards and deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the differences between the reported amounts of assets and liabilities and their tax bases. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all the deferred tax assets will not be realized. Deferred tax assets and liabilities are adjusted for the effects of the changes in tax laws and rates of the date of enactment. When tax returns are filed, it is highly certain that some positions taken would be sustained upon examination by the taxing authorities, while others are subject to uncertainty about the merits of the position taken or the amount of the position that would be ultimately sustained. The benefit of a tax position is recognized in the financial statements in the period during which, based on all available evidence, management believes it is more likely than not that the position will be sustained upon examination, including the resolution of appeals or litigation processes, if any. Tax positions taken are not offset or aggregated with other positions. Tax positions that meet the more-likely-than-not recognition threshold are measured as the largest amount of tax benefit that is more than (50%) fifty percent likely of being realized upon settlement with the applicable taxing authority. The portion of the benefits associated with tax positions taken that exceeds the amount measured as described above is reflected as a liability for unrecognized tax benefits in the accompanying balance sheet along with any associated interest and penalties that would be payable to the taxing authorities upon examination. | |
Recently Issued Accounting Pronouncements | Recently Issued Accounting Pronouncements In June 2018, FASB issued accounting standards update ASU 2018-07, (Topic 505) – “Shared-Based Payment Arrangements with Nonemployees”, which simplifies the accounting for share-based payments granted to nonemployees for goods and services. Under the ASU, most of the guidance on such payments to nonemployees will be aligned with the requirements for share-based payments granted to employees. Under the ASU 2018-07, the measurement of equity-classified nonemployee share-based payments will be fixed on the grant date, as defined in ASC 718, and will use the term nonemployee vesting period, rather than requisite service period. The amendments in this update are effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. For all other entities, the amendments are effective for fiscal years beginning after December 15, 2019, and interim periods within fiscal years beginning after December 15, 2020. Early adoption is permitted if financial statements have not yet been issued. The Company is currently evaluating the impact of the adoption of ASU 2018-07 on the Company’s financial statements. In August 2018, the FASB issued accounting standards update ASU 2018-13, (Topic 820) - “Fair Value Measurement”, which changes the unrealized gains and losses, the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements, and the narrative description of measurement uncertainty should be applied prospectively for only the most recent interim or annual period presented in the initial fiscal year of adoption. All other amendments should be applied retrospectively to all periods presented upon their effective date. The amendments in this update are effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019. Early adoption is permitted upon issuance. The Company is currently evaluation the impact of the adoption of ASU 2018-13, on the Company’s financial statements. Management does not believe that any other recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the accompanying condensed financial statements. | Recently Issued Accounting Pronouncements In August 2017, FASB issued accounting standards update ASU-2017-12, (Topic 815) – "Targeted Improvements to Accounting for Hedging Activities", to require an entity to present the earnings effect of the hedging instrument in the same statement line item in which the earnings effect of the hedged item is reported. The amendments in this update are effective for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years. For all other entities, the amendments are effective for fiscal years beginning after December 15, 2019, and interim periods with the fiscal years beginning after December 15, 2020. Early adoption is permitted in any interim period after issuance of the update. The Company does not believe the adoption of ASU-2017 would have a material impact on the Company's financial statements. In June 2018, FASB issued accounting standards update ASU 2018-07, (Topic 505) – "Shared-Based Payment Arrangements with Nonemployees", which simplifies the accounting for share-based payments granted to nonemployees for goods and services. Under the ASU, most of the guidance on such payments to nonemployees will be aligned with the requirements for share-based payments granted to employees. Under the ASU 2018-07, the measurement of equity-classified nonemployee share-based payments will be fixed on the grant date, as defined in ASC 718, and will use the term nonemployee vesting period, rather than requisite service period. The amendments in this update are effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. For all other entities, the amendments are effective for fiscal years beginning after December 15, 2019, and interim periods within fiscal years beginning after December 15, 2020. Early adoption is permitted if financial statements have not yet been issued. The Company is currently evaluating the impact of the adoption of ASU 2018-07 on the Company's financial statements. In August 2018, the FASB issued to accounting standards update ASU 2018-13, (Topic 820) - "Fair Value Measurement", which changes the unrealized gains and losses, the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements, and the narrative description of measurement uncertainty should be applied prospectively for only the most recent interim or annual period presented in the initial fiscal year of adoption. All other amendments should be applied retrospectively to all periods presented upon their effective date. The amendments in this update are effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019. Early adoption is permitted upon issuance. The Company is currently evaluation the impact of the adoption of ASU 2018-13, on the Company's financial statements. In December 2019, the FASB issued to accounting standards amendment updates to ASU 2019-12, (Topic 740) – "Income Taxes", which simplify the accounting for income taxes by removing certain exceptions to the general principles in Topic 740. The amendments also improve consistent application of and simplify GAAP for other areas of Topic 740 by clarifying and amending existing guidance. The amendments in this update are effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020. For all other entities, the amendments are effective for fiscal years beginning after December 15, 2021, and interim periods with fiscal years beginning after December 15, 2022. Early adoption of the amendments is permitted. The Company does not believe the adoption of ASU-2019-12, would have a material impact on the Company's financial statements. Management does not believe that any other recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the accompanying condensed financial statements. |
Summary of Significant Accoun_3
Summary of Significant Accounting Policies (Tables) | 3 Months Ended | 12 Months Ended |
Sep. 30, 2020 | Jun. 30, 2020 | |
Accounting Policies [Abstract] | ||
Schedule of measurement of assets and liabilities at fair value on recurring basis | Total (Level 1) (Level 2) (Level 3) Liabilities Derivative liability measured at fair value at 9/30/20 $ 61,037,804 - $ - $ 61,037,804 | Total (Level 1) (Level 2) (Level 3) Liabilities Derivative liability measured at fair value at 6/30/20 $ 59,657,719 $ - $ - $ 59,657,719 Derivative liability measured at fair value at 6/30/19 $ 3,905,721 $ - $ - $ 3,905,721 |
Schedule of reconciliation of the derivative liability | Balance as of June 30, 2020 59,657,719 Fair value of derivative liabilities issued - Loss on change in derivative liability 1,380,085 Balance as of September 30, 2020 $ 61,037,804 | Balance as of June 30, 2018 $ 10,857,698 Fair value of derivative liabilities at issuance 743,301 Gain on change in derivative liability (7,695,278 ) Balance as of June 30, 2019 3,905,721 Fair value of derivative liabilities issued 841,436 Loss on change in derivative liability 54,910,562 Balance as of June 30, 2020 $ 59,657,719 |
Schedule of intangible assets finite amortized over useful lives | Useful Lives 6/30/2020 6/30/2019 Domain-gross 15 years $ 5,315 $ 5,315 Less accumulated amortization (4,223 ) (3,868 ) Domain-net $ 1,092 $ 1,447 Trademark-gross 10 years $ 1,143 $ 1,143 Less accumulated amortization (371 ) (257 ) Domain-net $ 772 $ 886 Patents-gross 15 years $ 107,491 $ 107,491 Write-off of patent cost (6,349 ) - Less accumulated amortization (16,650 ) (10,391 ) Patents-net $ 84,492 $ 97,100 | |
Schedule of property and equipment estimated useful lives | Computers and peripheral equipment 5 Years | |
Schedule of net earnings per share calculations | For the Years Ended June 30, 2020 2019 Income (Loss) to common shareholders (Numerator) $ (57,529,338 ) $ 3,978,337 Basic weighted average number of common shares outstanding (Denominator) 1,551,749,054 924,582,860 Diluted weighted average number of common shares outstanding (Denominator) 1,551,749,054 924,582,860 |
Options (Tables)
Options (Tables) | 3 Months Ended | 12 Months Ended |
Sep. 30, 2020 | Jun. 30, 2020 | |
Share-based Payment Arrangement [Abstract] | ||
Schedule of the Company's stock option activity and related information | 9/30/2020 9/30/2019 Weighted Weighted Number average Number average of exercise of exercise Options price Options price Outstanding, beginning of period 196,250,000 $ 0.01 186,250,000 $ 0.01 Granted - $ 0.01 10,000,000 $ 0.01 Exercised - - - - Forfeited/Expired (250,000 ) - - - Outstanding, end of period 196,000,000 $ 0.01 196,250,000 $ 0.01 Exercisable at the end of period 174,332,250 $ 0.01 108,916,667 $ 0.01 | 6/30/2020 6/30/2019 Weighted Weighted Number average Number average of exercise of exercise Options price Options price Outstanding, beginning of period 186,250,000 $ 0.01 10,250,000 $ 0.01 Granted 10,000,000 $ 0.01 176,000,000 $ 0.01 Exercised - - - - Forfeited/Expired (250,000 ) - - - Outstanding, end of period 196,000,000 $ 0.01 186,250,000 $ 0.01 Exercisable at the end of period 160,493,150 $ 0.01 85,583,333 $ 0.01 |
Schedule of weighted average remaining contractual life of options outstanding | 9/30/20 9/30/19 Exercisable Stock Options Outstanding Stock Options Exercisable Weighted Average Remaining Contractual Life (years) Exercisable Price Stock Options Outstanding Stock Options Exercisable Weighted Average Remaining Contractual Life (years) $ - - - - $ 0.02 250,000 250,000 0.50 $ 0.01 10,000,000 10,000,000 2.01 $ 0.01 10,000,000 5,000,000 3.01 $ 0.0097-0.0099 176,000,000 157,110,167 5.32 - 5.34 $ 0.0097-0.0099 176,000,000 99,777,777 6.32 - 6.34 $ 0.006 10,000,000 7,222,083 5.81 $ 0.006 10,000,000 3,888,889 6.81 196,000,000 174,332,250 196,250,000 108,916,667 | 6/30/2020 6/30/2019 Exercisable Stock Options Outstanding Stock Options Exercisable Weighted Average Remaining Contractual Life (years) Exercisable Price Stock Options Outstanding Stock Options Exercisable Weighted Average Remaining Contractual Life (years) $ - - - - $ 0.02 250,000 250,000 0.75 $ 0.01 10,000,000 10,000,000 1.26 $ 0.01 10,000,000 5,250,000 3.26 $ 0.0097-0.0099 176,000,000 144,018,263 5.57 – 5.59 $ 0.0097-0.0099 176,000,000 60,666,667 6.57 - 6.84 $ 0.0060 10,000,000 6,474,887 6.06 $ - - - - 196,000,000 160,493,150 186,250,000 85,583,333 |
Schedule of share-based payment arrangement valuation assumptions | 6/30/20 6/30/19 Risk free interest rate 1.47% - 2.58 % 1.94 % Stock volatility factor 54.99% - 189.01 % 146 % Weighted average expected option life 6 years 7 years Expected dividend yield None None |
Deferred Tax Benefit (Tables)
Deferred Tax Benefit (Tables) | 12 Months Ended |
Jun. 30, 2020 | |
Share-based Payment Arrangement [Abstract] | |
Schedule of components of income tax expense benefit | 6/30/2020 6/30/2019 Book income (loss) $ (12,081,160 ) $ 1,193,500 Non-deductible expenses 11,950,635 ) (1,520,850 ) Depreciation and amortization 310 45 Related party accrual 7,875 (5,100 ) Valuation Allowance 122,340 332,405 Income tax expense $ - $ - |
Schedule of net deferred tax liabilities | 6/30/2020 6/30/2019 Deferred tax assets: NOL carryover $ 1,571,210 $ 2,070,125 Research and development 104,500 92,490 Related party accrual 44,465 52,275 Deferred tax liabilities: Depreciation and amortization $ (3,610 ) $ (5,340 ) Less Valuation Allowance $ (1,716,565 ) $ (2,209,550 ) Income tax expense $ - $ - |
Convertible Promissory Notes (T
Convertible Promissory Notes (Tables) | 3 Months Ended | 12 Months Ended |
Sep. 30, 2020 | Jun. 30, 2020 | |
Debt Disclosure [Abstract] | ||
Schedule of convertible promissory notes | Convertible Promissory Notes, net of debt discount $ 1,586,950 Less current portion 126,950 Total long-term liabilities $ 1,460,000 | Convertible Promissory Notes, net of debt discount $ 1,620,926 Less current portion 160,926 Total long-term liabilities $ 1,460,000 |
Schedule of maturities of long-term debt | Period Ended September 30, Amount 2021 337,000 2022 695,000 2023 625,000 2024 140,000 $ 1,797,000 | Period Ended June 30, Amount 2021 570,000 2022 575,000 2023 745,000 2024 140,000 $ 2,030,000 |
Derivative Liabilities (Tables)
Derivative Liabilities (Tables) | 3 Months Ended | 12 Months Ended |
Sep. 30, 2020 | Jun. 30, 2020 | |
Derivative Instruments and Hedging Activities Disclosure [Abstract] | ||
Schedule of fair market value of the derivative liability | Risk free interest rate 0.12% - 0.28% Stock volatility factor 150.0% - 274.0% Weighted average expected option life 3 months - 5 year Expected dividend yield None | Risk free interest rate 0.13% - 0.22% Stock volatility factor 80.0% - 267.0% Weighted average expected option life 0 months - 5 year Expected dividend yield None |
Summary of Significant Accoun_4
Summary of Significant Accounting Policies (Details) - USD ($) | 12 Months Ended | ||
Jun. 30, 2020 | Sep. 30, 2020 | Jun. 30, 2019 | |
Less accumulated amortization | $ 16,650 | $ 18,291 | $ 10,391 |
Trademark [Member] | |||
Intangible assets - gross | 1,143 | 1,143 | |
Less accumulated amortization | (371) | (257) | |
Intangible assets - net | $ 772 | 886 | |
Useful Lives | 10 years | ||
Patents [Member] | |||
Intangible assets - gross | $ 107,491 | 107,491 | |
Write-off of patent cost | (6,349) | ||
Less accumulated amortization | (16,650) | (10,391) | |
Intangible assets - net | $ 84,492 | 97,100 | |
Useful Lives | 15 years | ||
Domain [Member] | |||
Intangible assets - gross | $ 5,315 | 5,315 | |
Less accumulated amortization | (4,223) | (3,868) | |
Intangible assets - net | $ 1,092 | $ 1,447 | |
Useful Lives | 15 years |
Summary of Significant Accoun_5
Summary of Significant Accounting Policies (Details 1) | 12 Months Ended |
Jun. 30, 2020 | |
Computer and peripheral equipment [Member] | |
Computer and peripheral equipment, estimated useful life | 5 years |
Summary of Significant Accoun_6
Summary of Significant Accounting Policies (Details 2) - USD ($) | 3 Months Ended | 12 Months Ended | ||
Sep. 30, 2020 | Sep. 30, 2019 | Jun. 30, 2020 | Jun. 30, 2019 | |
Accounting Policies [Abstract] | ||||
Income (Loss) to common shareholders (Numerator) | $ (2,206,260) | $ (1,252,759) | $ (57,529,338) | $ 3,978,337 |
Basic weighted average number of common shares outstanding (Denominator) | 1,551,749,054 | 924,582,860 | ||
Diluted weighted average number of common shares outstanding (Denominator) | 1,551,749,054 | 924,582,860 |
Summary of Significant Accoun_7
Summary of Significant Accounting Policies (Details 3) - USD ($) | Sep. 30, 2020 | Jun. 30, 2020 | Jun. 30, 2019 | Jun. 30, 2018 |
Level 3 [Member] | ||||
Liabilities | ||||
Total derivative liabilities measured at fair value | $ 61,037,804 | $ 59,657,719 | $ 3,905,721 | $ 10,857,698 |
Fair value on a Recurring Basis [Member] | ||||
Liabilities | ||||
Total derivative liabilities measured at fair value | 61,037,804 | 59,657,719 | 3,905,721 | |
Fair value on a Recurring Basis [Member] | Level 1 [Member] | ||||
Liabilities | ||||
Total derivative liabilities measured at fair value | ||||
Fair value on a Recurring Basis [Member] | Level 2 [Member] | ||||
Liabilities | ||||
Total derivative liabilities measured at fair value | ||||
Fair value on a Recurring Basis [Member] | Level 3 [Member] | ||||
Liabilities | ||||
Total derivative liabilities measured at fair value | $ 61,037,804 | $ 59,657,719 | $ 3,905,721 |
Summary of Significant Accoun_8
Summary of Significant Accounting Policies (Details 4) - Level 3 [Member] - USD ($) | 3 Months Ended | 12 Months Ended | |
Sep. 30, 2020 | Jun. 30, 2020 | Jun. 30, 2019 | |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Beginning balance | $ 59,657,719 | $ 3,905,721 | $ 10,857,698 |
Fair value of derivative liabilities issued | 841,436 | 743,301 | |
Gain (loss) on change in derivative liability | 1,380,085 | 54,910,562 | (7,695,278) |
Ending balance | $ 61,037,804 | $ 59,657,719 | $ 3,905,721 |
Summary of Significant Accoun_9
Summary of Significant Accounting Policies (Details Textual) - USD ($) | Dec. 17, 2018 | Dec. 17, 2018 | Sep. 30, 2020 | Sep. 30, 2019 | Jun. 30, 2020 | Jun. 30, 2019 |
Summary of Significant Accounting Policies (Textual) | ||||||
Amortization expense | $ 1,758 | $ 2,052 | $ 7,651 | $ 6,360 | ||
Additional shares reserved under the plan | $ 114,000,000 | |||||
Stock options issued | 186,000,000 | 196,250,000 | 186,000,000 | |||
Total research and development costs | $ 138,260 | $ 143,395 | $ 615,721 | 528,901 | ||
Depreciation expense | 278 | 157 | $ 768 | 628 | ||
Income taxes, description | Tax positions that meet the more-likely-than-not recognition threshold are measured as the largest amount of tax benefit that is more than (50%) fifty percent likely of being realized upon settlement with the applicable taxing authority. | |||||
Stock options granted (in Shares) | 186,000,000 | |||||
Stock options reserve (in Shares) | 114,000,000 | |||||
Equity Incentive [Member] | ||||||
Summary of Significant Accounting Policies (Textual) | ||||||
Issuance pursuant to the Plan | 300,000,000 | |||||
Stock Options [Member] | ||||||
Summary of Significant Accounting Policies (Textual) | ||||||
Convertible debt | $ 1,797,000 | $ 2,118,100 | $ 2,030,000 | $ 2,320,486 | ||
Dilutive impact of outstanding stock options | 186,000,000 | 186,250,000 | ||||
Stock options outstanding | 10,000,000 | |||||
Percentage od execrise option | 10.00% | |||||
Share-based Payment Arrangement [Member] | ||||||
Summary of Significant Accounting Policies (Textual) | ||||||
Percentage od execrise option | 100.00% | |||||
Stock options granted (in Shares) | 10,000,000 |
Capital Stocks (Details)
Capital Stocks (Details) - USD ($) | 3 Months Ended | 12 Months Ended | |||
Sep. 30, 2020 | Sep. 30, 2019 | Jun. 30, 2020 | Jun. 30, 2019 | Jun. 30, 2018 | |
Accumulated Other Comprehensive Income (Loss) [Line Items] | |||||
Common stock value issued for services | $ 35,573,090 | $ 357,134 | $ 29,397,257 | ||
Common stock shares issued for services | 800,000 | 91,101,103 | 249,435 | ||
Minimum [Member] | |||||
Accumulated Other Comprehensive Income (Loss) [Line Items] | |||||
Fair value closing market price per share | $ 0.002 | ||||
Maximum [Member] | |||||
Accumulated Other Comprehensive Income (Loss) [Line Items] | |||||
Fair value closing market price per share | $ 0.0072 | ||||
Common Stock One [Member] | |||||
Accumulated Other Comprehensive Income (Loss) [Line Items] | |||||
Issuance of common stock (in shares) | 79,908,088 | 217,641,145 | 884,989,722 | 195,464,064 | |
Principal amount of partial convertible promissory note | $ 233,000 | $ 388,886 | $ 1,166,986 | $ 411,814 | |
Issuance of common stock on payment of accrued interest for convertible notes | 23,335 | 57,594 | 198,200 | 75,278 | |
Aggregate fair value loss on settlement | 623,594 | $ 1,053,517 | |||
Other fees | 900 | 3,500 | $ 12,000 | ||
Common stock value issued for services | $ 88,301 | $ 89,450 | |||
Common stock shares issued for services | 2,813,903 | 22,995,143 | |||
Common Stock One [Member] | Minimum [Member] | |||||
Accumulated Other Comprehensive Income (Loss) [Line Items] | |||||
Conversion prices ranging | $ 0.017995 | $ 0.0069 | |||
Fair value closing market price per share | 0.035 | 0.0050 | |||
Common Stock One [Member] | Maximum [Member] | |||||
Accumulated Other Comprehensive Income (Loss) [Line Items] | |||||
Conversion prices ranging | 0.00095 | 0.0035 | |||
Fair value closing market price per share | $ 0.028 | $ 0.0035 | |||
Common Stock [Member] | Minimum [Member] | |||||
Accumulated Other Comprehensive Income (Loss) [Line Items] | |||||
Conversion prices ranging | $ 0.00095 | $ 0.0055 | $ 0.0063 | ||
Common Stock [Member] | Maximum [Member] | |||||
Accumulated Other Comprehensive Income (Loss) [Line Items] | |||||
Conversion prices ranging | $ 0.0041 | $ 0.0099 | $ 0.0105 |
Options (Details)
Options (Details) - $ / shares | 3 Months Ended | 12 Months Ended | ||
Sep. 30, 2020 | Sep. 30, 2019 | Jun. 30, 2020 | Jun. 30, 2019 | |
Weighted average exercise price | ||||
Exercisable at the end of period | $ 0.01 | $ 0.01 | ||
Stock Option [Member] | ||||
Number of Options | ||||
Outstanding, beginning of period | 196,000,000 | 186,250,000 | 186,250,000 | 10,250,000 |
Granted | 10,000,000 | 10,000,000 | 176,000,000 | |
Exercised | ||||
Forfeited/Expired | (250,000) | (250,000) | ||
Outstanding, end of period | 196,000,000 | 196,250,000 | 196,000,000 | 186,250,000 |
Exercisable at the end of period | 174,332,250 | 108,916,667 | ||
Weighted average exercise price | ||||
Outstanding, beginning of period | $ 0.01 | $ 0.01 | $ 0.01 | $ 0.01 |
Granted | 0.01 | 0.01 | 0.01 | 0.01 |
Exercised | ||||
Forfeited/Expired | ||||
Outstanding, end of year | $ 0.01 | $ 0.01 | 0.01 | 0.01 |
Exercisable at the end of period | $ 0.01 | $ 0.01 |
Options (Details 1)
Options (Details 1) - $ / shares | 3 Months Ended | 12 Months Ended | ||
Sep. 30, 2020 | Sep. 30, 2019 | Jun. 30, 2020 | Jun. 30, 2019 | |
Options outstanding | ||||
Stock Options Outstanding | 196,000,000 | 196,250,000 | ||
Stock Options Exercisable | 174,332,250 | 108,916,667 | ||
Stock option [Member] | ||||
Options outstanding | ||||
Stock Options Outstanding | 196,000,000 | 186,250,000 | ||
Stock Options Exercisable | 160,493,150 | 85,583,333 | ||
0.02 [Member] | ||||
Options outstanding | ||||
Exercisable Price | $ 0.02 | |||
Stock Options Outstanding | 250,000 | |||
Stock Options Exercisable | 250,000 | |||
Weighted Average Remaining Contractual Life (years) | 6 months | |||
0.02 [Member] | Stock option [Member] | ||||
Options outstanding | ||||
Exercisable Price | $ 0.02 | |||
Stock Options Outstanding | 250,000 | |||
Stock Options Exercisable | 250,000 | |||
Weighted Average Remaining Contractual Life (years) | 9 months | |||
0.01 [Member] | ||||
Options outstanding | ||||
Exercisable Price | $ 0.01 | $ 0.01 | ||
Stock Options Outstanding | 10,000,000 | 10,000,000 | ||
Stock Options Exercisable | 10,000,000 | 5,000,000 | ||
Weighted Average Remaining Contractual Life (years) | 2 years 3 days | 3 years 3 days | ||
0.01 [Member] | Stock option [Member] | ||||
Options outstanding | ||||
Exercisable Price | $ 0.01 | $ 0.01 | ||
Stock Options Outstanding | 10,000,000 | 10,000,000 | ||
Stock Options Exercisable | 10,000,000 | 5,250,000 | ||
Weighted Average Remaining Contractual Life (years) | 1 year 3 months 4 days | 3 years 3 months 4 days | ||
0.0097-0.0099 [Member] | ||||
Options outstanding | ||||
Stock Options Outstanding | 176,000,000 | 176,000,000 | ||
Stock Options Exercisable | 157,110,167 | 99,777,777 | ||
0.0097-0.0099 [Member] | Minimum [Member] | ||||
Options outstanding | ||||
Exercisable Price | $ 0.0097 | $ 0.0097 | ||
Weighted Average Remaining Contractual Life (years) | 5 years 116 days | 6 years 116 days | ||
0.0097-0.0099 [Member] | Maximum [Member] | ||||
Options outstanding | ||||
Exercisable Price | $ 0.0099 | $ 0.0099 | ||
Weighted Average Remaining Contractual Life (years) | 5 years 124 days | 6 years 124 days | ||
0.0097-0.0099 [Member] | Stock option [Member] | ||||
Options outstanding | ||||
Stock Options Outstanding | 176,000,000 | 176,000,000 | ||
Stock Options Exercisable | 144,018,263 | 60,666,667 | ||
0.0097-0.0099 [Member] | Stock option [Member] | Minimum [Member] | ||||
Options outstanding | ||||
Exercisable Price | $ 0.0097 | $ 0.0097 | ||
Weighted Average Remaining Contractual Life (years) | 5 years 6 months 25 days | 6 years 6 months 25 days | ||
0.0097-0.0099 [Member] | Stock option [Member] | Maximum [Member] | ||||
Options outstanding | ||||
Exercisable Price | $ 0.0099 | $ 0.0099 | ||
Weighted Average Remaining Contractual Life (years) | 5 years 7 months 2 days | 6 years 10 months 3 days | ||
0.0060 [Member] | ||||
Options outstanding | ||||
Exercisable Price | $ 0.006 | $ 0.006 | ||
Stock Options Outstanding | 10,000,000 | 10,000,000 | ||
Stock Options Exercisable | 7,222,083 | 3,888,889 | ||
Weighted Average Remaining Contractual Life (years) | 5 years 295 days | 6 years 295 days | ||
0.0060 [Member] | Stock option [Member] | ||||
Options outstanding | ||||
Exercisable Price | $ 0.0060 | |||
Stock Options Outstanding | 10,000,000 | |||
Stock Options Exercisable | 6,474,887 | |||
Weighted Average Remaining Contractual Life (years) | 6 years 22 days |
Options (Details 2)
Options (Details 2) | 3 Months Ended | 12 Months Ended | |
Sep. 30, 2020 | Jun. 30, 2020 | Jun. 30, 2019 | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Expected dividend yield | |||
Minimum [Member] | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Risk free interest rate | 0.28% | 0.13% | |
Stock volatility factor | 274.00% | 80.00% | |
Weighted average expected option life | 3 months | 0 years | |
Maximum [Member] | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Risk free interest rate | 0.12% | 0.22% | |
Stock volatility factor | 150.00% | 267.00% | |
Weighted average expected option life | 5 years | 5 years | |
Employee Stock Option [Member] | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Risk free interest rate | 1.94% | ||
Stock volatility factor | 146.00% | ||
Weighted average expected option life | 6 years | 7 years | |
Expected dividend yield | |||
Employee Stock Option [Member] | Minimum [Member] | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Risk free interest rate | 1.47% | ||
Stock volatility factor | 54.99% | ||
Employee Stock Option [Member] | Maximum [Member] | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Risk free interest rate | 2.58% | ||
Stock volatility factor | 189.01% |
Options (Details Textual)
Options (Details Textual) - USD ($) | Mar. 31, 2020 | Jul. 22, 2019 | Jan. 31, 2019 | Jan. 23, 2019 | Oct. 02, 2017 | Jul. 22, 2019 | Jan. 31, 2019 | Jan. 23, 2019 | Sep. 30, 2020 | Sep. 30, 2019 | Jun. 30, 2020 | Jun. 30, 2019 |
Options (Textual) | ||||||||||||
Stock option, description | The Company issued 10,000,000 stock options, which one-third (1/3) vest immediately, and the remaining shall vest one-twenty fourth (1/24) per month from after the date of these options (remaining block). The first block shall become exercisable immediately and is exercisable for a period of seven (7) years. The options fully vest by July 22, 2021. | The Company issued 6,000,000 stock options, which two-third (2/3) vest immediately, and the remaining shall vest one-twelfth (1/12) per month from after the date of these options (remaining block). The first block shall become exercisable immediately and is exercisable for a period of seven (7) years. The options fully vested on January 31, 2020. | The Company issued 170,000,000 stock options, which one-third (1/3) vest immediately, and the remaining shall vest one-twenty fourth (1/24) after the date of these options (remaining block). The first block shall become exercisable immediately and is exercisable for a period of seven (7) years. The options fully vest by January 23, 2021. | The Company issued 10,000,000 stock options, of which one-third (1/3) vest immediately, and the remaining shall vest one-twenty fourth (1/24) per month from after the date of the option grant. The options expire 10 years from the initial grant date. The options fully vested on July 22, 2020.. | the Company issued 6,000,000 stock options, of which two-third (2/3) vest immediately, and the remaining amount shall vest one-twelfth (1/12) per month from after the date of the option grant. The options expire 10 years from the initial grant date. The options fully vested on January 31, 2020. | The Company issued 170,000,000 stock options. One-third of the options vested immediately, and the remainder vest 1/24 per month over the first twenty four months following the option grant. The options expire 10 years from the initial grant date. The options fully vest by January 23, 2022. | ||||||
Exercisable price | $ 0.01 | $ 0.01 | ||||||||||
Stock compensation expense | $ 11,203,500 | $ 246,994 | $ 473,853 | $ 735,772 | ||||||||
Non-qualified Common Stock Options [Member] | ||||||||||||
Options (Textual) | ||||||||||||
Options expiration date | Mar. 31, 2020 | |||||||||||
Stock option vested exercisable | 250,000 | |||||||||||
Non-qualified Common Stock Options [Member] | ||||||||||||
Options (Textual) | ||||||||||||
Non-qualified common stock outstanding | 10,000,000 | |||||||||||
Stock option, description | Of the 10,000,000 non-qualified common stock options, one-third vest immediately, and one-third vest the second and third year, such that, the options are fully vested with a maturity date of October 2, 2022, and are exercisable at an exercise price of $0.01 per share. | |||||||||||
Non-qualified common stock issued options | 10,000,000 | 10,000,000 | ||||||||||
Exercisable price | $ 0.01 | $ 0.01 | ||||||||||
Options expiration date | Oct. 2, 2022 |
Convertible Promissory Notes (D
Convertible Promissory Notes (Details) - USD ($) | Sep. 30, 2020 | Jun. 30, 2020 | Jun. 30, 2019 |
Debt Disclosure [Abstract] | |||
Convertible Promissory Notes, net of debt discount | $ 1,586,950 | $ 432,866 | $ 415,537 |
Less current portion | 126,950 | 160,926 | |
Total long-term liabilities | $ 1,460,000 | $ 1,460,000 |
Convertible Promissory Notes _2
Convertible Promissory Notes (Details 1) - USD ($) | Sep. 30, 2020 | Jun. 30, 2020 |
Debt Disclosure [Abstract] | ||
2021 | $ 337,000 | $ 570,000 |
2022 | 695,000 | 575,000 |
2023 | 625,000 | 745,000 |
2024 | 140,000 | 140,000 |
Total maturities of long-term debt | $ 1,797,000 | $ 2,030,000 |
Convertible Promissory Notes _3
Convertible Promissory Notes (Details Textual) - USD ($) | Jun. 18, 2020 | May 19, 2020 | Apr. 15, 2020 | Apr. 14, 2020 | Apr. 14, 2020 | Mar. 09, 2020 | Mar. 05, 2020 | Feb. 11, 2020 | Feb. 11, 2020 | Jan. 20, 2020 | Jan. 10, 2020 | Jul. 03, 2019 | Mar. 06, 2019 | Jan. 31, 2019 | Dec. 14, 2018 | Aug. 10, 2018 | Aug. 10, 2018 | Jun. 27, 2018 | Nov. 09, 2017 | Feb. 03, 2017 | Feb. 03, 2017 | Jan. 28, 2016 | Apr. 09, 2015 | Jun. 30, 2020 | Jun. 18, 2020 | May 19, 2020 | Apr. 15, 2020 | Aug. 28, 2019 | Feb. 14, 2019 | Jan. 18, 2019 | Jun. 27, 2018 | Nov. 09, 2017 | Nov. 27, 2019 | Oct. 02, 2019 | Sep. 30, 2020 | Sep. 30, 2019 | Aug. 12, 2019 | Jun. 30, 2020 | Dec. 31, 2019 | Jun. 30, 2019 |
Convertible Promissory Notes (Textual) | ||||||||||||||||||||||||||||||||||||||||
Convertible promissory note principal amount | $ 1,460,000 | $ 1,460,000 | $ 1,460,000 | |||||||||||||||||||||||||||||||||||||
Amount of tranches received | 856,500 | $ 804,500 | ||||||||||||||||||||||||||||||||||||||
Amortization of Debt Discount (Premium) | 199,024 | $ 242,392 | $ 714,145 | 610,917 | ||||||||||||||||||||||||||||||||||||
Convertible promissory notes [Member] | ||||||||||||||||||||||||||||||||||||||||
Convertible Promissory Notes (Textual) | ||||||||||||||||||||||||||||||||||||||||
Percentage of beneficial ownership | 4.99% | 4.99% | ||||||||||||||||||||||||||||||||||||||
Convertible debt | $ 2,030,000 | 1,797,000 | $ 2,030,000 | |||||||||||||||||||||||||||||||||||||
Debt discount | 409,074 | 210,050 | 409,074 | |||||||||||||||||||||||||||||||||||||
Net balance of convertible debt | 1,586,950 | $ 1,620,926 | ||||||||||||||||||||||||||||||||||||||
10% Unsecured Convertible Note [Member] | Jan 2020 Note [Member] | ||||||||||||||||||||||||||||||||||||||||
Convertible Promissory Notes (Textual) | ||||||||||||||||||||||||||||||||||||||||
Convertible promissory note principal amount | $ 80,000 | |||||||||||||||||||||||||||||||||||||||
Convertible notes, interest rate | 10.00% | |||||||||||||||||||||||||||||||||||||||
Debt instrument, maturity date description | The Jan 2020 Note matures on January 10, 2021. The Jan 2020 Note may be converted into shares of the Company's common stock at a conversion price of sixty-one (61%) percent of the average of the lowest two (2) trading prices per common stock during the thirty (30) trading day prior to the conversion date. | |||||||||||||||||||||||||||||||||||||||
Debt discount | 37,596 | $ 37,596 | ||||||||||||||||||||||||||||||||||||||
Net balance of convertible debt | $ 80,000 | |||||||||||||||||||||||||||||||||||||||
Accrued interest | $ 78,000 | |||||||||||||||||||||||||||||||||||||||
Amount received From Funds | $ 2,000 | |||||||||||||||||||||||||||||||||||||||
10% Unsecured Convertible Note [Member] | Dec-Jul Notes [Member] | ||||||||||||||||||||||||||||||||||||||||
Convertible Promissory Notes (Textual) | ||||||||||||||||||||||||||||||||||||||||
Convertible promissory note principal amount | $ 86,500 | $ 86,500 | $ 86,500 | |||||||||||||||||||||||||||||||||||||
Debt instrument, maturity date description | The Dec-Jan Notes matures on December 14, 2019 and January 18, 2020. The Dec-Jul Notes may be converted into shares of the Company’s common stock at a conversion price of sixty-one (61%) percent of the lowest trading prices per common stock during the fifteen (25) trading day prior to the conversion date. | The Dec-Jan Notes matures on December 14, 2019 and January 18, 2020. The Dec-Jul Notes may be converted into shares of the Company’s common stock at a conversion price of sixty-one (61%) percent of the lowest trading prices per common stock during the fifteen (25) trading day prior to the conversion date. | The Dec-Jan Notes matures on December 14, 2019 and January 18, 2020. The Dec-Jul Notes may be converted into shares of the Company’s common stock at a conversion price of sixty-one (61%) percent of the lowest trading prices per common stock during the fifteen (25) trading day prior to the conversion date. | |||||||||||||||||||||||||||||||||||||
Issuance of common stock (in shares) | 103,302,185 | |||||||||||||||||||||||||||||||||||||||
Convertible notes payable | $ 132,386 | |||||||||||||||||||||||||||||||||||||||
Debt discount | 91,714 | 91,714 | ||||||||||||||||||||||||||||||||||||||
Net balance of convertible debt | 0 | |||||||||||||||||||||||||||||||||||||||
Legal fees | 9,000 | |||||||||||||||||||||||||||||||||||||||
Accrued interest | 14,000 | |||||||||||||||||||||||||||||||||||||||
10% Unsecured Convertible Note [Member] | Aug 2018 Note [Member] | ||||||||||||||||||||||||||||||||||||||||
Convertible Promissory Notes (Textual) | ||||||||||||||||||||||||||||||||||||||||
Convertible promissory note principal amount | 100,000 | 100,000 | ||||||||||||||||||||||||||||||||||||||
Convertible notes, interest rate | 10.00% | 10.00% | ||||||||||||||||||||||||||||||||||||||
Interest expense amount | 11,233 | 11,233 | ||||||||||||||||||||||||||||||||||||||
Aggregate principal amount | $ 100,000 | $ 100,000 | ||||||||||||||||||||||||||||||||||||||
Conversion price | $ 0.005 | $ 0.005 | ||||||||||||||||||||||||||||||||||||||
Debt instrument, term | 60 months | |||||||||||||||||||||||||||||||||||||||
Debt instrument, maturity date description | The Aug 2018 Note matures on August 10, 2019, with an extension of sixty (60) months from the date of the note. The Aug 2018 Note matures on August 10, 2023. | |||||||||||||||||||||||||||||||||||||||
Maturity date | Aug. 10, 2019 | |||||||||||||||||||||||||||||||||||||||
Debt instrument, convertible, terms of conversion feature | The Aug 2018 Note may be converted into shares of the Company's common stock at a conversion price of the lesser of a) $0.005 per share or b) sixty-one (61%) percent of the lowest trading price per common stock recorded on any trade day after the effective date. | |||||||||||||||||||||||||||||||||||||||
Deposit Liabilities, Accrued Interest | 11,233 | 11,233 | ||||||||||||||||||||||||||||||||||||||
10% Unsecured Convertible Note [Member] | Oct 2018 Note [Member] | ||||||||||||||||||||||||||||||||||||||||
Convertible Promissory Notes (Textual) | ||||||||||||||||||||||||||||||||||||||||
Convertible notes, interest rate | 10.00% | |||||||||||||||||||||||||||||||||||||||
Debt instrument, maturity date description | The Feb-Aug Notes may be converted into shares of the Company's common stock at a conversion price of sixty-one (61%) percent of the lowest average two (2) trading prices per common stock during the fifteen (15) trading day prior to the conversion date. | |||||||||||||||||||||||||||||||||||||||
Maturity date | Feb. 14, 2019 | |||||||||||||||||||||||||||||||||||||||
Convertible debt | $ 252,000 | |||||||||||||||||||||||||||||||||||||||
10% Unsecured Convertible Note [Member] | Jan-Mar Note [Member] | ||||||||||||||||||||||||||||||||||||||||
Convertible Promissory Notes (Textual) | ||||||||||||||||||||||||||||||||||||||||
Convertible promissory note principal amount | 160,000 | 160,000 | ||||||||||||||||||||||||||||||||||||||
Convertible notes, interest rate | 10.00% | 10.00% | ||||||||||||||||||||||||||||||||||||||
Aggregate principal amount | $ 160,000 | $ 160,000 | $ 8,399 | $ 8,399 | ||||||||||||||||||||||||||||||||||||
Conversion price | $ 0 | $ 0 | ||||||||||||||||||||||||||||||||||||||
Debt instrument, maturity date description | The Jan-Mar Notes matures on January 31, 2020 and March 6, 2020. The Jan-Mar Notes may be converted into shares of the Company's common stock at a conversion price of sixty-one (61%) percent of the lowest two (2) trading prices per common stock during the fifteen (15) trading day prior to the conversion date. | The Jan-Mar Notes matures on January 31, 2020 and March 6, 2020. The Jan-Mar Notes may be converted into shares of the Company's common stock at a conversion price of sixty-one (61%) percent of the lowest two (2) trading prices per common stock during the fifteen (15) trading day prior to the conversion date. | ||||||||||||||||||||||||||||||||||||||
Maturity date | Mar. 6, 2020 | Jan. 31, 2020 | ||||||||||||||||||||||||||||||||||||||
Issuance of common stock (in shares) | 76,591,844 | 76,591,844 | ||||||||||||||||||||||||||||||||||||||
Debt discount | $ 101,698 | $ 101,698 | ||||||||||||||||||||||||||||||||||||||
Legal fees | $ 1,500 | |||||||||||||||||||||||||||||||||||||||
10% Unsecured Convertible Note [Member] | Jan 18, 2019 Note [Member] | ||||||||||||||||||||||||||||||||||||||||
Convertible Promissory Notes (Textual) | ||||||||||||||||||||||||||||||||||||||||
Aggregate principal amount | $ 86,500 | |||||||||||||||||||||||||||||||||||||||
10% Unsecured Convertible Note [Member] | Feb-Aug Notes [Member] | ||||||||||||||||||||||||||||||||||||||||
Convertible Promissory Notes (Textual) | ||||||||||||||||||||||||||||||||||||||||
Convertible promissory note principal amount | $ 252,000 | |||||||||||||||||||||||||||||||||||||||
Debt instrument, maturity date description | The Feb-Aug Notes may be converted into shares of the Company’s common stock at a conversion price of sixty-one (61%) percent of the lowest average two (2) trading prices per common stock during the fifteen (15) trading day prior to the conversion date. | |||||||||||||||||||||||||||||||||||||||
Issuance of common stock (in shares) | 116,025,867 | |||||||||||||||||||||||||||||||||||||||
Convertible notes payable | $ 252,000 | |||||||||||||||||||||||||||||||||||||||
Debt discount | 176,288 | 176,288 | ||||||||||||||||||||||||||||||||||||||
Net balance of convertible debt | 0 | |||||||||||||||||||||||||||||||||||||||
Accrued interest | 12,600 | |||||||||||||||||||||||||||||||||||||||
10% Unsecured Convertible Note [Member] | Feb 2020 Note [Member] | ||||||||||||||||||||||||||||||||||||||||
Convertible Promissory Notes (Textual) | ||||||||||||||||||||||||||||||||||||||||
Convertible promissory note principal amount | $ 80,000 | $ 80,000 | ||||||||||||||||||||||||||||||||||||||
Convertible notes, interest rate | 10.00% | 10.00% | ||||||||||||||||||||||||||||||||||||||
Debt instrument, maturity date description | The Feb 2020 Note matures on February 11, 2021. The Feb 2020 Note may be converted into shares of the Company's common stock at a conversion price of sixty-one (61%) percent of the lowest two (2) trading prices per common stock during the fifteen (15) trading day prior to the conversion date. | |||||||||||||||||||||||||||||||||||||||
Debt discount | 30,601 | 30,601 | ||||||||||||||||||||||||||||||||||||||
Amount received From Funds | $ 78,000 | 80,000 | ||||||||||||||||||||||||||||||||||||||
Other Fees | 2,000 | |||||||||||||||||||||||||||||||||||||||
10% Unsecured Convertible Note [Member] | March 5, 2020 [Member] | ||||||||||||||||||||||||||||||||||||||||
Convertible Promissory Notes (Textual) | ||||||||||||||||||||||||||||||||||||||||
Convertible promissory note principal amount | $ 80,000 | $ 80,000 | $ 40,000 | |||||||||||||||||||||||||||||||||||||
Convertible notes, interest rate | 10.00% | 10.00% | 10.00% | |||||||||||||||||||||||||||||||||||||
Debt instrument, maturity date description | The Mar 2020 Note matures on March 9, 2021. The Mar 2020 Note may be converted into shares of the Company's common stock at a conversion price of sixty-one (61%) percent of the average of the lowest two (2) trading prices per common stock during the fifteen (15) trading day prior to the conversion date. | |||||||||||||||||||||||||||||||||||||||
Maturity date | Apr. 14, 2020 | |||||||||||||||||||||||||||||||||||||||
Debt discount | 11,528 | 11,528 | ||||||||||||||||||||||||||||||||||||||
Amount received From Funds | $ 78,000 | $ 38,000 | 40,000 | |||||||||||||||||||||||||||||||||||||
Other Fees | 2,000 | $ 2,000 | ||||||||||||||||||||||||||||||||||||||
10% Unsecured Convertible Note [Member] | April 14, 2020 [Member] | ||||||||||||||||||||||||||||||||||||||||
Convertible Promissory Notes (Textual) | ||||||||||||||||||||||||||||||||||||||||
Debt discount | $ 16,658 | 16,658 | ||||||||||||||||||||||||||||||||||||||
Net balance of convertible debt | 0 | |||||||||||||||||||||||||||||||||||||||
Amount received From Funds | $ 80,000 | |||||||||||||||||||||||||||||||||||||||
10% Unsecured Convertible Note [Member] | April 15, 2020 [Member] | ||||||||||||||||||||||||||||||||||||||||
Convertible Promissory Notes (Textual) | ||||||||||||||||||||||||||||||||||||||||
Convertible promissory note principal amount | $ 50,000 | $ 50,000 | ||||||||||||||||||||||||||||||||||||||
Convertible notes, interest rate | 10.00% | 50.00% | 10.00% | 50.00% | ||||||||||||||||||||||||||||||||||||
Conversion price | $ 0.01 | $ 0.01 | ||||||||||||||||||||||||||||||||||||||
Debt instrument, term | 60 months | |||||||||||||||||||||||||||||||||||||||
Debt instrument, maturity date description | The Apr 2020 Note matures twelve (12) months from the effective dates of each respective tranche. The Apr 2020 Note matures on April 15, 2021, with an automatic extension of sixty (60) months from the effective date of each tranche. | |||||||||||||||||||||||||||||||||||||||
Maturity date | Apr. 15, 2021 | |||||||||||||||||||||||||||||||||||||||
Percentage of beneficial ownership | 4.99% | 4.99% | ||||||||||||||||||||||||||||||||||||||
Penalty amount | $ 2,000 | $ 2,000 | ||||||||||||||||||||||||||||||||||||||
Debt discount | 706 | 706 | ||||||||||||||||||||||||||||||||||||||
Amount received From Funds | $ 10,000 | |||||||||||||||||||||||||||||||||||||||
10% Unsecured Convertible Note [Member] | ConvertiblePromissoryMayOneNotesMember | ||||||||||||||||||||||||||||||||||||||||
Convertible Promissory Notes (Textual) | ||||||||||||||||||||||||||||||||||||||||
Convertible promissory note principal amount | $ 80,000 | $ 80,000 | ||||||||||||||||||||||||||||||||||||||
Convertible notes, interest rate | 10.00% | 10.00% | ||||||||||||||||||||||||||||||||||||||
Debt instrument, maturity date description | The May 2020 Note may be converted into shares of the Company's common stock at a conversion price of sixty-one (61%) percent of the lowest two (2) trading prices per common stock during the fifteen (15) trading day prior to the conversion date. | |||||||||||||||||||||||||||||||||||||||
Maturity date | May 19, 2021 | |||||||||||||||||||||||||||||||||||||||
Debt discount | $ 9,205 | 9,205 | ||||||||||||||||||||||||||||||||||||||
Amount received From Funds | $ 78,000 | 80,000 | ||||||||||||||||||||||||||||||||||||||
Other Fees | 2,000 | |||||||||||||||||||||||||||||||||||||||
10% Unsecured Convertible Note [Member] | June 18, 2020 [Member] | ||||||||||||||||||||||||||||||||||||||||
Convertible Promissory Notes (Textual) | ||||||||||||||||||||||||||||||||||||||||
Convertible promissory note principal amount | $ 160,000 | $ 160,000 | ||||||||||||||||||||||||||||||||||||||
Convertible notes, interest rate | 10.00% | 10.00% | ||||||||||||||||||||||||||||||||||||||
Debt instrument, maturity date description | The Jun 2020 Note may be converted into shares of the Company's common stock at a conversion price of sixty-one (61%) percent of the lowest two (2) trading prices per common stock during the fifteen (15) trading day prior to the conversion date. | |||||||||||||||||||||||||||||||||||||||
Maturity date | Jun. 19, 2021 | |||||||||||||||||||||||||||||||||||||||
Convertible debt | 5,260 | 5,260 | ||||||||||||||||||||||||||||||||||||||
Amount received From Funds | $ 156,000 | 160,000 | ||||||||||||||||||||||||||||||||||||||
Other Fees | 4,000 | |||||||||||||||||||||||||||||||||||||||
10% Convertible Promissory Note [Member] | Jan 2020 Note [Member] | ||||||||||||||||||||||||||||||||||||||||
Convertible Promissory Notes (Textual) | ||||||||||||||||||||||||||||||||||||||||
Convertible promissory note principal amount | $ 80,000 | |||||||||||||||||||||||||||||||||||||||
Convertible notes, interest rate | 10.00% | |||||||||||||||||||||||||||||||||||||||
Interest expense amount | $ 3,989 | |||||||||||||||||||||||||||||||||||||||
Debt instrument, maturity date description | The Jan 2020 Note had a maturity date of January 20, 2021. The Jan 2020 Note was convertible into shares of the Company’s common stock at a conversion price of sixty-one (61%) percent of the lowest two (2) trading prices per common stock during the fifteen (15) trading day prior to the conversion date. The conversion feature of the Jan 2020 Note was considered a derivative in accordance with current accounting guidelines because of the reset conversion features of the Jan 2020 Note. During the three months ended September 30, 2020, the Company issued 23,420,128 shares of common stock upon conversion of principal in the amount of $80,000, plus accrued interest of $3,989, and other fees of $300. The Company recorded amortization of debt discount, which was recognized as interest expense in the amount of $42,404 during the three months ended September 30, 2020. The Jan 2020 Note was fully converted as of September 30, 2020. On February 11, 2020, the Company issued a convertible promissory note (the “Feb 2020 Note”) to an investor (the “Feb 2020 Note”) in the principal amount of $80,000. The Company received funds of $78,000, less other fees of $2,000. The Feb 2020 Note had a maturity date of February 11, 2021. The Feb 2020 Note was convertible into shares of the Company’s common stock at a conversion price of sixty-one (61%) percent of the lowest two (2) trading prices per common stock during the fifteen (15) trading day prior to the conversion date. The conversion feature of the Feb 2020 Note was considered a derivative in accordance with current accounting guidelines because of the reset conversion features of the Feb 2020 Note. During the three months ended September 30, 2020, the Company issued 5,294,205 shares of common stock upon conversion of principal in the amount of $80,000, plus accrued interest of $3,989, and other fees of $300. The Company recorded amortization of debt discount, which was recognized as interest expense in the amount of $49,399 during the three months ended September 30, 2020. The Feb 2020 Note was fully converted as of September 30, 2020. On March 9, 2020, the Company issued a convertible promissory note (the “Mar 2020 Note”) to an investor, (the “Mar 2020 Note”) in the principal amount of $40,000. The Company received funds of $38,000, less other fees of $2,000. The Mar 2020 Note had a maturity date of March 9, 2021. The Mar 2020 Note was convertible into shares of the Company’s common stock at a conversion price of sixty-one (61%) percent of the lowest two (2) trading prices per common stock during the fifteen (15) trading day prior to the conversion date. The conversion feature of the Mar 2020 Note was considered a derivative in accordance with current accounting guidelines because of the reset conversion features of the Mar 2020 Note. During the three months ended September 30, 2020, the Company issued 2,390,871 shares of common stock upon conversion of principal in the amount of $40,000, plus accrued interest of $1,995, and other fees of $300. The Company recorded amortization of debt discount, which was recognized as interest expense in the amount of $25,708 during the three months ended September 30, 2020. The Mar 2020 Note was fully converted as of September 30, 2020. On April 14, 2020, the Company issued a convertible promissory note (the “April 2020 Note”) to an investor in the principal amount of $80,000. The Company received funds of $78,000, less other fees of $2,000. The April 2020 Note matures on April 14, 2021. The April 2020 Note may be converted into shares of the Company’s common stock at a conversion price of sixty-one (61%) percent of the average of the lowest two (2) trading prices per common stock during the fifteen (15) trading day prior to the conversion date. The conversion feature of the April 2020 Note was considered a derivative in accordance with current accounting guidelines because of the reset conversion features of the April 2020 Note. The Company recorded amortization of debt discount, which was recognized as interest expense in the amount of $20,164 during the three months ended September 30, 2020. The balance of the April 2020 Note as of September 30, 2020 was $80,000. On April 15, 2020, the Company issued a convertible promissory note (the “Apr 2020 Note”) to an investor in the aggregate principal amount of $50,000, of which the Company received $10,000 as of June 30, 2020. The Apr 2020 Note matures twelve (12) months from the effective dates of each respective tranche, such that the Apr 2020 Note matures on April 15, 2021, with an automatic extension of sixty (60) months from the effective date of each tranche. The Apr Note is convertible into shares of common stock of the Company at a price equal to a variable conversion price of the lesser of $0.01 per share or fifty percent (50%) of the lowest trading price of common stock recorded on any trade day after the effective date, or (c) the lowest effective price per share granted to any person or entity after the effective date to acquire common stock. If the Company fails to deliver shares in accordance with the timeframe of four (4) business days of the receipt of a notice of conversion, the lender, at any time prior to selling all of those shares, may rescind any portion, in whole or in part of that particular conversion attributable to the unsold shares and have the rescinded conversion amount returned to the principal sum with the rescinded conversion shares returned to the Company. In no event shall the lender be entitled to convert any portion of the Apr 2020 Note such that would result in beneficial ownership by the lender and its affiliates of more than 4.99% of the outstanding shares of common stock of the Company. In addition, for each conversion, in the event that shares are not delivered by the fourth business day (inclusive of the day of conversion), a penalty of $2,000 per day shall be assessed for each day after the fourth business day (inclusive of the day of the conversion) until the shares are delivered. The conversion feature of the April 2020 Note was considered a derivative in accordance with current accounting guidelines because of the reset conversion features of the Apr 2020 Note. The Company recorded amortization of debt discount, which was recognized as interest expense in the amount of $855 during the three months ended September 30, 2020. The balance of the Apr 2020 Note as of September 30, 2020 was $10,000. On May 19, 2020, the Company issued a convertible promissory note (the “May 2020 Note”) to an investor in the principal amount of $80,000. The Company received funds of $78,000, less other fees of $2,000. The May 2020 Note matures on May 19, 2021. The May 2020 Note may be converted into shares of the Company’s common stock at a conversion price of sixty-one (61%) percent of the lowest two (2) trading prices per common stock during the fifteen (15) trading day prior to the conversion date. | |||||||||||||||||||||||||||||||||||||||
Issuance of common stock (in shares) | 23,420,128 | |||||||||||||||||||||||||||||||||||||||
Convertible notes payable | $ 80,000 | |||||||||||||||||||||||||||||||||||||||
Accrued interest | $ 78,000 | |||||||||||||||||||||||||||||||||||||||
Amount received From Funds | $ 2,000 | |||||||||||||||||||||||||||||||||||||||
Deposit Liabilities, Accrued Interest | 3,989 | |||||||||||||||||||||||||||||||||||||||
Amortization of Debt Discount (Premium) | 42,404 | |||||||||||||||||||||||||||||||||||||||
10% Convertible Promissory Note [Member] | August 28, 2019 note [Member] | ||||||||||||||||||||||||||||||||||||||||
Convertible Promissory Notes (Textual) | ||||||||||||||||||||||||||||||||||||||||
Convertible promissory note principal amount | 80,000 | $ 80,000 | 80,000 | |||||||||||||||||||||||||||||||||||||
Convertible notes, interest rate | 10.00% | |||||||||||||||||||||||||||||||||||||||
Interest expense amount | 58,835 | $ 58,835 | ||||||||||||||||||||||||||||||||||||||
Debt instrument, maturity date description | The Aug Note matures on August 28, 2020. The Aug Note may be converted into shares of the Company's common stock at a conversion price of sixty-one (61%) percent of the lowest two (2) trading prices per common stock during the fifteen (15) trading day prior to the conversion date. | |||||||||||||||||||||||||||||||||||||||
Maturity date | Aug. 28, 2020 | |||||||||||||||||||||||||||||||||||||||
Issuance of common stock (in shares) | 30,227,789 | |||||||||||||||||||||||||||||||||||||||
Convertible notes payable | $ 80,000 | |||||||||||||||||||||||||||||||||||||||
Legal fees | 600 | |||||||||||||||||||||||||||||||||||||||
Accrued interest | 4,219 | |||||||||||||||||||||||||||||||||||||||
Amount received From Funds | $ 78,000 | |||||||||||||||||||||||||||||||||||||||
Other Fees | $ 2,000 | |||||||||||||||||||||||||||||||||||||||
Deposit Liabilities, Accrued Interest | 58,835 | 58,835 | ||||||||||||||||||||||||||||||||||||||
10% Convertible Promissory Note [Member] | Jan 2016 Note [Member] | ||||||||||||||||||||||||||||||||||||||||
Convertible Promissory Notes (Textual) | ||||||||||||||||||||||||||||||||||||||||
Convertible promissory note principal amount | $ 500,000 | 310,000 | $ 277,000 | $ 310,000 | ||||||||||||||||||||||||||||||||||||
Convertible notes, interest rate | 10.00% | |||||||||||||||||||||||||||||||||||||||
Amount of tranches received | $ 10,000 | |||||||||||||||||||||||||||||||||||||||
Amount of additional tranches received | 490,000 | |||||||||||||||||||||||||||||||||||||||
Aggregate principal amount | $ 500,000 | |||||||||||||||||||||||||||||||||||||||
Conversion price | $ 0.01 | |||||||||||||||||||||||||||||||||||||||
Percentage of trading price | 50.00% | |||||||||||||||||||||||||||||||||||||||
Debt instrument, term | 12 months | |||||||||||||||||||||||||||||||||||||||
Debt instrument, maturity date description | January 19, 2017, the investor extended the Jan 2016 Note for an additional sixty (60) months from the effective date of each tranche, which matures on January 27, 2022.The Jan 2016 Note is convertible into shares of common stock of the Company at a price equal to a variable conversion price of the lesser of $0.01 per share or fifty percent (50%) of the lowest trading price since the original effective date of each respective tranche or the lowest effective price per share granted to any person or entity after the effective date to acquire common stock. | |||||||||||||||||||||||||||||||||||||||
Maturity date | Jan. 27, 2022 | |||||||||||||||||||||||||||||||||||||||
Debt instrument, convertible, terms of conversion feature | Price equal to a variable conversion price of the lesser of $0.01 per share or fifty percent (50%) of the lowest trading price since the original effective date of each respective tranche or the lowest effective price per share granted to any person or entity after the effective date to acquire common stock. | |||||||||||||||||||||||||||||||||||||||
Percentage of beneficial ownership | 4.99% | |||||||||||||||||||||||||||||||||||||||
Penalty amount | $ 1,500 | |||||||||||||||||||||||||||||||||||||||
Issuance of common stock (in shares) | 48,802,884 | 280,606,492 | ||||||||||||||||||||||||||||||||||||||
Convertible notes payable | $ 33,000 | $ 190,000 | ||||||||||||||||||||||||||||||||||||||
Accrued interest | 13,363 | $ 76,576 | ||||||||||||||||||||||||||||||||||||||
10% Convertible Promissory Note [Member] | April 2015 Note [Member] | ||||||||||||||||||||||||||||||||||||||||
Convertible Promissory Notes (Textual) | ||||||||||||||||||||||||||||||||||||||||
Amount of tranches received | $ 50,000 | |||||||||||||||||||||||||||||||||||||||
Amount of additional tranches received | 450,000 | |||||||||||||||||||||||||||||||||||||||
Aggregate principal amount | $ 500,000 | |||||||||||||||||||||||||||||||||||||||
Conversion price | $ 0.01 | |||||||||||||||||||||||||||||||||||||||
Percentage of trading price | 50.00% | |||||||||||||||||||||||||||||||||||||||
Debt instrument, term | 9 months | |||||||||||||||||||||||||||||||||||||||
Debt instrument, maturity date description | On January 19, 2017, the investor extended the April 2015 Note for an additional (60) months from the effective date of each tranche. | |||||||||||||||||||||||||||||||||||||||
Maturity date | Apr. 9, 2020 | |||||||||||||||||||||||||||||||||||||||
Debt instrument, convertible, terms of conversion feature | Price equal to a variable conversion price of the lesser of $0.01 per share or fifty percent (50%) of the lowest trading price since the original effective date of each respective advance or the lowest effective price per share granted to any person or entity after the effective date to acquire common stock. | |||||||||||||||||||||||||||||||||||||||
Percentage of beneficial ownership | 4.99% | |||||||||||||||||||||||||||||||||||||||
Penalty amount | $ 1,500 | |||||||||||||||||||||||||||||||||||||||
Issuance of common stock (in shares) | 212,079,164 | |||||||||||||||||||||||||||||||||||||||
Convertible notes payable | $ 192,600 | |||||||||||||||||||||||||||||||||||||||
Convertible debt | 74,285 | 74,285 | ||||||||||||||||||||||||||||||||||||||
10% Convertible Promissory Note [Member] | Feb 2017 Note [Member] | ||||||||||||||||||||||||||||||||||||||||
Convertible Promissory Notes (Textual) | ||||||||||||||||||||||||||||||||||||||||
Convertible promissory note principal amount | $ 500,000 | $ 500,000 | 500,000 | $ 500,000 | ||||||||||||||||||||||||||||||||||||
Convertible notes, interest rate | 10.00% | 10.00% | ||||||||||||||||||||||||||||||||||||||
Amount of tranches received | $ 60,000 | $ 60,000 | ||||||||||||||||||||||||||||||||||||||
Amount of additional tranches received | 440,000 | 440,000 | ||||||||||||||||||||||||||||||||||||||
Aggregate principal amount | $ 500,000 | $ 500,000 | ||||||||||||||||||||||||||||||||||||||
Conversion price | $ 0.01 | $ 0.01 | ||||||||||||||||||||||||||||||||||||||
Percentage of trading price | 50.00% | 50.00% | ||||||||||||||||||||||||||||||||||||||
Debt instrument, term | 12 months | |||||||||||||||||||||||||||||||||||||||
Debt instrument, maturity date description | The Feb 2017 Note matures on February 3, 2018, with an automatic extension of sixty (60) months from the effective date of each tranche. | The Feb 2017 Note had a maturity date of February 3, 2018, with an automatic extension of sixty (60) months from the effective date of each tranche. | ||||||||||||||||||||||||||||||||||||||
Maturity date | Feb. 3, 2018 | |||||||||||||||||||||||||||||||||||||||
Debt instrument, convertible, terms of conversion feature | Price equal to a variable conversion price of the lesser of $0.01 per share or fifty percent (50%) of the lowest trading price since the original effective date of each respective tranche or the lowest effective price per share granted to any person or entity after the effective date to acquire common stock. | The Feb 2017 Note is convertible into shares of common stock of the Company at a price equal to a variable conversion price of the lesser of $0.01 per share or fifty percent (50%) of the lowest trading price since the original effective date of each respective tranche or the lowest effective price per share granted to any person or entity after the effective date to acquire common stock. | ||||||||||||||||||||||||||||||||||||||
Percentage of beneficial ownership | 4.99% | 4.99% | ||||||||||||||||||||||||||||||||||||||
Penalty amount | $ 1,500 | $ 1,500 | ||||||||||||||||||||||||||||||||||||||
10% Convertible Promissory Note [Member] | Nov 2017 Note [Member] | ||||||||||||||||||||||||||||||||||||||||
Convertible Promissory Notes (Textual) | ||||||||||||||||||||||||||||||||||||||||
Convertible promissory note principal amount | $ 500,000 | 500,000 | $ 500,000 | 500,000 | 500,000 | |||||||||||||||||||||||||||||||||||
Convertible notes, interest rate | 10.00% | 10.00% | ||||||||||||||||||||||||||||||||||||||
Amount of tranches received | $ 45,000 | $ 45,000 | ||||||||||||||||||||||||||||||||||||||
Amount of additional tranches received | 455,000 | 455,000 | ||||||||||||||||||||||||||||||||||||||
Aggregate principal amount | $ 500,000 | $ 500,000 | ||||||||||||||||||||||||||||||||||||||
Conversion price | $ 0.01 | $ 0.01 | ||||||||||||||||||||||||||||||||||||||
Percentage of trading price | 50.00% | 50.00% | ||||||||||||||||||||||||||||||||||||||
Debt instrument, term | 12 months | |||||||||||||||||||||||||||||||||||||||
Debt instrument, maturity date description | The Nov 2017 Note had a maturity date of November 9, 2018, with an automatic extension of sixty (60) months from the effective date of each tranche. | The Nov 2017 Note matures on November 9, 2018, with an automatic extension of sixty (60) months from the effective date of each tranche. | ||||||||||||||||||||||||||||||||||||||
Maturity date | Nov. 9, 2018 | |||||||||||||||||||||||||||||||||||||||
Debt instrument, convertible, terms of conversion feature | The Nov 2017 Note is convertible into shares of common stock of the Company at a price equal to a variable conversion price of the lesser of $0.01 per share or fifty percent (50%) of the lowest trading price since the original effective date of each respective tranche or the lowest effective price per share granted to any person or entity after the effective date to acquire common stock. | price equal to a variable conversion price of the lesser of $0.01 per share or fifty percent (50%) of the lowest trading price since the original effective date of each respective tranche or the lowest effective price per share granted to any person or entity after the effective date to acquire common stock. | ||||||||||||||||||||||||||||||||||||||
Percentage of beneficial ownership | 4.99% | 4.99% | ||||||||||||||||||||||||||||||||||||||
Penalty amount | $ 1,500 | $ 1,500 | ||||||||||||||||||||||||||||||||||||||
10% Convertible Promissory Note [Member] | Jun 2018 Note [Member] | ||||||||||||||||||||||||||||||||||||||||
Convertible Promissory Notes (Textual) | ||||||||||||||||||||||||||||||||||||||||
Convertible promissory note principal amount | $ 500,000 | 90,000 | $ 500,000 | 90,000 | 90,000 | |||||||||||||||||||||||||||||||||||
Convertible notes, interest rate | 10.00% | 10.00% | ||||||||||||||||||||||||||||||||||||||
Amount of tranches received | $ 50,000 | $ 50,000 | ||||||||||||||||||||||||||||||||||||||
Amount of additional tranches received | 40,000 | $ 40,000 | ||||||||||||||||||||||||||||||||||||||
Interest expense amount | 2,823 | 2,823 | ||||||||||||||||||||||||||||||||||||||
Aggregate principal amount | $ 90,000 | 90,000 | $ 90,000 | 90,000 | ||||||||||||||||||||||||||||||||||||
Conversion price | $ 0.01 | $ 0.01 | $ 90,000 | |||||||||||||||||||||||||||||||||||||
Percentage of trading price | 50.00% | 50.00% | ||||||||||||||||||||||||||||||||||||||
Debt instrument, term | 12 months | |||||||||||||||||||||||||||||||||||||||
Debt instrument, maturity date description | The Jun 2018 Note matured on June 27, 2019, which was automatically extended for sixty (60) months from the effective date of each tranche. | The Jun 2018 Note matures twelve (12) months from the effective dates of each respective tranche. | ||||||||||||||||||||||||||||||||||||||
Maturity date | Jun. 27, 2019 | |||||||||||||||||||||||||||||||||||||||
Debt instrument, convertible, terms of conversion feature | price equal to a variable conversion price of the lesser of $0.01 per share or fifty percent (50%) of the lowest trading price since the original effective date of each respective tranche or the lowest effective price per share granted to any person or entity after the effective date to acquire common stock. | |||||||||||||||||||||||||||||||||||||||
Percentage of beneficial ownership | 4.99% | 4.99% | ||||||||||||||||||||||||||||||||||||||
Penalty amount | $ 1,500 | $ 1,500 | ||||||||||||||||||||||||||||||||||||||
Deposit Liabilities, Accrued Interest | 2,823 | 2,823 | ||||||||||||||||||||||||||||||||||||||
10% Convertible Promissory Note [Member] | Aug 2018 Note [Member] | ||||||||||||||||||||||||||||||||||||||||
Convertible Promissory Notes (Textual) | ||||||||||||||||||||||||||||||||||||||||
Convertible promissory note principal amount | $ 100,000 | $ 100,000 | 100,000 | |||||||||||||||||||||||||||||||||||||
Convertible notes, interest rate | 10.00% | 10.00% | ||||||||||||||||||||||||||||||||||||||
Conversion price | $ 0.005 | $ 0.005 | ||||||||||||||||||||||||||||||||||||||
Debt instrument, maturity date description | The Aug 2018 Note had a maturity date of August 10, 2019, with an extension of sixty (60) months from the date of the note. The Aug 2018 Note matures on August 10, 2023. | |||||||||||||||||||||||||||||||||||||||
Debt instrument, convertible, terms of conversion feature | The Aug 2018 Note may be converted into shares of the Company’s common stock at a conversion price of the lesser of a) $0.005 per share or b) sixty-one (61%) percent of the lowest trading price per common stock recorded on any trade day after the effective date. | |||||||||||||||||||||||||||||||||||||||
10% Convertible Promissory Note [Member] | Oct 2, 2019 note [Member] | ||||||||||||||||||||||||||||||||||||||||
Convertible Promissory Notes (Textual) | ||||||||||||||||||||||||||||||||||||||||
Convertible promissory note principal amount | 0 | $ 80,000 | 0 | |||||||||||||||||||||||||||||||||||||
Convertible notes, interest rate | 10.00% | |||||||||||||||||||||||||||||||||||||||
Interest expense amount | 80,000 | 80,000 | ||||||||||||||||||||||||||||||||||||||
Aggregate principal amount | 80,000 | $ 80,000 | ||||||||||||||||||||||||||||||||||||||
Debt instrument, maturity date description | The Oct Note may be converted into shares of the Company's common stock at a conversion price of sixty-one (61%) percent of the lowest two (2) trading prices per common stock during the fifteen (15) trading day prior to the conversion date. | |||||||||||||||||||||||||||||||||||||||
Maturity date | Oct. 2, 2020 | |||||||||||||||||||||||||||||||||||||||
Issuance of common stock (in shares) | 39,676,622 | |||||||||||||||||||||||||||||||||||||||
Net balance of convertible debt | $ 0 | |||||||||||||||||||||||||||||||||||||||
Legal fees | 600 | |||||||||||||||||||||||||||||||||||||||
Accrued interest | 4,110 | |||||||||||||||||||||||||||||||||||||||
Amount received From Funds | $ 78,000 | |||||||||||||||||||||||||||||||||||||||
Other Fees | $ 2,000 | |||||||||||||||||||||||||||||||||||||||
Deposit Liabilities, Accrued Interest | 80,000 | 80,000 | ||||||||||||||||||||||||||||||||||||||
10% Convertible Promissory Note [Member] | Nov 27, 2019 note [Member] | ||||||||||||||||||||||||||||||||||||||||
Convertible Promissory Notes (Textual) | ||||||||||||||||||||||||||||||||||||||||
Convertible promissory note principal amount | $ 80,000 | |||||||||||||||||||||||||||||||||||||||
Convertible notes, interest rate | 10.00% | |||||||||||||||||||||||||||||||||||||||
Interest expense amount | $ 80,000 | |||||||||||||||||||||||||||||||||||||||
Debt instrument, maturity date description | The Nov Note matures on November 27, 2020. The Nov Note may be converted into shares of the Company's common stock at a conversion price of sixty-one (61%) percent of the lowest two (2) trading prices per common stock during the fifteen (15) trading day prior to the conversion date. | |||||||||||||||||||||||||||||||||||||||
Maturity date | Nov. 27, 2020 | |||||||||||||||||||||||||||||||||||||||
Issuance of common stock (in shares) | 26,579,747 | |||||||||||||||||||||||||||||||||||||||
Debt discount | $ 80,000 | 80,000 | ||||||||||||||||||||||||||||||||||||||
Legal fees | $ 300 | |||||||||||||||||||||||||||||||||||||||
Accrued interest | 4,011 | |||||||||||||||||||||||||||||||||||||||
Amount received From Funds | 78,000 | |||||||||||||||||||||||||||||||||||||||
Other Fees | 2,000 | |||||||||||||||||||||||||||||||||||||||
Deposit Liabilities, Accrued Interest | $ 80,000 | |||||||||||||||||||||||||||||||||||||||
10% Convertible Promissory Note [Member] | Feb 2020 Note [Member] | ||||||||||||||||||||||||||||||||||||||||
Convertible Promissory Notes (Textual) | ||||||||||||||||||||||||||||||||||||||||
Convertible promissory note principal amount | $ 80,000 | $ 80,000 | ||||||||||||||||||||||||||||||||||||||
Interest expense amount | $ 3,989 | |||||||||||||||||||||||||||||||||||||||
Debt instrument, maturity date description | The Feb 2020 Note had a maturity date of February 11, 2021. The Feb 2020 Note was convertible into shares of the Company’s common stock at a conversion price of sixty-one (61%) percent of the lowest two (2) trading prices per common stock during the fifteen (15) trading day prior to the conversion date. The conversion feature of the Feb 2020 Note was considered a derivative in accordance with current accounting guidelines because of the reset conversion features of the Feb 2020 Note. During the three months ended September 30, 2020, the Company issued 5,294,205 shares of common stock upon conversion of principal in the amount of $80,000, plus accrued interest of $3,989, and other fees of $300. The Company recorded amortization of debt discount, which was recognized as interest expense in the amount of $49,399 during the three months ended September 30, 2020. The Feb 2020 Note was fully converted as of September 30, 2020. On March 9, 2020, the Company issued a convertible promissory note (the “Mar 2020 Note”) to an investor, (the “Mar 2020 Note”) in the principal amount of $40,000. The Company received funds of $38,000, less other fees of $2,000. The Mar 2020 Note had a maturity date of March 9, 2021. The Mar 2020 Note was convertible into shares of the Company’s common stock at a conversion price of sixty-one (61%) percent of the lowest two (2) trading prices per common stock during the fifteen (15) trading day prior to the conversion date. The conversion feature of the Mar 2020 Note was considered a derivative in accordance with current accounting guidelines because of the reset conversion features of the Mar 2020 Note. During the three months ended September 30, 2020, the Company issued 2,390,871 shares of common stock upon conversion of principal in the amount of $40,000, plus accrued interest of $1,995, and other fees of $300. The Company recorded amortization of debt discount, which was recognized as interest expense in the amount of $25,708 during the three months ended September 30, 2020. The Mar 2020 Note was fully converted as of September 30, 2020. On April 14, 2020, the Company issued a convertible promissory note (the “April 2020 Note”) to an investor in the principal amount of $80,000. The Company received funds of $78,000, less other fees of $2,000. The April 2020 Note matures on April 14, 2021. The April 2020 Note may be converted into shares of the Company’s common stock at a conversion price of sixty-one (61%) percent of the average of the lowest two (2) trading prices per common stock during the fifteen (15) trading day prior to the conversion date. The conversion feature of the April 2020 Note was considered a derivative in accordance with current accounting guidelines because of the reset conversion features of the April 2020 Note. The Company recorded amortization of debt discount, which was recognized as interest expense in the amount of $20,164 during the three months ended September 30, 2020. The balance of the April 2020 Note as of September 30, 2020 was $80,000. On April 15, 2020, the Company issued a convertible promissory note (the “Apr 2020 Note”) to an investor in the aggregate principal amount of $50,000, of which the Company received $10,000 as of June 30, 2020. The Apr 2020 Note matures twelve (12) months from the effective dates of each respective tranche, such that the Apr 2020 Note matures on April 15, 2021, with an automatic extension of sixty (60) months from the effective date of each tranche. The Apr Note is convertible into shares of common stock of the Company at a price equal to a variable conversion price of the lesser of $0.01 per share or fifty percent (50%) of the lowest trading price of common stock recorded on any trade day after the effective date, or (c) the lowest effective price per share granted to any person or entity after the effective date to acquire common stock. If the Company fails to deliver shares in accordance with the timeframe of four (4) business days of the receipt of a notice of conversion, the lender, at any time prior to selling all of those shares, may rescind any portion, in whole or in part of that particular conversion attributable to the unsold shares and have the rescinded conversion amount returned to the principal sum with the rescinded conversion shares returned to the Company. In no event shall the lender be entitled to convert any portion of the Apr 2020 Note such that would result in beneficial ownership by the lender and its affiliates of more than 4.99% of the outstanding shares of common stock of the Company. In addition, for each conversion, in the event that shares are not delivered by the fourth business day (inclusive of the day of conversion), a penalty of $2,000 per day shall be assessed for each day after the fourth business day (inclusive of the day of the conversion) until the shares are delivered. The conversion feature of the April 2020 Note was considered a derivative in accordance with current accounting guidelines because of the reset conversion features of the Apr 2020 Note. The Company recorded amortization of debt discount, which was recognized as interest expense in the amount of $855 during the three months ended September 30, 2020. The balance of the Apr 2020 Note as of September 30, 2020 was $10,000. On May 19, 2020, the Company issued a convertible promissory note (the “May 2020 Note”) to an investor in the principal amount of $80,000. The Company received funds of $78,000, less other fees of $2,000. The May 2020 Note matures on May 19, 2021. The May 2020 Note may be converted into shares of the Company’s common stock at a conversion price of sixty-one (61%) percent of the lowest two (2) trading prices per common stock during the fifteen (15) trading day prior to the conversion date. | |||||||||||||||||||||||||||||||||||||||
Issuance of common stock (in shares) | 5,294,205 | |||||||||||||||||||||||||||||||||||||||
Convertible notes payable | $ 80,000 | |||||||||||||||||||||||||||||||||||||||
Amount received From Funds | $ 78,000 | |||||||||||||||||||||||||||||||||||||||
Deposit Liabilities, Accrued Interest | 3,989 | |||||||||||||||||||||||||||||||||||||||
Amortization of Debt Discount (Premium) | 49,399 | |||||||||||||||||||||||||||||||||||||||
10% Convertible Promissory Note [Member] | March 5, 2020 [Member] | ||||||||||||||||||||||||||||||||||||||||
Convertible Promissory Notes (Textual) | ||||||||||||||||||||||||||||||||||||||||
Convertible promissory note principal amount | $ 40,000 | |||||||||||||||||||||||||||||||||||||||
Interest expense amount | $ 1,995 | |||||||||||||||||||||||||||||||||||||||
Debt instrument, maturity date description | The April 2020 Note matures on April 14, 2021. The April 2020 Note may be converted into shares of the Company’s common stock at a conversion price of sixty-one (61%) percent of the average of the lowest two (2) trading prices per common stock during the fifteen (15) trading day prior to the conversion date. The conversion feature of the April 2020 Note was considered a derivative in accordance with current accounting guidelines because of the reset conversion features of the April 2020 Note. The Company recorded amortization of debt discount, which was recognized as interest expense in the amount of $20,164 during the three months ended September 30, 2020. The balance of the April 2020 Note as of September 30, 2020 was $80,000. On April 15, 2020, the Company issued a convertible promissory note (the “Apr 2020 Note”) to an investor in the aggregate principal amount of $50,000, of which the Company received $10,000 as of June 30, 2020. The Apr 2020 Note matures twelve (12) months from the effective dates of each respective tranche, such that the Apr 2020 Note matures on April 15, 2021, with an automatic extension of sixty (60) months from the effective date of each tranche. The Apr Note is convertible into shares of common stock of the Company at a price equal to a variable conversion price of the lesser of $0.01 per share or fifty percent (50%) of the lowest trading price of common stock recorded on any trade day after the effective date, or (c) the lowest effective price per share granted to any person or entity after the effective date to acquire common stock. If the Company fails to deliver shares in accordance with the timeframe of four (4) business days of the receipt of a notice of conversion, the lender, at any time prior to selling all of those shares, may rescind any portion, in whole or in part of that particular conversion attributable to the unsold shares and have the rescinded conversion amount returned to the principal sum with the rescinded conversion shares returned to the Company. In no event shall the lender be entitled to convert any portion of the Apr 2020 Note such that would result in beneficial ownership by the lender and its affiliates of more than 4.99% of the outstanding shares of common stock of the Company. In addition, for each conversion, in the event that shares are not delivered by the fourth business day (inclusive of the day of conversion), a penalty of $2,000 per day shall be assessed for each day after the fourth business day (inclusive of the day of the conversion) until the shares are delivered. The conversion feature of the April 2020 Note was considered a derivative in accordance with current accounting guidelines because of the reset conversion features of the Apr 2020 Note. The Company recorded amortization of debt discount, which was recognized as interest expense in the amount of $855 during the three months ended September 30, 2020. The balance of the Apr 2020 Note as of September 30, 2020 was $10,000. On May 19, 2020, the Company issued a convertible promissory note (the “May 2020 Note”) to an investor in the principal amount of $80,000. The Company received funds of $78,000, less other fees of $2,000. The May 2020 Note matures on May 19, 2021. The May 2020 Note may be converted into shares of the Company’s common stock at a conversion price of sixty-one (61%) percent of the lowest two (2) trading prices per common stock during the fifteen (15) trading day prior to the conversion date. | |||||||||||||||||||||||||||||||||||||||
Issuance of common stock (in shares) | 2,390,871 | |||||||||||||||||||||||||||||||||||||||
Convertible notes payable | $ 40,000 | |||||||||||||||||||||||||||||||||||||||
Amount received From Funds | $ 38,000 | |||||||||||||||||||||||||||||||||||||||
Deposit Liabilities, Accrued Interest | 1,995 | |||||||||||||||||||||||||||||||||||||||
Amortization of Debt Discount (Premium) | 25,708 | |||||||||||||||||||||||||||||||||||||||
10% Convertible Promissory Note [Member] | April 14, 2020 [Member] | ||||||||||||||||||||||||||||||||||||||||
Convertible Promissory Notes (Textual) | ||||||||||||||||||||||||||||||||||||||||
Convertible promissory note principal amount | $ 80,000 | $ 80,000 | 80,000 | |||||||||||||||||||||||||||||||||||||
Debt instrument, maturity date description | The April 2020 Note matures on April 14, 2021. The April 2020 Note may be converted into shares of the Company’s common stock at a conversion price of sixty-one (61%) percent of the average of the lowest two (2) trading prices per common stock during the fifteen (15) trading day prior to the conversion date. | |||||||||||||||||||||||||||||||||||||||
Amount received From Funds | $ 78,000 | |||||||||||||||||||||||||||||||||||||||
Amortization of Debt Discount (Premium) | 20,164 | |||||||||||||||||||||||||||||||||||||||
10% Convertible Promissory Note [Member] | April 15, 2020 [Member] | ||||||||||||||||||||||||||||||||||||||||
Convertible Promissory Notes (Textual) | ||||||||||||||||||||||||||||||||||||||||
Convertible promissory note principal amount | $ 50,000 | $ 50,000 | ||||||||||||||||||||||||||||||||||||||
Conversion price | $ 0.01 | $ 0.01 | ||||||||||||||||||||||||||||||||||||||
Percentage of trading price | 50.00% | |||||||||||||||||||||||||||||||||||||||
Debt instrument, maturity date description | The Apr 2020 Note matures twelve (12) months from the effective dates of each respective tranche, such that the Apr 2020 Note matures on April 15, 2021, with an automatic extension of sixty (60) months from the effective date of each tranche. | |||||||||||||||||||||||||||||||||||||||
Percentage of beneficial ownership | 4.99% | 4.99% | ||||||||||||||||||||||||||||||||||||||
Penalty amount | $ 2,000 | $ 2,000 | ||||||||||||||||||||||||||||||||||||||
Convertible notes payable | 10,000 | |||||||||||||||||||||||||||||||||||||||
Amount received From Funds | $ 10,000 | |||||||||||||||||||||||||||||||||||||||
Amortization of Debt Discount (Premium) | $ 855 | |||||||||||||||||||||||||||||||||||||||
10% Convertible Promissory Note [Member] | ConvertiblePromissoryMayOneNotesMember | ||||||||||||||||||||||||||||||||||||||||
Convertible Promissory Notes (Textual) | ||||||||||||||||||||||||||||||||||||||||
Convertible promissory note principal amount | $ 80,000 | 80,000 | $ 80,000 | 80,000 | ||||||||||||||||||||||||||||||||||||
Interest expense amount | 20,164 | 20,164 | ||||||||||||||||||||||||||||||||||||||
Debt instrument, maturity date description | The May 2020 Note matures on May 19, 2021. The May 2020 Note may be converted into shares of the Company’s common stock at a conversion price of sixty-one (61%) percent of the lowest two (2) trading prices per common stock during the fifteen (15) trading day prior to the conversion date. | |||||||||||||||||||||||||||||||||||||||
Maturity date | May 19, 2021 | |||||||||||||||||||||||||||||||||||||||
Amount received From Funds | $ 78,000 | |||||||||||||||||||||||||||||||||||||||
Deposit Liabilities, Accrued Interest | $ 20,164 | $ 20,164 | ||||||||||||||||||||||||||||||||||||||
10% Convertible Promissory Note [Member] | June 18, 2020 [Member] | ||||||||||||||||||||||||||||||||||||||||
Convertible Promissory Notes (Textual) | ||||||||||||||||||||||||||||||||||||||||
Convertible promissory note principal amount | $ 160,000 | 160,000 | $ 160,000 | |||||||||||||||||||||||||||||||||||||
Interest expense amount | $ 40,329 | 40,329 | ||||||||||||||||||||||||||||||||||||||
Debt instrument, maturity date description | The Jun 2020 Note matures on June 19, 2021. The Jun 2020 Note may be converted into shares of the Company’s common stock at a conversion price of sixty-one (61%) percent of the average of the lowest two (2) trading prices per common stock during the fifteen (15) trading day prior to the conversion date. | |||||||||||||||||||||||||||||||||||||||
Amount received From Funds | $ 156,000 | |||||||||||||||||||||||||||||||||||||||
Deposit Liabilities, Accrued Interest | $ 40,329 | $ 40,329 |
Derivative Liabilities (Details
Derivative Liabilities (Details) | 3 Months Ended | 12 Months Ended |
Sep. 30, 2020 | Jun. 30, 2020 | |
Derivative [Line Items] | ||
Expected dividend yield | ||
Minimum [Member] | ||
Derivative [Line Items] | ||
Risk free interest rate | 0.28% | 0.13% |
Stock volatility factor | 274.00% | 80.00% |
Weighted average expected option life | 3 months | 0 years |
Maximum [Member] | ||
Derivative [Line Items] | ||
Risk free interest rate | 0.12% | 0.22% |
Stock volatility factor | 150.00% | 267.00% |
Weighted average expected option life | 5 years | 5 years |
Derivative Liabilities (Detai_2
Derivative Liabilities (Details Textual) - USD ($) | 3 Months Ended | 12 Months Ended | |
Sep. 30, 2020 | Jun. 30, 2020 | Jun. 30, 2019 | |
Derivative Liabilities (Textual) | |||
Fair value of the derivative liability | $ 61,037,804 | $ 59,657,719 | $ 3,905,721 |
Net loss in change in derivative | $ 1,380,085 | 54,910,562 | |
Convertible Notes [Member] | |||
Derivative Liabilities (Textual) | |||
Convertible notes | $ 841,436 |
Common Stock Purchase Agreeme_2
Common Stock Purchase Agreements (Details) - USD ($) | Sep. 21, 2020 | Sep. 21, 2020 | Jul. 27, 2020 | Jul. 22, 2019 | Jan. 31, 2019 | Jan. 23, 2019 | Sep. 30, 2020 |
Common Stock Purchase Agreements (Details) [Line Items] | |||||||
Common stock purchase agreement, description | the Company issued 10,000,000 stock options, of which one-third (1/3) vest immediately, and the remaining shall vest one-twenty fourth (1/24) per month from after the date of the option grant. The options expire 10 years from the initial grant date. The options fully vested on July 22, 2020. | the Company issued 6,000,000 stock options, of which two-third (2/3) vest immediately, and the remaining amount shall vest one-twelfth (1/12) per month from after the date of the option grant. The options expire 10 years from the initial grant date. The options fully vested on January 31, 2020. | the Company issued 170,000,000 stock options. One-third of the options vested immediately, and the remainder vest 1/24 per month over the first twenty four months following the option grant. The options expire 10 years from the initial grant date. The options fully vest by January 23, 2022 | ||||
PurchaseAgreementOneMember | Investor [Member] | |||||||
Common Stock Purchase Agreements (Details) [Line Items] | |||||||
Purchase of common stock by investor | $ 4,000,000 | $ 300,000 | |||||
Common stock purchase agreement, description | the Company entered into a purchase agreement with an investor. Under the purchase agreement, the Company may sell, in its discretion (subject to the terms and conditions of the purchase agreement) up to an aggregate of $4,000,000 of common stock to the investor. The Company has the right, in its sole discretion, subject to the conditions and limitations in the purchase agreement, to direct the investor, by delivery of a purchase notice from time to time to purchase over the 6-month term of the purchase agreement, a minimum of $10,000 and up to a maximum of $400,000 of shares of common stock for each purchase notice (provided that, the purchase amount for any purchase will not exceed two times the average of the daily trading dollar volume of the common stock during the 10 business days preceding the purchase date). The number of purchase shares the Company will issue under each purchase will be equal to 112.5% of the purchase amount sold under such Purchase, divided by the purchase price per share (as defined under the purchase agreement). The “purchase price” is defined as 90% of the lowest end-of-day volume weighted average price of the common stock for the five consecutive business days immediately preceding the purchase date, including the purchase date. The Company may not deliver more than one purchase notice to the investor every ten business days, except as the parties may otherwise agree. | ||||||
Shares issued (in Shares) | 15,573,090 | ||||||
PurchaseAgreementOneMember | Minimum [Member] | Investor [Member] | |||||||
Common Stock Purchase Agreements (Details) [Line Items] | |||||||
Purchase of common stock by investor | $ 10,000 | ||||||
PurchaseAgreementOneMember | Maximum [Member] | Investor [Member] | |||||||
Common Stock Purchase Agreements (Details) [Line Items] | |||||||
Purchase of common stock by investor | $ 400,000 | ||||||
PurchaseAgreementMember | |||||||
Common Stock Purchase Agreements (Details) [Line Items] | |||||||
Common stock purchase agreement, description | The purchase price per share under the purchase agreement was 85% of the lowest closing price during the five (5) business days prior to closing, not to exceed the valuation cap set forth in the purchase agreement. During the three months ended September 30, 2020, the Company issued 20,000,000 shares of common stock at a purchase price of $0.025 per share under the purchase agreement. The Company received net proceeds of $460,350 after legal fees and commissions. | ||||||
PurchaseAgreementMember | Investor [Member] | |||||||
Common Stock Purchase Agreements (Details) [Line Items] | |||||||
Purchase of common stock by investor | $ 2 | $ 460,350 | |||||
Shares issued (in Shares) | 20,000,000 | ||||||
Share issued price per share (in Dollars per share) | $ 0.025 |
Deferred Tax Benefit (Details)
Deferred Tax Benefit (Details) - USD ($) | 12 Months Ended | |
Jun. 30, 2020 | Jun. 30, 2019 | |
Income Tax Disclosure [Abstract] | ||
Book income (loss) | $ (12,081,160) | $ 1,193,500 |
Non-deductible expenses | 11,950,635 | (1,520,850) |
Depreciation and amortization | 310 | 45 |
Related party accrual | 7,875 | (5,100) |
Valuation Allowance | 122,340 | 332,405 |
Income tax expense |
Deferred Tax Benefit (Details 1
Deferred Tax Benefit (Details 1) - USD ($) | Jun. 30, 2020 | Jun. 30, 2019 |
Deferred tax assets: | ||
NOL carryover | $ 1,571,210 | $ 2,070,125 |
Research and development | 104,500 | 92,490 |
Related party accrual | 44,465 | 52,275 |
Deferred tax liabilities: | ||
Depreciation and amortization | (3,610) | (5,340) |
Less Valuation Allowance | (1,716,565) | (2,209,550) |
Income tax expenses |
Deferred Tax Benefit (Details T
Deferred Tax Benefit (Details Textual) - USD ($) | 1 Months Ended | 12 Months Ended |
Jul. 02, 2018 | Jun. 30, 2020 | |
Deferred Tax Benefit (Textual) | ||
Net operating loss carry-forwards | $ 7,722,300 | |
Operating loss carry-forwards description | Expires in future years. | |
U.S. federal corporate income tax rate | 21.00% | |
Decrease in provision | $ 707,468 | |
Net adjustment of valuation allowance | $ 707,468 |
Commitments and Contingencies (
Commitments and Contingencies (Details) - USD ($) | Jun. 02, 2019 | Sep. 30, 2020 | Jun. 01, 2019 |
Commitments and Contingencies (Textual) | |||
Deposits paid | $ 26,250 | ||
Research agreement, description | The research agreement may be terminated by either party upon a sixty (60) day prior written notice or a material breach or default, which is not cured within 90 days of receipt of a written notice of such breach. | The Company entered into a research agreement with the University of Iowa. As consideration under the research agreement, the University of Iowa will receive a maximum of $299,966 from the Company. The research agreement may be terminated by either party upon a sixty (60) day prior written notice or a material breach or default, which is not cured within 90 days of receipt of a written notice of such breach. The term of the research agreement is from September 1, 2020 through August 31, 2020. As of September 30, 2020, the Company has accrued the amount due of $24, 997. | |
Maximum [Member] | |||
Commitments and Contingencies (Textual) | |||
Receive amount | $ 144,747 |
Related Party (Details)
Related Party (Details) - USD ($) | 3 Months Ended | 12 Months Ended |
Sep. 30, 2020 | Jun. 30, 2020 | |
Related Party Transactions [Abstract] | ||
Salary amount | $ 211,750 | $ 211,750 |
Subsequent Events (Details)
Subsequent Events (Details) - USD ($) | Dec. 01, 2020 | Nov. 12, 2020 | Nov. 10, 2020 | Oct. 27, 2020 | Oct. 16, 2020 | Oct. 07, 2020 | Oct. 05, 2020 | Sep. 01, 2020 | Jul. 15, 2020 | Jul. 14, 2020 | Jul. 13, 2020 | Dec. 28, 2020 | Sep. 21, 2020 | Sep. 11, 2020 | Sep. 04, 2020 | Aug. 12, 2020 | Jul. 27, 2020 | Sep. 30, 2020 | Sep. 30, 2019 | Jun. 30, 2020 | Jun. 30, 2019 |
Subsequent Events (Textual) | |||||||||||||||||||||
Common stock issued amount | $ 88,301 | $ 89,450 | $ 357,134 | $ 249,435 | |||||||||||||||||
Services value | 88,301 | 89,450 | 357,134 | 249,435 | |||||||||||||||||
Common Stock [Member] | |||||||||||||||||||||
Subsequent Events (Textual) | |||||||||||||||||||||
Common stock issued amount | $ 2,814 | $ 22,995 | $ 91,101 | $ 29,397 | |||||||||||||||||
Shares issued for services (in Shares) | 2,813,903 | 22,995,143 | 91,101,103 | 29,397,257 | |||||||||||||||||
Services value | $ 2,814 | $ 22,995 | $ 91,101 | $ 29,397 | |||||||||||||||||
Subsequent Event [Member] | |||||||||||||||||||||
Subsequent Events (Textual) | |||||||||||||||||||||
Common stock company issued | 53,615,458 | 5,315,949 | 5,294,205 | ||||||||||||||||||
Conversion of principal amount | $ 35,700 | $ 80,000 | |||||||||||||||||||
Common stock issued amount | $ 300,000 | $ 400,000 | $ 300,000 | $ 29,722 | |||||||||||||||||
Accrued interest | $ 15,235 | $ 4,011 | |||||||||||||||||||
Common stock purchase agreement, description | The Company entered into a securities purchase agreement with the purchaser set forth on the signature page thereto for the purchase and sale of an aggregate of 120,000,000 shares of the Company’s common stock and warrants to purchase an aggregate of up to 120,000,000 shares of common stock, in a registered direct offering at a combined purchase price of $0.075 per share and warrant, for aggregate gross proceeds to the Company of $9,000,000. | In consideration for the immediate exercise of the Prior Warrants for cash, the exercising investor received new unregistered warrants to purchase up to an aggregate of 132,000,000 shares of common stock (the “New Warrants”). The New Warrants have an exercise price of $0.075 per share, with an exercise period of three years from the date of issuance. The closing of the Exercise and issuance of the New Warrants occurred on December 29, 2020. The gross proceeds to the Company from the Exercise were $9.0 million, prior to deducting placement agent fees and offering expenses. | |||||||||||||||||||
Shares issued for services (in Shares) | 15,237,709 | 19,685,040 | 13,489,209 | 992,387 | |||||||||||||||||
Services value | $ 300,000 | $ 400,000 | $ 300,000 | $ 29,722 | |||||||||||||||||
Shares issued for principal amount (in Shares) | 53,615,458 | 5,315,949 | 5,294,205 | ||||||||||||||||||
Warrants, percentage | 7.00% | ||||||||||||||||||||
Aggregate of purchase shares | 8,400,000 | 120,000,000 | |||||||||||||||||||
Warrants exercise price | $ 0.0938 | $ 0.075 | |||||||||||||||||||
Subsequent Event [Member] | Maximum [Member] | |||||||||||||||||||||
Subsequent Events (Textual) | |||||||||||||||||||||
Research agreement, description | The research agreement may be terminated by either party upon sixty (60) days prior written notice or by either party upon notice of a material breach or default which is not cured within 90 days of receipt of written notice of such breach. This term of the research agreement runs through August 31, 2021, but may be extended upon mutual agreement of the parties. | ||||||||||||||||||||
Subsequent Event [Member] | Common Stock [Member] | |||||||||||||||||||||
Subsequent Events (Textual) | |||||||||||||||||||||
Common stock issued amount | $ 4,000,000 | ||||||||||||||||||||
Common stock purchase agreement, description | The Company has the right, in its sole discretion, subject to the conditions and limitations in the Purchase Agreement, to direct GHS, by delivery of a purchase notice from time to time (a "Purchase Notice") to purchase (each, a "Purchase") over the 6-month term of the Purchase Agreement, a minimum of $10,000 and up to a maximum of $400,000 (the "Purchase Amount") of shares of common stock (the "Purchase Shares") for each Purchase Notice (provided that, the Purchase Amount for any Purchase will not exceed two times the average of the daily trading dollar volume of the common stock during the 10 business days preceding the purchase date). The number of Purchase Shares we will issue under each Purchase will be equal to 112.5% of the Purchase Amount sold under such Purchase, divided by the Purchase Price per share (as defined under the Purchase Agreement). The "Purchase Price" is defined as 90% of the lowest end-of-day volume weighted average price of the common stock for the five consecutive business days immediately preceding the purchase date, including the purchase date. We may not deliver more than one Purchase Notice to GHS every ten business days, except as the parties may otherwise agree. | ||||||||||||||||||||
Percentage of net proceeds | 4.00% | ||||||||||||||||||||
Services value | $ 4,000,000 | ||||||||||||||||||||
Subsequent Event [Member] | Common stock six [Member] | |||||||||||||||||||||
Subsequent Events (Textual) | |||||||||||||||||||||
Common stock company issued | 48,802,884 | 1,047,679 | 23,420,128 | 2,390,871 | 929,546 | 836,678 | |||||||||||||||
Conversion of principal amount | $ 33,000 | $ 80,000 | $ 40,000 | $ 80,000 | |||||||||||||||||
Accrued interest | 3,989 | 1,995 | 3,989 | ||||||||||||||||||
Other fees | $ 13,363 | $ 300 | $ 300 | 300 | |||||||||||||||||
Amount for service | $ 29,335 | $ 29,699 | $ 29,267 | ||||||||||||||||||
Common stock purchase agreement, description | The Company entered into a common stock purchase agreement, whereby an investor purchased 20,000,000 shares of common stock at a purchase price of $0.025. | ||||||||||||||||||||
Shares issued for principal amount (in Shares) | 48,802,884 | 1,047,679 | 23,420,128 | 2,390,871 | 929,546 | 836,678 | |||||||||||||||
Subsequent Event [Member] | Warrant [Member] | |||||||||||||||||||||
Subsequent Events (Textual) | |||||||||||||||||||||
Warrants, percentage | 7.00% | ||||||||||||||||||||
Aggregate of purchase shares | 8,400,000 | ||||||||||||||||||||
Warrants exercise price | $ 0.0938 |